CINXE.COM
<!DOCTYPE html><html data-theme="light" class="light" lang="en" data-marquee="stopped"><head><meta charSet="utf-8" data-next-head=""/><meta name="viewport" content="width=device-width, initial-scale=1" data-next-head=""/><link rel="alternate" hrefLang="x-default" href="https://stocktwits.com/symbol/CADL" data-next-head=""/><title data-next-head="">Candel Therapeutics Inc (CADL) Stock Price Today, Quote, Latest Discussions, Interactive Chart and News</title><meta property="og:title" content="Candel Therapeutics Inc (CADL) Stock Price Today, Quote, Latest Discussions, Interactive Chart and News" data-next-head=""/><meta name="twitter:title" content="Candel Therapeutics Inc (CADL) Stock Price Today, Quote, Latest Discussions, Interactive Chart and News" data-next-head=""/><meta property="og:image:width" content="200" data-next-head=""/><meta property="og:image:height" content="200" data-next-head=""/><meta name="twitter:card" content="summary_large_image" data-next-head=""/><meta name="twitter:image" content="https://stocktwits.com/images/stocktwits-meta-image.png" data-next-head=""/><meta property="og:description" content="Track Candel Therapeutics Inc (CADL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors" data-next-head=""/><meta name="description" content="Track Candel Therapeutics Inc (CADL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors" data-next-head=""/><meta name="twitter:description" content="Track Candel Therapeutics Inc (CADL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors" data-next-head=""/><meta property="og:keywords" content="Candel Therapeutics Inc stock price, Candel Therapeutics Inc, CADL, CADL stock price today, CADL chart, CADL quote, CADL messages, CADL discussion, CADL community, CADL news, CADL message board" data-next-head=""/><meta name="keywords" content="Candel Therapeutics Inc stock price, Candel Therapeutics Inc, CADL, CADL stock price today, CADL chart, CADL quote, CADL messages, CADL discussion, CADL community, CADL news, CADL message board" data-next-head=""/><link rel="canonical" href="https://stocktwits.com/symbol/CADL" data-next-head=""/><script data-next-head="">window.performance.mark('chartiq-start');</script><script id="js-chartiq" type="module" async="" data-next-head="">import {CIQ} from '/_assets/stocktwits-chartiq-8.2.0-9c946a38/js/advanced.js';Object.assign(window,{CIQ});if(window.setChartiqJsStatus){window.setChartiqJsStatus(true)};</script><script id="corporation-schema" type="application/ld+json">{ "@context":"http://schema.org", "@type":"Corporation", "name":"CADL", "url":"https://stocktwits.com/symbol/CADL", "tickerSymbol": "CADL" }</script><script id="webpage-schema" type="application/ld+json">{ "@context":"http://schema.org", "description":"Track Candel Therapeutics Inc (CADL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors", "@type":"WebPage", "name":"Candel Therapeutics Inc (CADL) Stock Price Today, Quote, Latest Discussions, Interactive Chart and News", "url":"https://www.stocktwits.com/symbol/CADL", "speakable":{ "@type":"SpeakableSpecification", "cssSelector":["Title"] } }</script><script id="SiteNavigationElement" type="application/ld+json">{"@context":"https://schema.org","@type":"SiteNavigationElement","about":{"@type":"Thing","name":"Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA."},"hasPart":[{"@type":"SiteNavigationElement","name":"News","url":"https://stocktwits.com/symbol/CADL/news"},{"@type":"SiteNavigationElement","name":"Sentiment","url":"https://stocktwits.com/symbol/CADL/sentiment"},{"@type":"SiteNavigationElement","name":"About","url":"https://stocktwits.com/symbol/CADL/about"},{"@type":"SiteNavigationElement","name":"Earnings","url":"https://stocktwits.com/symbol/CADL/earnings"},{"@type":"SiteNavigationElement","name":"Fundamentals","url":"https://stocktwits.com/symbol/CADL/fundamentals"}],"mainEntityOfPage":{"@id":"https://stocktwits.com/symbol/CADL","@type":"WebPage"},"name":"Candel Therapeutics Inc","url":"https://stocktwits.com/symbol/CADL"}</script><script id="BreadcrumbListSchema" type="application/ld+json" data-next-head="">{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","item":"https://stocktwits.com/","name":"home","position":1},{"@type":"ListItem","item":"https://stocktwits.com/symbol","name":"Symbol","position":2},{"@type":"ListItem","name":"CADL","position":3}]}</script><meta name="apple-itunes-app" content="app-id=389157776"/><meta name="apple-mobile-web-app-title" content="Stocktwits"/><meta name="apple-mobile-web-app-capable" content="yes"/><meta name="HandheldFriendly" content="true"/><link rel="preconnect" href="//cdn.cookielaw.org"/><link rel="dns-prefetch" href="//cdn.cookielaw.org"/><link rel="preconnect" href="https://api.stocktwits.com/api/2/" crossorigin=""/><link rel="preconnect" href="https://ql.stocktwits.com/" crossorigin=""/><link rel="preconnect" href="https://a.pub.network/" crossorigin=""/><link rel="preconnect" href="https://b.pub.network/" crossorigin=""/><link rel="preconnect" href="https://c.pub.network/" crossorigin=""/><link rel="preconnect" href="https://d.pub.network/" crossorigin=""/><link rel="preconnect" href="https://c.amazon-adsystem.com" crossorigin=""/><link rel="preconnect" href="https://s.amazon-adsystem.com" crossorigin=""/><link rel="preload" as="script" href="https://securepubads.g.doubleclick.net/tag/js/gpt.js"/><link rel="preload" as="script" href="https://d3lcz8vpax4lo2.cloudfront.net/ads-code/6f83f478-eee3-4828-b55c-3385e33fc440.js"/><link rel="preconnect" href="https://btloader.com/" crossorigin=""/><link rel="preconnect" href="https://api.btloader.com/" crossorigin=""/><link rel="preconnect" href="https://confiant-integrations.global.ssl.fastly.net" crossorigin=""/><script id="js-consent-defaults" type="text/javascript" charSet="UTF-8"> // Define dataLayer and the gtag function. window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} // Default ad_storage to 'denied'. gtag('consent', 'default', { ad_storage: "granted", analytics_storage: "granted", functionality_storage: "granted", personalization_storage: "granted", security_storage: "granted", ad_user_data: "granted", ad_personalization: "granted", 'wait_for_update': 500 }); </script><script id="js-gtm-config" type="text/javascript" charSet="UTF-8">window.dataLayer.push({"userGroup":"Unregistered","userType":"Unregistered"})</script><script id="js-gtm-script" type="text/javascript" charSet="UTF-8"> (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-PW9TNB7'); </script><script id="js-onetrust-script" src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charSet="UTF-8" data-domain-script="bb67a836-2a23-4b28-ae7c-f69a7b7da25c"></script><script id="js-optanon-init" type="text/javascript">function OptanonWrapper() {}</script><script src="https://cdn.cookielaw.org/opt-out/otCCPAiab.js" type="text/javascript" charSet="UTF-8" ccpa-opt-out-ids="C0004" ccpa-opt-out-geo="us" ccpa-opt-out-lspa="true"></script><script id="js-pbjs-init" type="text/javascript">var pbjs = pbjs || {}; pbjs.que = pbjs.que || []; pbjs.que.push(function() { pbjs.setConfig({ consentManagement: { gdpr: { cmpApi: 'iab', allowAuctionWithoutConsent: false, timeout: 3000 }, } }); }); </script><script async="" src="https://scripts.webcontentassessor.com/scripts/6c1ba5ce9e1f02fc3536a598c46ccac36d5cdd2f907847c1ad0b2aa6a4917f03" type="application/javascript"></script><script src="https://chunks-prd.stocktwits-cdn.com/js/asc.stocktwits.js" async=""></script><script type="text/javascript">window.googletag = window.googletag || {cmd: []}; googletag.cmd.push(function() { googletag.pubads().setTargeting('domain', window.location.hostname); googletag.pubads().setTargeting('path', window.location.pathname); googletag.pubads().setTargeting('env', 'production'); })</script><script async="" defer="" src="https://launchpad-wrapper.privacymanager.io/e031648f-6de6-4093-9197-8082b9e79535/launchpad-liveramp.js"></script><link rel="dns-prefetch" href="https://api.stocktwits.com/api/2/"/><link rel="dns-prefetch" href="https://ql.stocktwits.com/"/><link rel="dns-prefetch" href="https://charts.stocktwits-cdn.com/cdn-cgi/image/"/><link rel="dns-prefetch" href="https://sih-st-charts.stocktwits-cdn.com/"/><link rel="dns-prefetch" href="https://avatars.stocktwits-cdn.com/cdn-cgi/image/"/><link rel="dns-prefetch" href="https://sih-st-avatars.stocktwits-cdn.com/"/><link rel="dns-prefetch" href="//fonts.googleapis.com"/><link rel="dns-prefetch" href="//live.primis.tech"/><link rel="dns-prefetch" href="//ads.pubmatic.com"/><link rel="dns-prefetch" href="//securepubads.g.doubleclick.net"/><link rel="preload" as="font" href="/_assets/a3a5f5442fc38e545ed15708628baa15/fonts/source-sans-pro-v19-latin-ext_latin-600.woff2" crossorigin="anonymous"/><link rel="preload" as="font" href="/_assets/a3a5f5442fc38e545ed15708628baa15/fonts/source-sans-pro-v19-latin-ext_latin-700.woff2" crossorigin="anonymous"/><link rel="preload" as="font" href="/_assets/a3a5f5442fc38e545ed15708628baa15/fonts/source-sans-pro-v19-latin-ext_latin-regular.woff2" crossorigin="anonymous"/><link rel="apple-touch-icon" sizes="180x180" href="/apple-touch-icon.png"/><link rel="icon" href="/favicon.png?cb=1713811200000"/><link rel="icon" href="/favicon-16x16.png?cb=1713811200000" sizes="16x16"/><link rel="icon" href="/favicon-32x32.png?cb=1713811200000" sizes="32x32"/><meta property="og:site_name" content="Stocktwits"/><meta property="og:type" content="article"/><meta name="Author" content="StockTwits Inc (stocktwits.com)"/><meta name="Copyright" content="StockTwits"/><meta name="application-name" content="Stocktwits"/><meta name="google-site-verification" content="aKYidXr1_551Wb1zJeekLePBo4681p_VKVnkFKPehkw"/><meta name="y_key" content="80f3fdc8ba1b0d33"/><meta name="msvalidate.01" content="C1713B1F6321F08D4DB6862D229ACDFE"/><meta property="fb:admins" content="687256873"/><meta property="fb:app_id" content="138643396152005"/><style type="text/css">@font-face{font-display:swap;font-family:"Source Sans Pro";font-style:normal;font-weight:400;src:url(/_assets/a3a5f5442fc38e545ed15708628baa15/fonts/source-sans-pro-v19-latin-ext_latin-regular.woff2)format("woff2"),url(/_assets/a3a5f5442fc38e545ed15708628baa15/fonts/source-sans-pro-v19-latin-ext_latin-regular.woff)format("woff")}@font-face{font-display:swap;font-family:"Source Sans Pro";font-style:normal;font-weight:600;src:url(/_assets/a3a5f5442fc38e545ed15708628baa15/fonts/source-sans-pro-v19-latin-ext_latin-600.woff2)format("woff2"),url(/_assets/a3a5f5442fc38e545ed15708628baa15/fonts/source-sans-pro-v19-latin-ext_latin-600.woff)format("woff")}@font-face{font-display:swap;font-family:"Source Sans Pro";font-style:normal;font-weight:700;src:url(/_assets/a3a5f5442fc38e545ed15708628baa15/fonts/source-sans-pro-v19-latin-ext_latin-700.woff2)format("woff2"),url(/_assets/a3a5f5442fc38e545ed15708628baa15/fonts/source-sans-pro-v19-latin-ext_latin-700.woff)format("woff")}</style><script> var _sift = window._sift = window._sift || []; _sift.push(['_setAccount', 'a8a3203b2d']); _sift.push(['_setSessionId', 'df47592002a62a127a0ba27d7be2c6c68957ba185f66a4236949a71eb2fb74dd']); _sift.push(['_trackPageview']); (function() { function ls() { var e = document.createElement('script'); e.src = 'https://cdn.siftscience.com/s.js'; document.body.appendChild(e); } if (window.attachEvent) { window.attachEvent('onload', ls); } else { window.addEventListener('load', ls, false); } })(); </script><script>try{window.sessionStorage.sid='df47592002a62a127a0ba27d7be2c6c68957ba185f66a4236949a71eb2fb74dd'}catch(e){}</script><script id="js-mparticle" type="text/javascript"> window.mParticle = { config: { isDevelopmentMode: false } }; (function(t){window.mParticle=window.mParticle||{};window.mParticle.EventType={Unknown:0,Navigation:1,Location:2,Search:3,Transaction:4,UserContent:5,UserPreference:6,Social:7,Other:8};window.mParticle.eCommerce={Cart:{}};window.mParticle.Identity={};window.mParticle.config=window.mParticle.config||{};window.mParticle.config.rq=[];window.mParticle.config.snippetVersion=2.2;window.mParticle.ready=function(t){window.mParticle.config.rq.push(t)};var e=["endSession","logError","logBaseEvent","logEvent","logForm","logLink","logPageView","setSessionAttribute","setAppName","setAppVersion","setOptOut","setPosition","startNewSession","startTrackingLocation","stopTrackingLocation"];var o=["setCurrencyCode","logCheckout"];var i=["identify","login","logout","modify"];e.forEach(function(t){window.mParticle[t]=n(t)});o.forEach(function(t){window.mParticle.eCommerce[t]=n(t,"eCommerce")});i.forEach(function(t){window.mParticle.Identity[t]=n(t,"Identity")});function n(e,o){return function(){if(o){e=o+"."+e}var t=Array.prototype.slice.call(arguments);t.unshift(e);window.mParticle.config.rq.push(t)}}var mp=document.createElement("script");mp.type="text/javascript";mp.async=true;mp.src="https://stocktwits.com/_next/static/mparticle.js";var c=document.getElementsByTagName("script")[0];c.parentNode.insertBefore(mp,c)})('d2903ad31ed42949872c8a9470b8049e'); </script><script src="https://btloader.com/tag?o=5070086696337408&upapi=true" async=""></script><link rel="preload" href="https://chunks-prd.stocktwits-cdn.com/_next/static/css/a3a4b17e93685877.css" as="style" crossorigin="anonymous"/><link rel="stylesheet" href="https://chunks-prd.stocktwits-cdn.com/_next/static/css/a3a4b17e93685877.css" crossorigin="anonymous" data-n-g=""/><link rel="preload" href="https://chunks-prd.stocktwits-cdn.com/_next/static/css/1c6cb702022e3b09.css" as="style" crossorigin="anonymous"/><link rel="stylesheet" href="https://chunks-prd.stocktwits-cdn.com/_next/static/css/1c6cb702022e3b09.css" crossorigin="anonymous" data-n-p=""/><link rel="preload" href="https://chunks-prd.stocktwits-cdn.com/_next/static/css/2e89a5a947d4b5ab.css" as="style" crossorigin="anonymous"/><link rel="stylesheet" href="https://chunks-prd.stocktwits-cdn.com/_next/static/css/2e89a5a947d4b5ab.css" crossorigin="anonymous"/><link rel="preload" href="https://chunks-prd.stocktwits-cdn.com/_next/static/css/cb2350e6ffe08844.css" as="style" crossorigin="anonymous"/><link rel="stylesheet" href="https://chunks-prd.stocktwits-cdn.com/_next/static/css/cb2350e6ffe08844.css" crossorigin="anonymous"/><link rel="preload" href="https://chunks-prd.stocktwits-cdn.com/_next/static/css/ed21aa710bfff723.css" as="style" crossorigin="anonymous"/><link rel="stylesheet" href="https://chunks-prd.stocktwits-cdn.com/_next/static/css/ed21aa710bfff723.css" crossorigin="anonymous"/><link rel="preload" href="https://chunks-prd.stocktwits-cdn.com/_next/static/css/05abc6706463db5b.css" as="style" crossorigin="anonymous"/><link rel="stylesheet" href="https://chunks-prd.stocktwits-cdn.com/_next/static/css/05abc6706463db5b.css" crossorigin="anonymous"/><link rel="preload" href="https://chunks-prd.stocktwits-cdn.com/_next/static/css/ef46db3751d8e999.css" as="style" crossorigin="anonymous"/><link rel="stylesheet" href="https://chunks-prd.stocktwits-cdn.com/_next/static/css/ef46db3751d8e999.css" crossorigin="anonymous"/><link rel="preload" href="https://chunks-prd.stocktwits-cdn.com/_next/static/css/34184c5330ac4c67.css" as="style" crossorigin="anonymous"/><link rel="stylesheet" href="https://chunks-prd.stocktwits-cdn.com/_next/static/css/34184c5330ac4c67.css" crossorigin="anonymous"/><noscript data-n-css=""></noscript><script defer="" crossorigin="anonymous" nomodule="" src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/polyfills-42372ed130431b0a.js"></script><script defer="" src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/17-7e208b40f101f554.js" crossorigin="anonymous"></script><script defer="" src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/7545.da5e6c1b145406c3.js" crossorigin="anonymous"></script><script defer="" src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/8489-7a1feb15283a4a96.js" crossorigin="anonymous"></script><script defer="" src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/3150.bfa15466c8e4fa17.js" crossorigin="anonymous"></script><script defer="" src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/702.acda99e15e619e7e.js" crossorigin="anonymous"></script><script defer="" src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/9465.b025348158277ee3.js" crossorigin="anonymous"></script><script defer="" src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/1499.50b2f37849bd0adf.js" crossorigin="anonymous"></script><script defer="" src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/8195.a4e7d5deeaf20a6d.js" crossorigin="anonymous"></script><script src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/webpack-61f0aec386deef5a.js" defer="" crossorigin="anonymous"></script><script src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/framework-dd253615bf3bcf2d.js" defer="" crossorigin="anonymous"></script><script src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/main-c14603b4733418bc.js" defer="" crossorigin="anonymous"></script><script src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/pages/_app-129d146f82598fcb.js" defer="" crossorigin="anonymous"></script><script src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/9768-161cc5b6baef68d3.js" defer="" crossorigin="anonymous"></script><script src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/2501-112b21b896197216.js" defer="" crossorigin="anonymous"></script><script src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/5294-4f373b62cb8db634.js" defer="" crossorigin="anonymous"></script><script src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/29-1165e58320352062.js" defer="" crossorigin="anonymous"></script><script src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/4149-e6059e1077e999f5.js" defer="" crossorigin="anonymous"></script><script src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/4901-d70edce39a744cd5.js" defer="" crossorigin="anonymous"></script><script src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/2563-d332687ceedc697e.js" defer="" crossorigin="anonymous"></script><script src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/2304-8113566d9c69efca.js" defer="" crossorigin="anonymous"></script><script src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/1403-158dbe6e758831bf.js" defer="" crossorigin="anonymous"></script><script src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/1256-97651c22ab0827f4.js" defer="" crossorigin="anonymous"></script><script src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/5964-5d2e5b4558502510.js" defer="" crossorigin="anonymous"></script><script src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/2598-7f399d2a9089cf58.js" defer="" crossorigin="anonymous"></script><script src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/1741-c60ddcb585989ce6.js" defer="" crossorigin="anonymous"></script><script src="https://chunks-prd.stocktwits-cdn.com/_next/static/chunks/pages/symbol/%5Bsymbol%5D/%5B%5B...tab%5D%5D-90f9e10b29a0114e.js" defer="" crossorigin="anonymous"></script><script src="https://chunks-prd.stocktwits-cdn.com/_next/static/WXsZwB9OA8hIuXCTVBkbf/_buildManifest.js" defer="" crossorigin="anonymous"></script><script src="https://chunks-prd.stocktwits-cdn.com/_next/static/WXsZwB9OA8hIuXCTVBkbf/_ssgManifest.js" defer="" crossorigin="anonymous"></script></head><body class="bg-primary-background !mt-0 symbol-active-tab-feed"><div id="__next"><div class="bg-primary-background"><div class="Layout_layoutContainer__NH7Il flex flex-row min-h-screen desktopXxl|mx-auto Layout_layoutBorder__qMIMd bg-primary-background border-x tabletSm-down|border-x-0 border-primary-hairline" id="Layout"><div class="Sidebar_sidebarContainer__ctxbC tabletSm-down|hidden h-full min-h-screen top-0 z-40 fixed bg-primary-background" data-testid="sidebar-container"></div><div class="Main_mainContainer__Pzz7u Main_main__3C253 min-h-screen w-full"><div class="MainHeader_mainHeader__L2Fez top-0 tabletMd-down|left-0 tabletMd-down|right-0 z-25 fixed bg-primary-background border-b border-primary-hairline tabletSm|dark|border-l tabletMd|border-l tabletSm-down|border-x-0 MainHeader_mainHeaderBorder__RIXJZ border-r border-primary-hairline" id="app-main-header"><div class="MainHeader_mobileHeaderContainer___mWoe tabletMd|hidden"><div class="MobileHeader_container__jMTt_ relative text-primary-text border-b border-primary-hairline tabletMd-down|h-[52px] h-full"><nav class="MobileHeader_nav__T_c0N w-full h-full flex flex-row justify-between pr-2 items-center"><span><button class="MobileHeader_navButton__g0EGn MobileHeader_navButtonBase__w6cJF h-[50px] flex justify-center items-center cursor-pointer w-[50px]"><svg width="100%" height="100%" viewBox="0 0 12 10" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="MobileHeader_icon__kG_Ap w-[17px] h-[13px]"><path d="M1 1.3999H18.8" stroke="currentColor" stroke-width="1.2" stroke-linecap="round"></path><path d="M1 9.3999H18.8" stroke="currentColor" stroke-width="1.2" stroke-linecap="round"></path></svg></button></span><div class="flex flex-row justify-between items-center flex"><a class="STButton_md__qsWaf text-[15px] px-5 gap-2 STButton_button__ObG_J h-[--size] inline-flex flex-row items-center justify-center border rounded-full font-semibold whitespace-nowrap STButton_black-secondary__xIxs1 bg-white text-black border-secondary-button-border dark|bg-transparent dark|text-white hover|!bg-light-grey-6 dark|hover|!bg-dark-grey-5 MobileHeader_useAppButton__x8iPf !h-[32px] !w-[100px] px-4 my-auto font-semibold mr-2" role="button" tabindex="0" type="button" href="https://stocktwits.onelink.me/NjIT/geja8ly0"><svg aria-hidden="true" focusable="false" data-prefix="far" data-icon="mobile" class="svg-inline--fa fa-mobile MobileHeader_mobileIcon__tLrIo w-[17px] h-[13px] pr-1" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512"><path fill="currentColor" d="M80 48c-8.8 0-16 7.2-16 16V448c0 8.8 7.2 16 16 16H304c8.8 0 16-7.2 16-16V64c0-8.8-7.2-16-16-16H80zM16 64C16 28.7 44.7 0 80 0H304c35.3 0 64 28.7 64 64V448c0 35.3-28.7 64-64 64H80c-35.3 0-64-28.7-64-64V64zM160 400h64c8.8 0 16 7.2 16 16s-7.2 16-16 16H160c-8.8 0-16-7.2-16-16s7.2-16 16-16z"></path></svg>Use App</a><button class="MobileHeader_navMenuButton__521co MobileHeader_navButtonBase__w6cJF h-[50px] flex justify-center items-center cursor-pointer w-[35px]"><svg aria-hidden="true" focusable="false" data-prefix="fal" data-icon="magnifying-glass" class="svg-inline--fa fa-magnifying-glass " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M384 208A176 176 0 1 0 32 208a176 176 0 1 0 352 0zM343.3 366C307 397.2 259.7 416 208 416C93.1 416 0 322.9 0 208S93.1 0 208 0S416 93.1 416 208c0 51.7-18.8 99-50 135.3L507.3 484.7c6.2 6.2 6.2 16.4 0 22.6s-16.4 6.2-22.6 0L343.3 366z"></path></svg></button></div></nav><div class="MobileHeader_center__l_JVA absolute top-2/4 left-2/4 transform -translate-x-2/4 -translate-y-2/4 text-primary-text flex justify-center items-end cursor-pointer"><span class="absolute opacity-0 pointer-events-none">Stocktwits</span><a title="Stocktwits" class="MobileHeader_logoLink__1wldO block w-full h-full p-2" href="/"><svg width="100%" height="100%" viewBox="0 0 32 28" fill="none" xmlns="http://www.w3.org/2000/svg"><g clip-path="url(#clip0_8680_547)"><path fill-rule="evenodd" clip-rule="evenodd" d="M8.43835 0.374634H29.818V0.375255C31.4269 0.375255 32.333 1.62625 31.8327 3.15452L26.4417 19.6217C26.0621 20.7813 24.7526 21.7307 23.532 21.7307H17.8413L7.84361 27.9106L9.86606 21.7307H2.15224C0.54355 21.7307 -0.36256 20.4797 0.13772 18.9514L5.52869 2.48361C5.90831 1.32401 7.21782 0.374634 8.43835 0.374634ZM20.3165 2.59513L18.82 4.5743C17.9663 4.57338 17.2605 4.57175 16.7138 4.57048C16.5421 4.5701 16.386 4.56971 16.2461 4.56945C13.0738 4.56089 10.8185 7.35907 11.7039 9.81416C12.0889 11.1591 13.6515 11.7941 14.8779 12.2925L14.8964 12.2999C15.1545 12.4046 15.3971 12.503 15.6099 12.6013C16.1784 12.8481 15.9633 13.6945 15.3424 13.6982C14.2449 13.7085 8.19588 13.7311 8.19588 13.7311L5.4818 17.3202H9.2007L7.70839 19.2933H11.4273L12.9196 17.3202H13.1469C13.4144 17.3214 13.691 17.3281 13.9738 17.3354C15.4795 17.3732 17.1339 17.414 18.2636 16.673C20.1472 15.5853 20.7169 13.6921 20.2672 12.0761H20.2666C19.8816 10.7305 18.319 10.0955 17.0926 9.59715L17.0604 9.58409C16.8081 9.48152 16.5703 9.3849 16.3612 9.28828C15.7927 9.04086 16.0078 8.19569 16.6287 8.19143C17.7262 8.18107 23.7752 8.15854 23.7752 8.15854L26.4893 4.56945C25.0463 4.57247 23.7265 4.5743 22.5389 4.57492L24.0366 2.59513H20.3165Z" fill="currentColor"></path></g><defs><clipPath id="clip0_8680_547"><rect width="32" height="28" fill="white"></rect></clipPath></defs></svg></a></div></div></div><div class="MainHeader_desktopHeaderContainer__sKsDd hidden tabletMd|block border-primary-hairline border-b"><div class="DesktopHeader_container__4nFE3 flex flex-row justify-between items-center h-[50px] gap-x-5 tabletXxl|gap-x-8 px-5 max-w-[1340px]"><div class="w-full"><div class="DesktopHeader_search__9FdhP relative z-10 w-full max-w-[400px] min-w-[360px] DesktopHeader_transition__0b3LE transition-all duration-150 ease-in-out"></div></div><div class="DesktopHeader_nav___J3Kw flex flex-row justify-end items-center"><ul class="SiteNav_navbar__LXGWZ flex flex-row justify-end gap-x-[32px]"><li class="SiteNav_navbarLink__dEMWl SiteNav_link__n2uAf items-center text-primary-text inline-flex justify-between tabletMd-down|mr-5 tabletMd-down|border-b tabletMd-down|border-sitenav-border SiteNav_linkWithFontSize__K1HuW text-[13px]" data-testid="markets-site-nav-link"><a class="SiteNav_linkText__Bgfr8 tabletSm|text-right block" href="/sentiment">Trending</a></li><li class="SiteNav_navbarLink__dEMWl SiteNav_link__n2uAf items-center text-primary-text inline-flex justify-between tabletMd-down|mr-5 tabletMd-down|border-b tabletMd-down|border-sitenav-border SiteNav_linkWithFontSize__K1HuW text-[13px]"><a class="SiteNav_linkText__Bgfr8 tabletSm|text-right block" href="/news-articles">News</a></li><li class="SiteNav_navbarLink__dEMWl SiteNav_link__n2uAf items-center text-primary-text inline-flex justify-between tabletMd-down|mr-5 tabletMd-down|border-b tabletMd-down|border-sitenav-border SiteNav_linkWithFontSize__K1HuW text-[13px]"><a class="SiteNav_linkText__Bgfr8 tabletSm|text-right block" href="/sentiment/calendar">Earnings</a></li><li class="SiteNav_navbarLink__dEMWl SiteNav_link__n2uAf items-center text-primary-text inline-flex justify-between tabletMd-down|mr-5 tabletMd-down|border-b tabletMd-down|border-sitenav-border SiteNav_linkWithFontSize__K1HuW text-[13px]"><a class="SiteNav_linkText__Bgfr8 tabletSm|text-right block" target="_blank" href="https://www.stocktwits.com/newsletters">Newsletters</a></li><li class="SiteNav_navbarLink__dEMWl SiteNav_link__n2uAf items-center text-primary-text inline-flex justify-between tabletMd-down|mr-5 tabletMd-down|border-b tabletMd-down|border-sitenav-border SiteNav_linkWithFontSize__K1HuW text-[13px]"><a class="SiteNav_linkText__Bgfr8 tabletSm|text-right block" target="_blank" href="https://stocktwits.com/about/contact/?subject=Advertising%20Inquiries">Advertise</a></li></ul></div></div></div><div class="MainHeader_secondaryHeaderContainer__G0oQ4 border-t-0"><div class="Trending_containerThin__lOpNq Trending_container__6jqOE flex items-center justify-between overflow-hidden whitespace-nowrap font-semibold text-xs tabletSm|py-2.5 py-2.5" data-testid="trending-view"><div class="whitespace-pre-wrap"></div><div class="Trending_indicesShort__K_CXM flex flex-row items-center justify-between tabletSm|justify-between pl-5 pr-4 tabletSm-down|uppercase tabletSm-down|grow Trending_indicesShortUS__nOSfR w-[260px] Trending_disabledMarquee__6ilIf"><a class="Trending_ticker__j67AD pl-[11px] first|pl-0 first|mr-2" href="/symbol/DIA"><div class="Trending_tickerLabel__4iKnb flex gap-x-1 text-primary-text"><span class="Trending_tickerName__Qgolo tabletMd-down|inline-block tabletMd-down|mr-0.25">DIA</span><span class="Trending_tickerChange__n6QUj block h-[16px]"><span class="Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green" aria-label="Change"><span class="Change_arrow__AjLH9 relative flex items-center Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green text-[9px]" role="presentation"><svg aria-hidden="true" focusable="false" data-prefix="fas" data-icon="arrow-up-long" class="svg-inline--fa fa-arrow-up-long " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512"><path fill="currentColor" d="M214.6 9.4c-12.5-12.5-32.8-12.5-45.3 0l-128 128c-12.5 12.5-12.5 32.8 0 45.3s32.8 12.5 45.3 0L160 109.3V480c0 17.7 14.3 32 32 32s32-14.3 32-32V109.3l73.4 73.4c12.5 12.5 32.8 12.5 45.3 0s12.5-32.8 0-45.3l-128-128z"></path></svg></span><span class="Change_amount__l5O_n whitespace-nowrap" aria-label="Change">1.46%</span></span></span></div></a><a class="Trending_ticker__j67AD pl-[11px] first|pl-0 first|mr-2" href="/symbol/SPY"><div class="Trending_tickerLabel__4iKnb flex gap-x-1 text-primary-text"><span class="Trending_tickerName__Qgolo tabletMd-down|inline-block tabletMd-down|mr-0.25">SPY</span><span class="Trending_tickerChange__n6QUj block h-[16px]"><span class="Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green" aria-label="Change"><span class="Change_arrow__AjLH9 relative flex items-center Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green text-[9px]" role="presentation"><svg aria-hidden="true" focusable="false" data-prefix="fas" data-icon="arrow-up-long" class="svg-inline--fa fa-arrow-up-long " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512"><path fill="currentColor" d="M214.6 9.4c-12.5-12.5-32.8-12.5-45.3 0l-128 128c-12.5 12.5-12.5 32.8 0 45.3s32.8 12.5 45.3 0L160 109.3V480c0 17.7 14.3 32 32 32s32-14.3 32-32V109.3l73.4 73.4c12.5 12.5 32.8 12.5 45.3 0s12.5-32.8 0-45.3l-128-128z"></path></svg></span><span class="Change_amount__l5O_n whitespace-nowrap" aria-label="Change">1.95%</span></span></span></div></a><a class="Trending_ticker__j67AD pl-[11px] first|pl-0 first|mr-2" href="/symbol/QQQ"><div class="Trending_tickerLabel__4iKnb flex gap-x-1 text-primary-text"><span class="Trending_tickerName__Qgolo tabletMd-down|inline-block tabletMd-down|mr-0.25">QQQ</span><span class="Trending_tickerChange__n6QUj block h-[16px]"><span class="Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green" aria-label="Change"><span class="Change_arrow__AjLH9 relative flex items-center Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green text-[9px]" role="presentation"><svg aria-hidden="true" focusable="false" data-prefix="fas" data-icon="arrow-up-long" class="svg-inline--fa fa-arrow-up-long " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512"><path fill="currentColor" d="M214.6 9.4c-12.5-12.5-32.8-12.5-45.3 0l-128 128c-12.5 12.5-12.5 32.8 0 45.3s32.8 12.5 45.3 0L160 109.3V480c0 17.7 14.3 32 32 32s32-14.3 32-32V109.3l73.4 73.4c12.5 12.5 32.8 12.5 45.3 0s12.5-32.8 0-45.3l-128-128z"></path></svg></span><span class="Change_amount__l5O_n whitespace-nowrap" aria-label="Change">2.33%</span></span></span></div></a></div><div class="Trending_trending__DXWES tabletSm-down|flex w-full flex-row grow-[2] gap-x-[15px] pr-6 border-l border-primary-hairline contents tabletSm-down|hidden"><div class="flex flex-row justify-between items-center mr-2"><div class="Trending_trendingLabel__2JYHk tabletSm-down|hidden uppercase tabletSm|flex items-center Trending_updatedTrendingLabel__nZod8 text-[9px]"><span>Trending</span><svg aria-hidden="true" focusable="false" data-prefix="far" data-icon="circle-info" class="svg-inline--fa fa-circle-info Disclosures_icon__sUHXX ml-1 cursor-pointer !text-[12px]" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M256 48a208 208 0 1 1 0 416 208 208 0 1 1 0-416zm0 464A256 256 0 1 0 256 0a256 256 0 1 0 0 512zM216 336c-13.3 0-24 10.7-24 24s10.7 24 24 24h80c13.3 0 24-10.7 24-24s-10.7-24-24-24h-8V248c0-13.3-10.7-24-24-24H216c-13.3 0-24 10.7-24 24s10.7 24 24 24h24v64H216zm40-144a32 32 0 1 0 0-64 32 32 0 1 0 0 64z"></path></svg></div></div><div class="flex"><div class="Trending_tickers__QRjxC flex mr-2 Trending_disabledMarquee__6ilIf"><a class="Trending_ticker__j67AD pl-[11px] first|pl-0 first|mr-2" href="/symbol/ALT"><div class="Trending_tickerLabel__4iKnb flex gap-x-1 text-primary-text"><img alt="Top trending ticker" class="inline" height="12" src="https://chunks-prd.stocktwits-cdn.com/_next/static/media/hot.d13a6f1f.svg" width="10"/><span class="Trending_tickerName__Qgolo tabletMd-down|inline-block tabletMd-down|mr-0.25">ALT</span><span class="Trending_tickerChange__n6QUj block h-[16px]"><span class="Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green" aria-label="Change"><span class="Change_arrow__AjLH9 relative flex items-center Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green text-[9px]" role="presentation"><svg aria-hidden="true" focusable="false" data-prefix="fas" data-icon="arrow-up-long" class="svg-inline--fa fa-arrow-up-long " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512"><path fill="currentColor" d="M214.6 9.4c-12.5-12.5-32.8-12.5-45.3 0l-128 128c-12.5 12.5-12.5 32.8 0 45.3s32.8 12.5 45.3 0L160 109.3V480c0 17.7 14.3 32 32 32s32-14.3 32-32V109.3l73.4 73.4c12.5 12.5 32.8 12.5 45.3 0s12.5-32.8 0-45.3l-128-128z"></path></svg></span><span class="Change_amount__l5O_n whitespace-nowrap" aria-label="Change">15.54%</span></span></span></div></a><a class="Trending_ticker__j67AD pl-[11px] first|pl-0 first|mr-2" href="/symbol/4CHAN.X"><div class="Trending_tickerLabel__4iKnb flex gap-x-1 text-primary-text"><span class="Trending_tickerName__Qgolo tabletMd-down|inline-block tabletMd-down|mr-0.25">4CHAN.X</span><span class="Trending_tickerChange__n6QUj block h-[16px]"><span class="Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green" aria-label="Change"><span class="Change_arrow__AjLH9 relative flex items-center Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green text-[9px]" role="presentation"><svg aria-hidden="true" focusable="false" data-prefix="fas" data-icon="arrow-up-long" class="svg-inline--fa fa-arrow-up-long " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512"><path fill="currentColor" d="M214.6 9.4c-12.5-12.5-32.8-12.5-45.3 0l-128 128c-12.5 12.5-12.5 32.8 0 45.3s32.8 12.5 45.3 0L160 109.3V480c0 17.7 14.3 32 32 32s32-14.3 32-32V109.3l73.4 73.4c12.5 12.5 32.8 12.5 45.3 0s12.5-32.8 0-45.3l-128-128z"></path></svg></span><span class="Change_amount__l5O_n whitespace-nowrap" aria-label="Change">0.10%</span></span></span></div></a><a class="Trending_ticker__j67AD pl-[11px] first|pl-0 first|mr-2" href="/symbol/XRP.X"><div class="Trending_tickerLabel__4iKnb flex gap-x-1 text-primary-text"><span class="Trending_tickerName__Qgolo tabletMd-down|inline-block tabletMd-down|mr-0.25">XRP.X</span><span class="Trending_tickerChange__n6QUj block h-[16px]"><span class="Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green" aria-label="Change"><span class="Change_arrow__AjLH9 relative flex items-center Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green text-[9px]" role="presentation"><svg aria-hidden="true" focusable="false" data-prefix="fas" data-icon="arrow-up-long" class="svg-inline--fa fa-arrow-up-long " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512"><path fill="currentColor" d="M214.6 9.4c-12.5-12.5-32.8-12.5-45.3 0l-128 128c-12.5 12.5-12.5 32.8 0 45.3s32.8 12.5 45.3 0L160 109.3V480c0 17.7 14.3 32 32 32s32-14.3 32-32V109.3l73.4 73.4c12.5 12.5 32.8 12.5 45.3 0s12.5-32.8 0-45.3l-128-128z"></path></svg></span><span class="Change_amount__l5O_n whitespace-nowrap" aria-label="Change">6.88%</span></span></span></div></a><a class="Trending_ticker__j67AD pl-[11px] first|pl-0 first|mr-2" href="/symbol/MUX"><div class="Trending_tickerLabel__4iKnb flex gap-x-1 text-primary-text"><span class="Trending_tickerName__Qgolo tabletMd-down|inline-block tabletMd-down|mr-0.25">MUX</span><span class="Trending_tickerChange__n6QUj block h-[16px]"><span class="Change_negative__3Cz_W Change_container__GNa_f inline-flex gap-1 text-red" aria-label="Change"><span class="Change_arrow__AjLH9 relative flex items-center Change_negative__3Cz_W Change_container__GNa_f inline-flex gap-1 text-red text-[9px]" role="presentation"><svg aria-hidden="true" focusable="false" data-prefix="fas" data-icon="arrow-down-long" class="svg-inline--fa fa-arrow-down-long " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512"><path fill="currentColor" d="M169.4 502.6c12.5 12.5 32.8 12.5 45.3 0l128-128c12.5-12.5 12.5-32.8 0-45.3s-32.8-12.5-45.3 0L224 402.7 224 32c0-17.7-14.3-32-32-32s-32 14.3-32 32l0 370.7L86.6 329.4c-12.5-12.5-32.8-12.5-45.3 0s-12.5 32.8 0 45.3l128 128z"></path></svg></span><span class="Change_amount__l5O_n whitespace-nowrap" aria-label="Change">3.34%</span></span></span></div></a><a class="Trending_ticker__j67AD pl-[11px] first|pl-0 first|mr-2" href="/symbol/AVXL"><div class="Trending_tickerLabel__4iKnb flex gap-x-1 text-primary-text"><span class="Trending_tickerName__Qgolo tabletMd-down|inline-block tabletMd-down|mr-0.25">AVXL</span><span class="Trending_tickerChange__n6QUj block h-[16px]"><span class="Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green" aria-label="Change"><span class="Change_arrow__AjLH9 relative flex items-center Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green text-[9px]" role="presentation"><svg aria-hidden="true" focusable="false" data-prefix="fas" data-icon="arrow-up-long" class="svg-inline--fa fa-arrow-up-long " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512"><path fill="currentColor" d="M214.6 9.4c-12.5-12.5-32.8-12.5-45.3 0l-128 128c-12.5 12.5-12.5 32.8 0 45.3s32.8 12.5 45.3 0L160 109.3V480c0 17.7 14.3 32 32 32s32-14.3 32-32V109.3l73.4 73.4c12.5 12.5 32.8 12.5 45.3 0s12.5-32.8 0-45.3l-128-128z"></path></svg></span><span class="Change_amount__l5O_n whitespace-nowrap" aria-label="Change">5.18%</span></span></span></div></a><a class="Trending_ticker__j67AD pl-[11px] first|pl-0 first|mr-2" href="/symbol/QBTS"><div class="Trending_tickerLabel__4iKnb flex gap-x-1 text-primary-text"><span class="Trending_tickerName__Qgolo tabletMd-down|inline-block tabletMd-down|mr-0.25">QBTS</span><span class="Trending_tickerChange__n6QUj block h-[16px]"><span class="Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green" aria-label="Change"><span class="Change_arrow__AjLH9 relative flex items-center Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green text-[9px]" role="presentation"><svg aria-hidden="true" focusable="false" data-prefix="fas" data-icon="arrow-up-long" class="svg-inline--fa fa-arrow-up-long " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512"><path fill="currentColor" d="M214.6 9.4c-12.5-12.5-32.8-12.5-45.3 0l-128 128c-12.5 12.5-12.5 32.8 0 45.3s32.8 12.5 45.3 0L160 109.3V480c0 17.7 14.3 32 32 32s32-14.3 32-32V109.3l73.4 73.4c12.5 12.5 32.8 12.5 45.3 0s12.5-32.8 0-45.3l-128-128z"></path></svg></span><span class="Change_amount__l5O_n whitespace-nowrap" aria-label="Change">45.02%</span></span></span></div></a><a class="Trending_ticker__j67AD pl-[11px] first|pl-0 first|mr-2" href="/symbol/GTBIF"><div class="Trending_tickerLabel__4iKnb flex gap-x-1 text-primary-text"><span class="Trending_tickerName__Qgolo tabletMd-down|inline-block tabletMd-down|mr-0.25">GTBIF</span><span class="Trending_tickerChange__n6QUj block h-[16px]"><span class="Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green" aria-label="Change"><span class="Change_arrow__AjLH9 relative flex items-center Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green text-[9px]" role="presentation"><svg aria-hidden="true" focusable="false" data-prefix="fas" data-icon="arrow-up-long" class="svg-inline--fa fa-arrow-up-long " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512"><path fill="currentColor" d="M214.6 9.4c-12.5-12.5-32.8-12.5-45.3 0l-128 128c-12.5 12.5-12.5 32.8 0 45.3s32.8 12.5 45.3 0L160 109.3V480c0 17.7 14.3 32 32 32s32-14.3 32-32V109.3l73.4 73.4c12.5 12.5 32.8 12.5 45.3 0s12.5-32.8 0-45.3l-128-128z"></path></svg></span><span class="Change_amount__l5O_n whitespace-nowrap" aria-label="Change">1.17%</span></span></span></div></a><a class="Trending_ticker__j67AD pl-[11px] first|pl-0 first|mr-2" href="/symbol/TGTX"><div class="Trending_tickerLabel__4iKnb flex gap-x-1 text-primary-text"><span class="Trending_tickerName__Qgolo tabletMd-down|inline-block tabletMd-down|mr-0.25">TGTX</span><span class="Trending_tickerChange__n6QUj block h-[16px]"><span class="Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green" aria-label="Change"><span class="Change_arrow__AjLH9 relative flex items-center Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green text-[9px]" role="presentation"><svg aria-hidden="true" focusable="false" data-prefix="fas" data-icon="arrow-up-long" class="svg-inline--fa fa-arrow-up-long " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512"><path fill="currentColor" d="M214.6 9.4c-12.5-12.5-32.8-12.5-45.3 0l-128 128c-12.5 12.5-12.5 32.8 0 45.3s32.8 12.5 45.3 0L160 109.3V480c0 17.7 14.3 32 32 32s32-14.3 32-32V109.3l73.4 73.4c12.5 12.5 32.8 12.5 45.3 0s12.5-32.8 0-45.3l-128-128z"></path></svg></span><span class="Change_amount__l5O_n whitespace-nowrap" aria-label="Change">10.59%</span></span></span></div></a><a class="Trending_ticker__j67AD pl-[11px] first|pl-0 first|mr-2" href="/symbol/PRO.X"><div class="Trending_tickerLabel__4iKnb flex gap-x-1 text-primary-text"><span class="Trending_tickerName__Qgolo tabletMd-down|inline-block tabletMd-down|mr-0.25">PRO.X</span><span class="Trending_tickerChange__n6QUj block h-[16px]"><span class="Change_negative__3Cz_W Change_container__GNa_f inline-flex gap-1 text-red" aria-label="Change"><span class="Change_arrow__AjLH9 relative flex items-center Change_negative__3Cz_W Change_container__GNa_f inline-flex gap-1 text-red text-[9px]" role="presentation"><svg aria-hidden="true" focusable="false" data-prefix="fas" data-icon="arrow-down-long" class="svg-inline--fa fa-arrow-down-long " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512"><path fill="currentColor" d="M169.4 502.6c12.5 12.5 32.8 12.5 45.3 0l128-128c12.5-12.5 12.5-32.8 0-45.3s-32.8-12.5-45.3 0L224 402.7 224 32c0-17.7-14.3-32-32-32s-32 14.3-32 32l0 370.7L86.6 329.4c-12.5-12.5-32.8-12.5-45.3 0s-12.5 32.8 0 45.3l128 128z"></path></svg></span><span class="Change_amount__l5O_n whitespace-nowrap" aria-label="Change">6.08%</span></span></span></div></a><a class="Trending_ticker__j67AD pl-[11px] first|pl-0 first|mr-2" href="/symbol/KSPI"><div class="Trending_tickerLabel__4iKnb flex gap-x-1 text-primary-text"><span class="Trending_tickerName__Qgolo tabletMd-down|inline-block tabletMd-down|mr-0.25">KSPI</span><span class="Trending_tickerChange__n6QUj block h-[16px]"><span class="Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green" aria-label="Change"><span class="Change_arrow__AjLH9 relative flex items-center Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green text-[9px]" role="presentation"><svg aria-hidden="true" focusable="false" data-prefix="fas" data-icon="arrow-up-long" class="svg-inline--fa fa-arrow-up-long " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512"><path fill="currentColor" d="M214.6 9.4c-12.5-12.5-32.8-12.5-45.3 0l-128 128c-12.5 12.5-12.5 32.8 0 45.3s32.8 12.5 45.3 0L160 109.3V480c0 17.7 14.3 32 32 32s32-14.3 32-32V109.3l73.4 73.4c12.5 12.5 32.8 12.5 45.3 0s12.5-32.8 0-45.3l-128-128z"></path></svg></span><span class="Change_amount__l5O_n whitespace-nowrap" aria-label="Change">0.66%</span></span></span></div></a></div></div><div class="mr-2"><a class="Trending_more__C6Qly tabletSm-down|hidden flex font-normal items-center gap-1 bg-primary-background text-primary-text" data-testid="trending-view-more-button" href="/sentiment/trending">More<svg aria-hidden="true" focusable="false" data-prefix="fas" data-icon="chevron-right" class="svg-inline--fa fa-chevron-right Trending_moreIcon__D_foA tabletSm-down|hidden text-primary-text text-xxs" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 320 512"><path fill="currentColor" d="M310.6 233.4c12.5 12.5 12.5 32.8 0 45.3l-192 192c-12.5 12.5-32.8 12.5-45.3 0s-12.5-32.8 0-45.3L242.7 256 73.4 86.6c-12.5-12.5-12.5-32.8 0-45.3s32.8-12.5 45.3 0l192 192z"></path></svg></a></div></div></div></div></div><div class="Body_container__f_XJ0 flex flex-column desktopXxl|pr-0 Body_containerBorder__3T8GJ border-primary-hairline border-l tabletSm-down|border-x-0"><div class="Body_content__07Yri w-full max-w-[980px] tabletMd-down|max-w-none"><div class="SymbolPage_container__tRK07 tabletMd|max-w-[970px] w-full grid gap-2.5"><div class="SymbolPage_symbolPageBorder__gg8Gr border-primary-hairline border-r"><div class="SymbolPageHero_container__P6ghF mb-2.5 tabletSm-down|mb-0 tabletSm|p-2.5 tabletMd|p-0 tabletMd|mb-2.5 tabletMd|max-w-[660px]"><div></div><div class="Pod_container__AI83J bg-primary-background text-primary-text rounded-md"><div class="flex flex-row justify-start items-center Breadcrumbs_breadcrumbs__Rczip gap-2 tabletSm-down|gap-1 tabletSm-down|text-xxs h-8 px-4 tabletSm|px-5 text-st-tertiary-text text-xs w-full border-primary-hairline border-b whitespace-nowrap overflow-x-auto scrollbar-hidden"><a href="/"><span class="Breadcrumbs_breadcrumbsLink__sisdv hover|underline hover|text-st-primary-text cursor-pointer capitalize shrink-0">home</span></a><svg aria-hidden="true" focusable="false" data-prefix="far" data-icon="chevron-right" class="svg-inline--fa fa-chevron-right fa-sm Breadcrumbs_chevronRight__Ifb18 mx-1 pt-[1px]" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 320 512"><path fill="currentColor" d="M305 239c9.4 9.4 9.4 24.6 0 33.9L113 465c-9.4 9.4-24.6 9.4-33.9 0s-9.4-24.6 0-33.9l175-175L79 81c-9.4-9.4-9.4-24.6 0-33.9s24.6-9.4 33.9 0L305 239z"></path></svg><a href="/symbol"><span class="Breadcrumbs_breadcrumbsLink__sisdv hover|underline hover|text-st-primary-text cursor-pointer capitalize shrink-0">Symbol</span></a><svg aria-hidden="true" focusable="false" data-prefix="far" data-icon="chevron-right" class="svg-inline--fa fa-chevron-right fa-sm Breadcrumbs_chevronRight__Ifb18 mx-1 pt-[1px]" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 320 512"><path fill="currentColor" d="M305 239c9.4 9.4 9.4 24.6 0 33.9L113 465c-9.4 9.4-24.6 9.4-33.9 0s-9.4-24.6 0-33.9l175-175L79 81c-9.4-9.4-9.4-24.6 0-33.9s24.6-9.4 33.9 0L305 239z"></path></svg><span class="capitalize">CADL</span></div><div class="SymbolPageHero_head__SRDI5 SymbolPageHero_grid__xbZvk grid tabletSm|px-5 tabletSm|py-2"><div class="SymbolPageHero_lede__LS_6R"><div class="SymbolInfo_container__wI07q flex flex-col"><div class="SymbolInfo_content__n_HwR"><div class="SymbolInfo_info__AFfk4 flex justify-between tabletMd|items-center tabletSm-down|px-4"><div class="SymbolLede_container__tlm6Y w-full flex flex-row items-center justify-between pb-2"><h1><div class="flex flex-row justify-start items-center gap-x-2 py-0.5"><span class="SymbolLede_label__SmBPZ block font-bold !text-[17px] leading-[22px] tabletSm-down|pt-2" data-testid="symbol-text">CADL </span></div><span class="SymbolLede_title__O8aWL block text-tertiary-text text-xs font-normal tabletSm-down|max-w-[200px]">Candel Therapeutics Inc</span></h1><div class="SymbolLede_buttons__frYVl flex flex-row gap-2 items-center tabletMd-down|mt-2.5"><div class="SymbolLede_watch__R83q9 flex"><div class="SymbolWatchers_container__5vi3I flex items-center gap-3"><span class="SymbolWatchers_watchers__sp1FU tabletSm-down|hidden inline-flex gap-1.5 items-center text-xs"><svg fill="none" height="100%" viewBox="0 0 12 12" width="100%" xmlns="http://www.w3.org/2000/svg" class="SymbolWatchers_icon__w3PFN w-[10px] h-[10px]"><circle cx="6" cy="3" r="2" stroke="currentcolor"></circle><path d="M1 11.5C1.62805 9.18934 3.62886 7.5 6 7.5C8.37114 7.5 10.3719 9.18934 11 11.5" stroke="currentcolor"></path></svg>6,683</span></div></div></div></div></div><div class="SymbolInfo_pricing__UbjwC pt-1 border-t border-primary-hairline flex justify-between items-center relative"></div><div class="SymbolInfo_pricing__UbjwC pt-1 border-t border-primary-hairline flex justify-between items-center relative border-none"><div class="SymbolPricing_container__7FqjG relative flex flex-row justify-between items-center w-full tabletSm|w-auto tabletSm-down|px-4"><div class="SymbolPricing_priceContainer__6OFmu"><div class="SymbolPricing_amountContainer__Hx2b0 flex flex-col gap-x-2"><div class="SymbolPricing_updatedAmountFont__3N7up text-[35px] font-normal SymbolPricing_amount__UX8jT text-[35px] leading-10 font-light mb-1 h-[36px]">$8.75</div><div class="SymbolPricing_changeContainer__lBLyv text-[13px] flex flex-row gap-x-1 mb-1 h-[17px] leading-[17px]"><span class="SymbolPricing_change__DzzzZ whitespace-nowrap"><span class="Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green" aria-label="Change"><div class="flex flex-row justify-between items-end gap-0.5"><div class="flex flex-row justify-between items-center gap-1"><span class="Change_arrow__AjLH9 relative flex items-center Change_positive__2H4d1 Change_container__GNa_f inline-flex gap-1 text-green" role="presentation"><svg aria-hidden="true" focusable="false" data-prefix="fas" data-icon="arrow-up-long" class="svg-inline--fa fa-arrow-up-long " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 384 512"><path fill="currentColor" d="M214.6 9.4c-12.5-12.5-32.8-12.5-45.3 0l-128 128c-12.5 12.5-12.5 32.8 0 45.3s32.8 12.5 45.3 0L160 109.3V480c0 17.7 14.3 32 32 32s32-14.3 32-32V109.3l73.4 73.4c12.5 12.5 32.8 12.5 45.3 0s12.5-32.8 0-45.3l-128-128z"></path></svg></span><span data-testid="stock-price-change">$0.81</span></div><div class="flex flex-row justify-between items-center gap-1"><span data-testid="stock-price-percent-change"> (10.20%)</span></div></div></span></span><span>Today</span></div></div></div><div><table class="SymbolPricingFundamentals_container__a5E1m text-xs text-dark-grey flex flex-col tabletSm|hidden"><tbody><tr class="SymbolPricingFundamentals_row__eVoxP flex justify-between"><td class="SymbolPricingFundamentals_title__ojEt4 mr-2">Watchers</td><td>6,683</td></tr></tbody></table></div></div></div></div></div></div></div><div class="flex flex-col justify-between items-center cursor-pointer FundamentalsDataSummary_container__riWEH mt-4 mx-5 px-4 tabletSm-down|mx-4 tabletSm-down|px-4 py-2 mb-4 border border-primary-border rounded-lg FundamentalsDataSummary_hoverState__sUhGl hover|bg-light-grey-6-rgba-50 dark|hover|bg-dark-grey-5 cursor-pointer"><div class="flex flex-row justify-between items-center w-full"><div class="flex flex-row justify-around items-center w-full"><div><div class="flex flex-col justify-between items-center"><span class="FundamentalsDataSummary_itemTitle__Z1vQw text-xs text-st-secondary-text">Mkt Cap</span><span class="FundamentalsDataSummary_itemValue__NfAfA text-sm">$389.16M</span></div></div><div><div class="flex flex-col justify-between items-center"><span class="FundamentalsDataSummary_itemTitle__Z1vQw text-xs text-st-secondary-text">Volume</span><span class="FundamentalsDataSummary_itemValue__NfAfA text-sm">1.02M</span></div></div><div><div class="flex flex-col justify-between items-center"><span class="FundamentalsDataSummary_itemTitle__Z1vQw text-xs text-st-secondary-text">52W High</span><span class="FundamentalsDataSummary_itemValue__NfAfA text-sm">$14.60</span></div></div><div><div class="flex flex-col justify-between items-center"><span class="FundamentalsDataSummary_itemTitle__Z1vQw text-xs text-st-secondary-text">52W Low</span><span class="FundamentalsDataSummary_itemValue__NfAfA text-sm">$1.34</span></div></div><div class="tabletSm-down|hidden"><div class="flex flex-col justify-between items-center"><span class="FundamentalsDataSummary_itemTitle__Z1vQw text-xs text-st-secondary-text">PE Ratio</span><span class="FundamentalsDataSummary_itemValue__NfAfA text-sm">-4.99</span></div></div></div><svg aria-hidden="true" focusable="false" data-prefix="fas" data-icon="chevron-down" class="svg-inline--fa fa-chevron-down FundamentalsDataSummary_chevron__jnhnT w-[12px] ml-5" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M233.4 406.6c12.5 12.5 32.8 12.5 45.3 0l192-192c12.5-12.5 12.5-32.8 0-45.3s-32.8-12.5-45.3 0L256 338.7 86.6 169.4c-12.5-12.5-32.8-12.5-45.3 0s-12.5 32.8 0 45.3l192 192z"></path></svg></div></div><div><div><div id="symbol-page-hero-tabs" class="react-tabs__tab-list Tab_reactTabList__DlGgm border-t !h-10 border-primary-hairline text-tertiary-text SymbolPageHero_symbolPageHeroTabs__s3VCs justify-around bg-legacy-white-four dark|bg-tertiary-background"><div data-cy="about-tab" class="react-tabs__tab Tab_reactTab__AN_bb relative border-b-2 border-transparent bg-primary-background SymbolPageHero_tab___OATW !bg-emphasized-tab-background SymbolPageHero_tab-about__lvD4w"><div class="SymbolPageHero_noPadding__dFwEA"><a href="/symbol/CADL/about" class="Tab_text__yKwPe text-sm font-semibold"><h2 class="SymbolPageHero_label__pWp6i font-semibold text-[13px] h-[17px] leading-[17px]">About</h2></a></div></div><span></span><div data-cy="feed-tab" class="react-tabs__tab Tab_reactTab__AN_bb relative border-b-2 border-transparent bg-primary-background SymbolPageHero_tab___OATW !bg-emphasized-tab-background SymbolPageHero_tab-feed__TPjt2"><div class="SymbolPageHero_noPadding__dFwEA"><a href="/symbol/CADL" class="Tab_text__yKwPe text-sm font-semibold"><h2 class="SymbolPageHero_label__pWp6i font-semibold text-[13px] h-[17px] leading-[17px]">Feed</h2></a></div></div><span></span><div data-cy="news-tab" class="react-tabs__tab Tab_reactTab__AN_bb relative border-b-2 border-transparent bg-primary-background SymbolPageHero_tab___OATW !bg-emphasized-tab-background SymbolPageHero_tab-news__2_yPc"><div class="SymbolPageHero_noPadding__dFwEA"><a href="/symbol/CADL/news" class="Tab_text__yKwPe text-sm font-semibold"><h2 class="SymbolPageHero_label__pWp6i font-semibold text-[13px] h-[17px] leading-[17px]">News</h2></a></div></div><span></span><div data-cy="sentiment-tab" class="react-tabs__tab Tab_reactTab__AN_bb relative border-b-2 border-transparent bg-primary-background SymbolPageHero_tab___OATW !bg-emphasized-tab-background SymbolPageHero_tab-sentiment__rTL7t"><div class="SymbolPageHero_noPadding__dFwEA"><a href="/symbol/CADL/sentiment" class="Tab_text__yKwPe text-sm font-semibold"><h2 class="SymbolPageHero_label__pWp6i font-semibold text-[13px] h-[17px] leading-[17px]">Sentiment</h2></a></div></div><span></span><div data-cy="earnings-tab" class="react-tabs__tab Tab_reactTab__AN_bb relative border-b-2 border-transparent bg-primary-background SymbolPageHero_tab___OATW !bg-emphasized-tab-background SymbolPageHero_tab-earnings__XxMb3"><div class="SymbolPageHero_noPadding__dFwEA"><a href="/symbol/CADL/earnings" class="Tab_text__yKwPe text-sm font-semibold"><h2 class="SymbolPageHero_label__pWp6i font-semibold text-[13px] h-[17px] leading-[17px]">Earnings</h2></a></div></div><span></span><div data-cy="fundamentals-tab" class="react-tabs__tab Tab_reactTab__AN_bb relative border-b-2 border-transparent bg-primary-background SymbolPageHero_tab___OATW !bg-emphasized-tab-background SymbolPageHero_tab-fundamentals__n0pH9"><div class="SymbolPageHero_noPadding__dFwEA"><a href="/symbol/CADL/fundamentals" class="Tab_text__yKwPe text-sm font-semibold"><h2 class="SymbolPageHero_label__pWp6i font-semibold text-[13px] h-[17px] leading-[17px]">Fundamentals</h2></a></div></div><span></span></div><div><div class="SymbolPageHero_tabContent__OXeMQ hidden SymbolPageHero_aboutContent__rfdc4"></div><div class="SymbolPageHero_tabContent__OXeMQ hidden SymbolPageHero_feedContent__hrN9a"><div class="SymbolPageHero_fullViewContainer__4dxkj SymbolPageHero_mediaContainer__ht6Wg grid min-h-[304px]" data-cy="symbol-page-hero-media"><script id="table-schema" type="application/ld+json">{ "@context": "https://schema.org", "@type": "Table", "about": "CADL Fundamentals" }</script><span itemscope="" itemType="https://schema.org/DataFeed"><meta itemProp="name" content="Candel Therapeutics Inc (CADL) Stock Price Today, Quote, Latest Discussions, Interactive Chart and News"/><meta itemProp="description" content="Track Candel Therapeutics Inc (CADL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors"/><meta itemProp="keywords" content="Candel Therapeutics Inc stock price, Candel Therapeutics Inc, CADL, CADL stock price today, CADL chart, CADL quote, CADL messages, CADL discussion, CADL community, CADL news, CADL message board"/><meta itemProp="dateModified" content="03/14/2025, 03:59:13 PM EDT"/><span itemType="https://schema.org/DataFeedItem" itemscope="" itemProp="dataFeedElement"><meta itemProp="dateModified" content="03/14/2025, 03:59:13 PM EDT"/><span itemscope="" itemProp="item" itemType="https://schema.org/Thing"><meta itemProp="name" content="Last Price"/><meta itemProp="sameAs" content="https://stocktwits.com/symbol/CADL"/></span></span></span><div class="Chart_container__B5j4Y relative w-full pt-10 pb-2 tabletMd|min-w-[503px]"><div class="Loading_loading__e823d flex justify-center items-center Chart_loading__8LWA_ Chart_overlay__a7uEa absolute inset-0 flex items-center justify-center backdrop-filter backdrop-blur-sm" style="height:322px"><span class="Loading_loadingIcon__k8BrD flex justify-center items-center"><svg aria-hidden="true" focusable="false" data-prefix="fal" data-icon="spinner-third" class="svg-inline--fa fa-spinner-third " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M463.9 376c7.6 4.4 17.5 1.8 21.4-6.1c17.1-34.3 26.7-73 26.7-113.9C512 120 405.9 8.8 272 .5c-8.8-.5-16 6.7-16 15.5s7.2 15.9 16 16.6C388.2 40.8 480 137.7 480 256c0 35.1-8.1 68.3-22.5 97.9c-3.9 8-1.3 17.7 6.4 22.1z"></path></svg></span></div></div></div></div><div class="SymbolPageHero_tabContent__OXeMQ hidden SymbolPageHero_feedContent__hrN9a"></div><div class="SymbolPageHero_tabContent__OXeMQ hidden SymbolPageHero_feedContent__hrN9a"></div><div class="SymbolPageHero_tabContent__OXeMQ hidden SymbolPageHero_earningsContent__7UNcV"></div><div class="SymbolPageHero_tabContent__OXeMQ hidden SymbolPageHero_sentimentContent__nVVMH"></div><div class="SymbolPageHero_tabContent__OXeMQ hidden SymbolPageHero_fundamentalsContent__0Q3Cr"></div><div class="SymbolPageHero_tabContent__OXeMQ hidden SymbolPageHero_newsContent__IqYuY"></div></div></div></div></div></div><div class="SymbolPage_discussion__QZZgN"></div><div class="SymbolPage_feedContainer__9RhsB tabletSm|bg-primary-background tabletMd|bg-transparent"><div class="SymbolPage_feedGrid__faEen h-full tabletSm|mx-auto tabletMd|mx-0 max-w-[660px] mx-auto"><div><div id="symbol-page-above-streams-line" role="presentation"></div><div></div></div></div></div></div><div class="SymbolPage_sidebar__BMi4v tabletSm-down|hidden flex flex-col gap-2.5"><div role="presentation"><div class="NewsBucketCompact_container__w_DxG relative bg-primary-background text-primary-text overflow-hidden rounded-md pb-2 NewsBucketCompact_containerBorder__XpYYs border-primary-hairline border"><div class="NewsBucketCompactHeader_container__bYeeJ pt-4 pb-2 px-4 w-full flex justify-between items-center bg-primary-background text-primary-text text-sm"><h2 class="NewsBucketCompactHeader_title__PrvOb font-semibold">Latest CADL News</h2><a class="NewsBucketCompactHeader_more__8_psJ cursor-pointer" href="/symbol/CADL/news">View<svg aria-hidden="true" focusable="false" data-prefix="far" data-icon="chevron-right" class="svg-inline--fa fa-chevron-right NewsBucketCompactHeader_icon__TttqM ml-1 text-xxs" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 320 512"><path fill="currentColor" d="M305 239c9.4 9.4 9.4 24.6 0 33.9L113 465c-9.4 9.4-24.6 9.4-33.9 0s-9.4-24.6 0-33.9l175-175L79 81c-9.4-9.4-9.4-24.6 0-33.9s24.6-9.4 33.9 0L305 239z"></path></svg></a></div></div></div><div class="flex items-center justify-center"><div class="Primis_container__OlMHR overflow-hidden relative SymbolPage_primis__YHE0l invisible tabletMd|visible"><div class="flex flex-col"><div style="height:169px;width:300px"><div role="presentation"></div></div><p class="Disclosure_disclosure__GmLV4 Disclosure_disclosureCompact__7OUvM mx-auto text-center text-tertiary-text text-[10px] leading-[16px] pb-3">Advertisement.<span> <a class="Disclosure_removeAdsLink__3yG8W text-primary-text underline cursor-pointer" href="/subscriptions">Remove ads.</a></span></p></div></div></div><div class="relative Insticator_adClass__aZKoy min-h-[250px] z-1 leading-none"><div class="BackgroundLoaderAd_container__BFoDY overflow-hidden text-dark-grey-2 dark|text-grey-5 font-light rounded-md absolute top-0 right-0 bottom-0 left-0 flex items-center justify-center bg-transparent Insticator_loaderClass__mVUIh min-h-[250px] z-1 rounded-none"></div><div class="Insticator_adClass__aZKoy min-h-[250px] z-1 leading-none"></div></div><p class="Disclosure_disclosure__GmLV4 Disclosure_disclosureCompact__7OUvM mx-auto text-center text-tertiary-text text-[10px] leading-[16px] pb-3">Advertisement.<span> <a class="Disclosure_removeAdsLink__3yG8W text-primary-text underline cursor-pointer" href="/subscriptions">Remove ads.</a></span></p><div class="sticky-outer-wrapper"><div class="sticky-inner-wrapper" style="position:relative;top:0px"><div class="relative SidebarRightAd_adClass__7j2lf leading-none"><div class="BackgroundLoaderAd_container__BFoDY overflow-hidden text-dark-grey-2 dark|text-grey-5 font-light rounded-md absolute top-0 right-0 bottom-0 left-0 flex items-center justify-center bg-transparent SidebarRightAd_loaderClass__NUf_b z-[-1] rounded-none"></div><div class="SidebarRightAd_adClass__7j2lf leading-none"></div></div><p class="Disclosure_disclosure__GmLV4 Disclosure_disclosureCompact__7OUvM mx-auto text-center text-tertiary-text text-[10px] leading-[16px] pb-3">Advertisement.<span> <a class="Disclosure_removeAdsLink__3yG8W text-primary-text underline cursor-pointer" href="/subscriptions">Remove ads.</a></span></p></div></div></div></div></div></div></div></div></div></div><script id="__NEXT_DATA__" type="application/json" crossorigin="anonymous">{"props":{"hasToken":false,"__N_SSP":true,"pageProps":{"hasToken":false,"initialData":{"id":20360,"symbol":"CADL","symbolMic":"CADL.XNAS","exchange":"NASDAQ","region":"US","title":"Candel Therapeutics Inc","aliases":[],"isFollowing":false,"watchlistCount":6683,"hasPricing":true,"instrumentClass":"Stock","liveEvent":false,"earningsCta":"up_earn_tab","earningsId":null,"sector":"HealthTechnology","industry":"Biotechnology","logoUrl":"https://logos.stocktwits-cdn.com/placeholder.png","trending":false,"trendingScore":-1.89582,"trends":null,"tradeStatus":"WHOLE","features":{"alertsPrice":true,"socialData":true,"trendingMessages":true,"earnings":true},"cusip":"137404109","isin":"US1374041093","shouldSeoIndex":true,"lastUpdated":"03/14/2025, 03:59:13 PM EDT","priceData":{"outcome":"Success","extendedHoursChange":0,"uTCOffset":"-4","iSO8601":"2025-03-14T20:00:00Z","last":8.75,"lastSize":36049,"volume":1022591,"previousCloseDate":"2025-03-13","type":"equity","previousClose":7.94,"change":0.81,"extendedHoursPrice":8.75,"message":"Delay times are 15 mins for NASDAQ.","dateTime":"2025-03-14 16:00:00","identifier":"CADL","extendedHoursType":"PostMarket","extendedHoursPercentChange":0,"extendedHoursDateTime":"2025-03-14 19:59:13","symbol":"CADL","open":7.96,"high":8.79,"low":7.96,"percentChange":10.202,"lastClose":"8.75","lastCloseTime":"2025-03-14 16:00:00"},"discussions":{},"fundamentals":{"totalDebt":"13.471","grossIncomeMargin":"","totalEnterpriseValue":"185.75665968","totalExpenses":"33.371","ePS":"-1.742","sharesHeldByInstitutions":"16.029977","earningsGrowth":"-33.7884","averageDailyVolumeLastMonth":"1437496.6316","dividendPayoutRatio":"","eBITDA":"","bookValuePerShare":"1.41322","5YearAveragePERatio":"","totalLiabilities":"40.816","lowPriceLast52Weeks":"1.34","numberOfEmployees":"38","symbol":"CADL","beta":"1.0408","floatCurrent":"32.4749","totalAssets":"107.143","pERatio":"-4.99","industryName":"Biotechnology","enterpriseOverEBITDA":"","priceToBook":"6.1915","highPriceLast52Weeks":"14.6","marketCapitalization":"389.1606","name":"Candel Therapeutics Inc","instrumentClass":"Stock","salesOrRevenue":"0","dividendsPerShareSecurity":"0","fiscalPeriodEndDate":"12/31/2024 12:00:00 AM","dividendExDate":"","businessDescription":"Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.","sectorName":"Health Technology","50DayMovingAverage":"8.2627","dividendRate":"0","pEGRatio":"","totalCash":"102.654","dividendYieldSecurity":"0","revenueToAssets":"0","lastUpdated":"03/14/2025","revenuePerEmployee":"0","sharesOutstanding":"46.933088","averageDailyVolumeLast3Months":"1774938.25"},"quote":{"previousCloseDate":"2025-03-13","dateTime":"2025-03-14 16:00:00","uTCOffset":"-4","low":7.96,"extendedHoursPercentChange":0,"extendedHoursDateTime":"2025-03-14 19:59:13","type":"equity","outcome":"Success","extendedHoursPrice":8.75,"easternDateTime":"03/14/2025, 12:00:00 PM EDT","easternExtendedHoursDateTime":"03/14/2025, 03:59:13 PM EDT","symbol":"CADL","previousClose":7.94,"volume":1022591,"lastSize":"36049","percentChange":10.202,"change":0.81,"last":8.75,"extendedHoursType":"PostMarket","iSO8601":"2025-03-14T20:00:00Z","high":8.79,"extendedHoursChange":0,"message":"Delay times are 15 mins for NASDAQ.","open":7.96},"articles":[{"author":{"description":"Ramakrishnan is a senior writer at Stocktwits, the largest social network for investors and traders. He specializes in covering the US markets and writes extensively on stocks, commodities, ETFs, and other asset classes, with a soft spot for EV companies and Big Tech.","designation":"Senior Staff Writer","id":3,"name":"Ramakrishnan M","profile_avatar":"https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/ram_author_image_resized_and_compressed_1_0022abb723.jpg","profile_link":"","social_media_links":{"facebook":"https://in.linkedin.com/in/ramakrishnan-m","twitter":"https://x.com/heyram27?lang=en","website":"https://stocktwits.com/BangaloreBidder"},"type":"Stocktwits"},"canonical_url":"","category":{"id":2,"name":"Markets"},"content":"\u003cp\u003e\u003cstrong\u003eCandel Therapeutics Inc. (13% jump in followers)\u003c/strong\u003e\u003c/p\u003e\u003cp\u003eCandel Therapeutics Inc. shares gained momentum as Wall Street analysts\u0026nbsp;\u003ca href=\"https://stocktwits.com/news-articles/markets/equity/cadl-stock-jumps-on-canaccord-buy-rating/ch5uUlPRwp\"\u003ehighlighted\u003c/a\u003e the potential of its lead cancer drug candidate, CAN-2409. Canaccord expects continued clinical success in prostate, pancreatic, and non-small cell lung cancer, noting a significant increase in median overall survival in testing so far. Citi’s modeling suggests CAN-2409 could extend survival in localized prostate cancer by as much as eight to nine years over radiotherapy alone.\u0026nbsp;\u003c/p\u003e\u003cp\u003eThe stock is up over 35% year-to-date.\u003c/p\u003e\u003cp\u003e\u003cstrong\u003eAcelyrin Inc. (12% jump in followers)\u003c/strong\u003e\u003c/p\u003e\u003cp\u003eAcelyrin confirmed that Concentra Biosciences, controlled by Tang Capital Partners, submitted an unsolicited offer to acquire all outstanding shares of Acelyrin for $3.00 per share in cash, plus a contingent value right tied to future licensing or asset sales.\u003c/p\u003e\u003cp\u003eEarlier in the month, Acelyrin announced a merger agreement with Alumis in an all-stock transaction expected to close in the second quarter of 2025, pending shareholder approval.\u0026nbsp;\u003c/p\u003e\u003cp\u003eAcelyrin stock is down over 18% year-to-date.\u003c/p\u003e\u003cp\u003e\u003cstrong\u003eSolid Biosciences Inc. (11% jump in followers)\u003c/strong\u003e\u003c/p\u003e\u003cp\u003eSolid Biosciences shares surged after early-stage data from its gene therapy candidate SGT-003 for Duchenne muscular dystrophy\u0026nbsp;\u003ca href=\"https://stocktwits.com/news-articles/markets/equity/sldb-stock-soars-on-dmd-trial-data/ch5rNeJRvt\"\u003eshowed\u003c/a\u003e promising results.\u0026nbsp;\u003c/p\u003e\u003cp\u003eFollowing the data release, Chardan raised its price target on the stock and increased the therapy’s probability of success to 48%, citing strong early efficacy signals and manageable safety risks.\u003c/p\u003e\u003cp\u003eSolid Biosciences stock is up 43% year-to-date.\u003c/p\u003e\u003cp\u003e\u003cstrong\u003eEstrella Immunopharma Inc. (11% jump in followers)\u003c/strong\u003e\u003c/p\u003e\u003cp\u003eEstrella Immunopharma received a bullish initiation from D. Boral Capital, which started coverage with a ‘Buy’ rating and a $16 price target. The firm sees Estrella as a potential major player in immuno-oncology, with its EB103 therapy using ARTEMIS T-cell engineering technology to target solid tumors.\u0026nbsp;\u003c/p\u003e\u003cp\u003eThe company also completed the first dose cohort in its Phase I/II trial, receiving approval from the Data and Safety Monitoring Board to proceed to the second dose level.\u0026nbsp;\u003c/p\u003e\u003cp\u003eEstrella stock is up over 22% year-to-date.\u003c/p\u003e\u003cp\u003e\u003cstrong\u003eAditxt Inc. (10% jump in followers)\u003c/strong\u003e\u003c/p\u003e\u003cp\u003eAditxt announced that its subsidiary, Pearsanta, has engaged Dominari Securities as the lead underwriter for its planned initial public offering. The IPO aims to support Pearsanta’s U.S. and international commercial launch of its Mitomic Technology platform for early cancer detection.\u0026nbsp;\u003c/p\u003e\u003cp\u003ePearsanta is developing a non-invasive blood test to detect cancer at earlier stages by leveraging mitochondrial DNA deletions as biomarkers. IPO proceeds will fund the U.S. launch of its Laboratory Developed Tests (LDTs) and drive global commercialization through distribution partnerships and regulatory approvals.\u0026nbsp;\u003c/p\u003e\u003cp\u003eAditxt stock is down over 53% year-to-date.\u003c/p\u003e\u003cp\u003e\u003ci\u003eFor updates and corrections, email newsroom[at]stocktwits[dot]com.\u003c/i\u003e\u003c/p\u003e","created_at":"2025-02-24T02:56:52Z","featured_image":"https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/biotech_representative_resized_434d5b5c0c.jpg","featured_image_attributes":{"alt_text":"Woman examining laboratory samples - stock photo | Image source: Getty Images","caption":"Woman examining laboratory samples - stock photo | Image source: Getty Images","url":"https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/biotech_representative_resized_434d5b5c0c.jpg"},"headline":"Top 5 Biotech Stocks That Saw Biggest Retail Following Jump Last Week","image_url":"https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/biotech_representative_resized_434d5b5c0c.jpg","meta_description":"Investors on Stocktwits flocked to these five biotech stocks last week, ending Feb. 21, 2025, driven by buyout buzz, bullish analyst calls, and promising clinical developments.","meta_keywords":"Candel Therapeutics stock, CADL stock, Acelyrin stock, SLRN stock, Solid Biosciences stock, SLDB stock, Estrella Immunopharma stock, ESLA stock, Aditxt stock, ADTX stock, biotech stocks\n","meta_title":"Top 5 Biotech Stocks That Saw Biggest Retail Following Jump Last Week","primary_symbol_code":"CADL","sid":"chdPSY1RDy","source":{"id":1071,"source_name":"Stocktwits","url_domain":"stocktwits.com"},"subcategory":{"id":3,"name":"Equity","parent_id":2},"summary":"Investors on Stocktwits flocked to these five biotech stocks last week, ending Feb. 21, 2025, driven by buyout buzz, bullish analyst calls, and promising clinical developments.\n","symbol_codes":["CADL","SLRN","SLDB","ESLA","ADTX"],"tags":[{"id":2,"tag_name":"Trending"},{"id":3,"tag_name":"Small Cap"},{"id":6,"tag_name":"Mid Cap"},{"id":10,"tag_name":"Retail"},{"id":17,"tag_name":"Equities"}],"type":"article","updated_at":"2025-02-24T02:56:52Z","url_slug":"stocktwits-hottest-biotech-stocks-weekly-feb-21-2024"},{"author":{"description":"Ramakrishnan is a senior writer at Stocktwits, the largest social network for investors and traders. He specializes in covering the US markets and writes extensively on stocks, commodities, ETFs, and other asset classes, with a soft spot for EV companies and Big Tech.","designation":"Senior Staff Writer","id":3,"name":"Ramakrishnan M","profile_avatar":"https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/ram_author_image_resized_and_compressed_1_0022abb723.jpg","profile_link":"","social_media_links":{"facebook":"https://in.linkedin.com/in/ramakrishnan-m","twitter":"https://x.com/heyram27?lang=en","website":"https://stocktwits.com/BangaloreBidder"},"type":"Stocktwits"},"canonical_url":"","category":{"id":2,"name":"Markets"},"content":"\u003cp\u003eShares of Candel Therapeutics Inc. surged nearly 10% on Wednesday and extended gains in after-hours trading following a bullish call from Wall Street.\u003c/p\u003e\u003cp\u003eCanaccord initiated coverage on the stock with a ‘Buy’ rating and a $20 price target, implying a 91% upside from the last close.\u0026nbsp;\u003c/p\u003e\u003cp\u003eThe research firm expects continued clinical success for Candel’s lead asset, CAN-2409, in prostate, pancreatic, and non-small cell lung cancer.\u0026nbsp;\u003c/p\u003e\u003cp\u003eIn testing so far, CAN-2409 has shown a significant increase in median overall survival. If this trend continues, it could become a “best-in-class therapy” for borderline resectable pancreatic ductal adenocarcinoma, according to the analyst.\u0026nbsp;\u003c/p\u003e\u003cp\u003eOn Stocktwits, sentiment turned ‘extremely bullish’ on Wednesday as message volume jumped by 50% and new followers increased by 4%.\u0026nbsp;\u003c/p\u003e\u003cfigure class=\"image\"\u003e\u003cimg style=\"aspect-ratio:1316/316;\" src=\"https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/CADL_sentiment_and_message_volume_Feb_19_d3c9416772.png\" alt=\"CADL sentiment and message volume Feb 19.png\" width=\"1316\" height=\"316\"\u003e\u003cfigcaption\u003eCADL sentiment and message volume Feb 19 | source: Stocktwits\u003c/figcaption\u003e\u003c/figure\u003e\u003cp\u003eTraders speculated that upcoming data could drive a major rally, with some predicting that strong results from the pancreatic study could push shares into the $30-$40 range.\u003c/p\u003e\u003cp\u003e\u003cstembedurl\u003ehttps://stocktwits.com/Xanderzzzzzzz/message/604910450\u003c/stembedurl\u003e\u003c/p\u003e\u003cp\u003e\u003cstembedurl\u003ehttps://stocktwits.com/drizz/message/604899234\u003c/stembedurl\u003e\u003c/p\u003e\u003cp\u003eLast week, BofA Securities also\u0026nbsp;\u003ca href=\"https://stocktwits.com/news-articles/markets/equity/cadl-stock-surges-on-bofa-buy-call/chPzAKRRtG\"\u003einitiated\u003c/a\u003e coverage on Candel with a ‘Buy’ rating and a $15 price target, citing promising early data for CAN-2409 and CAN-3110 as key drivers of its bullish outlook.\u0026nbsp;\u003c/p\u003e\u003cp\u003eThe research firm noted that CAN-2409’s early results in prostate cancer suggest a potential breakthrough, while CAN-3110 has shown signs of nearly doubling overall survival in patients with recurrent high-grade glioma.\u003c/p\u003e\u003cp\u003eCandel has outlined several key milestones ahead.\u0026nbsp;\u003c/p\u003e\u003cp\u003eUpdated overall survival data from Phase 2a trials of CAN-2409 in pancreatic and non-small cell lung cancer is expected in the first quarter of 2025.\u0026nbsp;\u003c/p\u003e\u003cp\u003ePhase 1b survival data for CAN-3110 in recurrent high-grade glioma is set for the fourth quarter of 2025, while a Biologics License Application (BLA) submission for CAN-2409 in prostate cancer is targeted for the fourth quarter of 2026.\u003c/p\u003e\u003cp\u003e\u003ca href=\"https://stocktwits.com/symbol/CADL\"\u003eCandel stock\u003c/a\u003e is up more than 22% this year. Short interest was 6.2% as of last week, down from 14.1% at the start of the year, per Koyfin data.\u003c/p\u003e\u003cp\u003e\u003ci\u003eFor updates and corrections, email newsroom[at]stocktwits[dot]com.\u003c/i\u003e\u003c/p\u003e","created_at":"2025-02-20T07:34:38Z","featured_image":"https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/stock_rising_resized_f17852d7aa.jpg","featured_image_attributes":{"alt_text":"Rising stock market chart on a trading board background.","caption":"Rising stock market chart on a trading board background. | Image source: Yuichiro Chino on Getty Images","url":"https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/stock_rising_resized_f17852d7aa.jpg"},"headline":"Candel Therapeutics Stock Rallies On Canaccord’s Vote Of Confidence In Lead Cancer Drug: Retail Traders Rejoice","image_url":"https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/stock_rising_resized_f17852d7aa.jpg","meta_description":"CAN-2409 could become a “best-in-class therapy” for borderline resectable pancreatic ductal adenocarcinoma, according to the analyst. ","meta_keywords":"Candel Therapeutics, CADL stock, CAN-2409, CAN-3110, pancreatic cancer, prostate cancer, non-small cell lung cancer, high-grade glioma\n","meta_title":"Candel Therapeutics Stock Rallies On Canaccord’s Vote Of Confidence In Lead Cancer Drug: Retail Traders Rejoice","primary_symbol_code":"CADL","sid":"ch5uUlPRwp","source":{"id":1071,"source_name":"Stocktwits","url_domain":"stocktwits.com"},"subcategory":{"id":3,"name":"Equity","parent_id":2},"summary":"CAN-2409 could become a “best-in-class therapy” for borderline resectable pancreatic ductal adenocarcinoma, according to the analyst. ","symbol_codes":["CADL","VTI","HDG","IWM"],"tags":[{"id":2,"tag_name":"Trending"},{"id":3,"tag_name":"Small Cap"},{"id":9,"tag_name":"Afterhours"},{"id":10,"tag_name":"Retail"},{"id":17,"tag_name":"Equities"}],"type":"article","updated_at":"2025-02-20T07:34:38Z","url_slug":"cadl-stock-jumps-on-canaccord-buy-rating"},{"author":{"description":"Ramakrishnan is a senior writer at Stocktwits, the largest social network for investors and traders. He specializes in covering the US markets and writes extensively on stocks, commodities, ETFs, and other asset classes, with a soft spot for EV companies and Big Tech.","designation":"Senior Staff Writer","id":3,"name":"Ramakrishnan M","profile_avatar":"https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/ram_author_image_resized_and_compressed_1_0022abb723.jpg","profile_link":"","social_media_links":{"facebook":"https://in.linkedin.com/in/ramakrishnan-m","twitter":"https://x.com/heyram27?lang=en","website":"https://stocktwits.com/BangaloreBidder"},"type":"Stocktwits"},"canonical_url":"","category":{"id":2,"name":"Markets"},"content":"\u003cp\u003eShares of Candel Therapeutics Inc.\u0026nbsp;(CADL)\u0026nbsp;surged over 9% on Friday morning, reaching their highest level in nearly a month and setting the stage for their best weekly gain (+20%) since Dec. 20.\u003c/p\u003e\u003cp\u003eBofA Securities initiated coverage of Candel with a 'Buy' rating and a $15 price target, according to The Fly, implying an upside of about 92% from the previous close.\u0026nbsp;\u003c/p\u003e\u003cp\u003eThe brokerage highlighted promising early data for Candel's two lead drug candidates —\u0026nbsp;\u003ca href=\"https://stocktwits.com/news-articles/markets/5/cadl-stock-soars-after-prostate-cancer-drug-trial-data/cJa3iD5R0a\"\u003eCAN-2409\u003c/a\u003e and CAN-3110 — as key drivers of its bullish outlook.\u003c/p\u003e\u003cp\u003eThe analyst noted that CAN-2409's early data in prostate cancer suggests the potential for a meaningful breakthrough, given the lack of significant advancements in available treatments.\u0026nbsp;\u003c/p\u003e\u003cp\u003eBofA added that CAN-3110 has shown early indications of nearly doubling overall survival in patients with recurrent high-grade glioma.\u003c/p\u003e\u003cp\u003eLast month, Candel provided a broad update on what to expect this year and beyond:\u003c/p\u003e\u003cul style=\"list-style-type:circle;\"\u003e\u003cli\u003eQ1 2025: Updated overall survival data from Phase 2a clinical trials of CAN-2409 in pancreatic ductal adenocarcinoma and non-small cell lung cancer.\u003c/li\u003e\u003cli\u003eQ4 2025: Phase 1b overall survival data for CAN-3110 in patients with recurrent high-grade glioma.\u003c/li\u003e\u003cli\u003eQ4 2026: Biologics License Application (BLA) submission for CAN-2409 in prostate cancer.\u003c/li\u003e\u003cli\u003eUpcoming scientific conferences: Presentation of Phase 3 data for CAN-2409 in prostate cancer.\u003c/li\u003e\u003c/ul\u003e\u003cp\u003eCandel also disclosed that its cash and cash equivalents stood at approximately $103 million as of\u0026nbsp;Dec. 31, 2024, which the company expects to fund its operations into the first quarter of 2027.\u003c/p\u003e\u003cfigure class=\"image\"\u003e\u003cimg style=\"aspect-ratio:1318/324;\" src=\"https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/CADL_sentiment_and_message_volume_Feb_7_0ea124a0a6.png\" alt=\"CADL sentiment and message volume Feb 7.png\" width=\"1318\" height=\"324\"\u003e\u003cfigcaption\u003eCADL sentiment and message volume Feb 7 as of 11 am ET | source: Stocktwits\u003c/figcaption\u003e\u003c/figure\u003e\u003cp\u003eStocktwits sentiment on Candel flipped to ‘bullish’ (71/100) on Friday from a ‘bearish’ (42/100) reading last week, amid a spike in message volume.\u0026nbsp;\u003c/p\u003e\u003cp\u003eRetail traders cheered BofA's bullish rating, with one urging investors to stay long on the stock.\u003c/p\u003e\u003cp\u003e\u003cstembedurl\u003ehttps://stocktwits.com/LongLTC/message/603284668\u003c/stembedurl\u003e\u003c/p\u003e\u003cp\u003eAdding to the optimism, a retail investor flagged a 13G\u0026nbsp;\u003ca target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https://www.sec.gov/Archives/edgar/data/315066/000031506625000400/xslSCHEDULE_13G_X01/primary_doc.xml\"\u003efiling\u003c/a\u003e from Fidelity Investments on Friday, revealing that it now owns a 9.3% stake in Candel.\u003c/p\u003e\u003cp\u003e\u003cstembedurl\u003ehttps://stocktwits.com/jzellner/message/603322436\u003c/stembedurl\u003e\u003c/p\u003e\u003cp\u003eNotably, according to Koyfin data, short interest in Candel stock dropped from 14.1% at the beginning of January to 6.9% by the end of the month.\u003c/p\u003e\u003cp\u003e\u003ca href=\"https://stocktwits.com/symbol/CADL\"\u003eCandel shares\u003c/a\u003e have skyrocketed 560% over the past 12 months — and with bullish sentiment building, some traders believe the rally is far from over.\u003c/p\u003e\u003cp\u003e\u003ci\u003eFor updates and corrections, email newsroom[at]stocktwits[dot]com.\u003c/i\u003e\u003c/p\u003e","created_at":"2025-02-07T16:11:28Z","featured_image":"https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/wall_street_analyst_resized_2295475502.jpg","featured_image_attributes":{"alt_text":"Photo caption: BofA’s $15 price target implies an upside of about 92% from the previous close. | Image source: Getty Images","caption":"Photo caption: BofA’s $15 price target implies an upside of about 92% from the previous close. | Image source: Getty Images","url":"https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/wall_street_analyst_resized_2295475502.jpg"},"headline":"Candel Therapeutics Stock Headed For 20% Weekly Gains: Retail Over The Moon With BofA's 'Buy' Call","image_url":"https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/wall_street_analyst_resized_2295475502.jpg","meta_description":"The analyst noted that CAN-2409's early data in prostate cancer suggests the potential for a meaningful breakthrough, given the lack of significant advancements in available treatments.","meta_keywords":"Candel Therapeutics stock, CADL stock, Candel BofA rating, CAN-2409, CAN-3110, Candel prostate cancer treatment, Candel glioma therapy\n","meta_title":"Candel Therapeutics Stock Headed For 20% Weekly Gains: Retail Over The Moon With BofA's 'Buy' Call","primary_symbol_code":"CADL","sid":"chPzAKRRtG","source":{"id":1071,"source_name":"Stocktwits","url_domain":"stocktwits.com"},"subcategory":{"id":3,"name":"Equity","parent_id":2},"summary":"The analyst noted that CAN-2409's early data in prostate cancer suggests the potential for a meaningful breakthrough, given the lack of significant advancements in available treatments.\n","symbol_codes":["CADL","VTI","IWM","HDG"],"tags":[{"id":2,"tag_name":"Trending"},{"id":3,"tag_name":"Small Cap"},{"id":10,"tag_name":"Retail"},{"id":17,"tag_name":"Equities"}],"type":"article","updated_at":"2025-02-07T16:12:21Z","url_slug":"cadl-stock-surges-on-bofa-buy-call"},{"author":{"description":"Ramakrishnan is a senior writer at Stocktwits, the largest social network for investors and traders. He specializes in covering the US markets and writes extensively on stocks, commodities, ETFs, and other asset classes, with a soft spot for EV companies and Big Tech.","designation":"Senior Staff Writer","id":3,"name":"Ramakrishnan M","profile_avatar":"https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/ram_author_image_resized_and_compressed_1_0022abb723.jpg","profile_link":"","social_media_links":{"facebook":"https://in.linkedin.com/in/ramakrishnan-m","twitter":"https://x.com/heyram27?lang=en","website":"https://stocktwits.com/BangaloreBidder"},"type":"Stocktwits"},"canonical_url":"","category":{"id":2,"name":"Markets"},"content":"\u003cp\u003eBiotech stocks, particularly in the small- and mid-cap space, were hot topics among retail investors in 2024, often spurred by major announcements or clinical developments.\u0026nbsp;\u003c/p\u003e\u003cp\u003eCollectively, these stocks attracted significant chatter on Stocktwits.\u0026nbsp;\u003c/p\u003e\u003cp\u003eHere are the top five biotech stocks with the highest message volume growth this year:\u003c/p\u003e\u003cp\u003e\u003cstrong\u003eTonix Pharmaceuticals Holding Corp. (TNXP)\u003c/strong\u003e: +47,066% Message Volume\u003c/p\u003e\u003cp\u003eTonix focuses on developing therapies to treat and prevent diseases. Its TNX-102 SL, a non-opioid analgesic for fibromyalgia, gained attention when the FDA\u0026nbsp;\u003ca href=\"https://stocktwits.com/news-articles/markets/equity/govx-tnpx-ebs-siga-stocks-face-mixed-signals-on-mpox-news/c7voqTBRTH\"\u003eaccepted\u003c/a\u003e its New Drug Application in December. Earlier in the year, the company also reiterated its\u0026nbsp;\u003ca href=\"https://stocktwits.com/news-articles/markets/5/tnxp-stocktwits-chatter-explodes-after-fda-nod-for-nda/cJaVYSzR1F\"\u003ecommitment\u003c/a\u003e to developing an mpox vaccine. Despite these milestones, TNXP shares are down over 97% this year.\u003c/p\u003e\u003cp\u003e\u003cstrong\u003eCandel Therapeutics Inc. (CADL)\u003c/strong\u003e: +16,000% Message Volume\u003c/p\u003e\u003cp\u003eCandel develops viral immunotherapies targeting cancer. Its lead product, CAN-2409, is under trial for various cancers, including prostate and non-small cell lung cancer. Positive late-stage\u0026nbsp;\u003ca href=\"https://stocktwits.com/news-articles/markets/5/cadl-stock-soars-after-prostate-cancer-drug-trial-data/cJa3iD5R0a\"\u003eresults\u003c/a\u003e released this month for CAN-2409 in prostate cancer drove retail interest. Shares of CADL are up over 500% this year.\u003c/p\u003e\u003cp\u003e\u003cstrong\u003eCardio Diagnostics Holdings Inc. (CDIO)\u003c/strong\u003e: +11,650% Message Volume\u003c/p\u003e\u003cp\u003eCardio Diagnostics gained traction with its AI-powered PrecisionCHD test for coronary heart disease. The test demonstrated significant cost-saving potential in healthcare, according to the company. Cardio also received final pricing determinations from the Centers for Medicare \u0026amp; Medicaid Services for its products. Its stock has fallen nearly 63% year-to-date.\u003c/p\u003e\u003cp\u003e\u003cstrong\u003eRecursion Pharmaceuticals Inc. (RXRX)\u003c/strong\u003e: +9,600% Message Volume\u003c/p\u003e\u003cp\u003eRecursion uses AI and automation to discover medicines. A $50 million investment from Nvidia to support AI-driven drug discovery efforts primarily sparked significant retail interest this year, although RXRX shares have declined 22% so far in 2024.\u003c/p\u003e\u003cp\u003e\u003cstrong\u003eGalectin Therapeutics Inc. (GALT)\u003c/strong\u003e: +5,800% Message Volume\u003c/p\u003e\u003cp\u003eGalectin’s focus on fibrotic and inflammatory diseases, led by its drug belapectin, caught investors’ attention despite mixed trial results. While the drug didn’t meet statistical significance for a key endpoint in an early liver disease trial, further data analysis is expected in early 2025. GALT shares are down over 48% this year.\u003c/p\u003e\u003cp\u003e\u003ci\u003eFor updates and corrections, email newsroom[at]stocktwits[dot]com.\u003c/i\u003e\u003c/p\u003e","created_at":"2024-12-26T17:47:23Z","featured_image":"https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/biotech_stocks_chart_resized_a25a478437.jpg","featured_image_attributes":{"alt_text":"Hand holding test tube over stock data on computer monitor. | Image source: Getty Images","caption":"Hand holding test tube over stock data on computer monitor. | Image source: Getty Images","url":"https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/biotech_stocks_chart_resized_a25a478437.jpg"},"headline":"Top 5 Biotech Stocks Dominating Retail Investor Conversations In 2024","image_url":"https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/biotech_stocks_chart_resized_a25a478437.jpg","meta_description":"From Tonix Pharmaceuticals’ progress on fibromyalgia treatments to Nvidia-backed Recursion Pharmaceuticals, these stocks sparked significant message volume growth on Stocktwits.","meta_keywords":"top biotech stocks, TNXP stock, Tonix Pharmaceuticals, Candel Therapeutics stock, CADL stock, Cardio Diagnostics stock, CDIO stock, Recursion Pharmaceuticals stock, RXRX Nvidia investment, Galectin Therapeutics stock, GALT belapectin","meta_title":"Top 5 Biotech Stocks Dominating Retail Investor Conversations In 2024","primary_symbol_code":"TNXP","sid":"cJOEinNRjV","source":{"id":1071,"source_name":"Stocktwits","url_domain":"stocktwits.com"},"subcategory":{"id":3,"name":"Equity","parent_id":2},"summary":"From Tonix Pharmaceuticals’ progress on fibromyalgia treatments to Nvidia-backed Recursion Pharmaceuticals, these stocks sparked significant message volume growth on Stocktwits.","symbol_codes":["TNXP","CADL","CDIO","RXRX","GALT"],"tags":[{"id":2,"tag_name":"Trending"},{"id":3,"tag_name":"Small Cap"},{"id":6,"tag_name":"Mid Cap"},{"id":10,"tag_name":"Retail"}],"type":"article","updated_at":"2024-12-26T17:48:01Z","url_slug":"top-biotech-stocks-with-highest-retail-chatter-in-2024"},{"author":{"description":"Ramakrishnan is a senior writer at Stocktwits, the largest social network for investors and traders. He specializes in covering the US markets and writes extensively on stocks, commodities, ETFs, and other asset classes, with a soft spot for EV companies and Big Tech.","designation":"Senior Staff Writer","id":3,"name":"Ramakrishnan M","profile_avatar":"https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/ram_author_image_resized_and_compressed_1_0022abb723.jpg","profile_link":"","social_media_links":{"facebook":"https://in.linkedin.com/in/ramakrishnan-m","twitter":"https://x.com/heyram27?lang=en","website":"https://stocktwits.com/BangaloreBidder"},"type":"Stocktwits"},"canonical_url":"","category":{"id":2,"name":"Markets"},"content":"\u003cp\u003eShares of Candel Therapeutics surged more than 100% on Wednesday, reaching seven-month highs, as the clinical-stage biopharmaceutical company announced positive results from a late-stage study of its CAN-2409 viral immunotherapy for prostate cancer.\u0026nbsp;\u003c/p\u003e\u003cp\u003eThe dramatic jump in stock price was accompanied by trading volume that was 94 times the daily average, propelling the company to the top of Stocktwits’ trending tickers.\u003c/p\u003e\u003cp\u003eThe Phase 3 multicenter study showed that CAN-2409, when combined with radiation therapy, provided a statistically significant and clinically meaningful benefit for patients with intermediate- to high-risk localized prostate cancer.\u0026nbsp;\u003c/p\u003e\u003cp\u003eThe treatment arm exhibited a 14.5% relative improvement in disease-free survival (DFS) at 54 months compared to the placebo group.\u0026nbsp;\u003c/p\u003e\u003cp\u003eCAN-2409 also demonstrated a significant effect on prostate cancer-free survival and a higher percentage of patients achieving a prostate-specific antigen nadir, a key biomarker in prostate cancer treatment.\u003c/p\u003e\u003cp\u003eFollowing these promising results, Candel said it plans to initiate talks with the U.S. Food and Drug Administration (FDA) to determine the regulatory pathway for CAN-2409 in this patient population.\u003c/p\u003e\u003cfigure class=\"image\"\u003e\u003cimg style=\"aspect-ratio:1318/324;\" src=\"https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/CADL_sentiment_and_message_volume_on_Dec_11_e64061707f.png\" alt=\"CADL sentiment and message volume on Dec 11.png\" width=\"1318\" height=\"324\"\u003e\u003cfigcaption\u003eCADL sentiment and message volume on Dec 11 as of 10:45 am ET | source: Stocktwits\u003c/figcaption\u003e\u003c/figure\u003e\u003cp\u003eOn Stocktwits, sentiment for CADL flipped to ‘extremely bullish’ from ‘bearish’ a day ago, with a notable surge in message volume.\u003c/p\u003e\u003cp\u003eSome optimistic retail investors were setting ambitious price targets.\u0026nbsp;\u003c/p\u003e\u003cp\u003e\u003cstembedurl\u003ehttps://stocktwits.com/austinvrabel/message/596029083\u003c/stembedurl\u003e\u003c/p\u003e\u003cp\u003e\u003cstembedurl\u003ehttps://stocktwits.com/Cassiopeia7/message/596027954\u003c/stembedurl\u003e\u003c/p\u003e\u003cp\u003eEarlier in the year, Candel’s stock also saw a significant boost after promising trial data for CAN-2409.\u0026nbsp;\u003c/p\u003e\u003cp\u003eThe company’s financials remain a concern, with cash reserves dropping from $35.4 million at the end of 2023 to $16.6 million by September 30, 2024.\u0026nbsp;\u003c/p\u003e\u003cp\u003eHowever, the company believes its current cash will be enough to support operations through the first quarter of 2025.\u003c/p\u003e\u003cp\u003eA Stocktwits poll shows that 53% of retail investors think CADL will face an offering soon to fund its subsequent trials, while 24% think it won’t as partnerships are likely to come.\u003c/p\u003e\u003cp\u003e\u003ca href=\"https://stocktwits.com/symbol/CADL\"\u003eCADL stock\u003c/a\u003e has soared more than 600% so far in 2024, driven by the strong clinical results and enthusiasm surrounding the company’s progress in cancer treatment.\u003c/p\u003e\u003cp\u003e\u003ci\u003eFor updates and corrections, email newsroom[at]stocktwits[dot]com.\u003c/i\u003e\u003c/p\u003e","created_at":"2024-12-11T16:10:21Z","featured_image":"https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/prostate_cancer_cells_resized_06df0a6792.jpg","featured_image_attributes":{"alt_text":"Prostate cancer cells, 3D illustration. Prostate cancer awareness image. | Image source: KATERYNA KON/SCIENCE PHOTO LIBRARY via Getty Images","caption":"Prostate cancer cells, 3D illustration. Prostate cancer awareness image. | Image source: KATERYNA KON/SCIENCE PHOTO LIBRARY via Getty Images","url":"https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/prostate_cancer_cells_resized_06df0a6792.jpg"},"headline":"Candel Therapeutics Stock More Than Doubles After Strong Prostate Cancer Trial Results: Retail Goes Wild","image_url":"https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/prostate_cancer_cells_resized_06df0a6792.jpg","meta_description":"Candel said it plans to initiate talks with the U.S. Food and Drug Administration (FDA) to determine the regulatory pathway for CAN-2409.","meta_keywords":"Candel Therapeutics, CADL stock surge, CAN-2409 viral immunotherapy, prostate cancer treatment, CADL Phase 3 study results, disease-free survival improvement, prostate cancer-free survival, PSA nadir biomarker, Candel FDA discussions","meta_title":"Candel Therapeutics Stock More Than Doubles After Strong Prostate Cancer Trial Results: Retail Goes Wild","primary_symbol_code":"CADL","sid":"cJa3iD5R0a","source":{"id":1071,"source_name":"Stocktwits","url_domain":"stocktwits.com"},"subcategory":{"id":3,"name":"Equity","parent_id":2},"summary":"Candel said it plans to initiate talks with the U.S. Food and Drug Administration (FDA) to determine the regulatory pathway for CAN-2409.\n","symbol_codes":["CADL"],"tags":[{"id":2,"tag_name":"Trending"},{"id":3,"tag_name":"Small Cap"},{"id":10,"tag_name":"Retail"}],"type":"article","updated_at":"2024-12-11T17:27:40Z","url_slug":"cadl-stock-soars-after-prostate-cancer-drug-trial-data"},{"author":{},"canonical_url":"https://www.prnewswire.com/news-releases/biotech-innovations-revolutionary-treatments-aim-to-boost-pancreatic-cancer-survival-rates-302220317.html","category":{"id":0},"content":"","created_at":"2024-08-12T20:37:00Z","headline":"Biotech Innovations: Revolutionary Treatments Aim to Boost Pancreatic Cancer Survival Rates","image_url":"","primary_symbol_code":"CADL","sid":"c7v30vVbkaEf","source":{"id":93,"source_name":"PR Newswire","url_domain":"PR Newswire"},"subcategory":{"id":0},"summary":"Biotech Innovations: Revolutionary Treatments Aim to Boost Pancreatic Cancer Survival Rates Biotech Innovations: Revolutionary Treatments Aim to Boost Pancreatic Cancer Survival Rates PR Newswire...","symbol_codes":["CADL","MRUS","HALO","ONC.XTSE","ONCY"],"tags":null,"type":"article","updated_at":"2024-08-13T13:00:28Z"},{"author":{},"canonical_url":"https://www.prnewswire.com/news-releases/pancreatic-cancer-on-the-rise-how-biotech-firms-are-developing-groundbreaking-treatments-302170926.html","category":{"id":0},"content":"","created_at":"2024-06-13T13:01:10Z","headline":"Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments","image_url":"","primary_symbol_code":"VSTM","sid":"c7noEqBbjnuM","source":{"id":93,"source_name":"PR Newswire","url_domain":"PR Newswire"},"subcategory":{"id":0},"summary":"Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments PR Newswire...","symbol_codes":["VSTM","CADL","REGN","FGEN","ONC.XTSE","ONCY"],"tags":null,"type":"article","updated_at":"2024-06-13T13:01:10Z"},{"author":{},"canonical_url":"https://www.benzinga.com/news/earnings/24/05/39011409/candel-reports-upbeat-data-from-lung-cancer-study?utm_source=TechInvestorNews\u0026utm_campaign=partner_feed\u0026utm_medium=partner_feed\u0026utm_content=site","category":{"id":0},"content":"","created_at":"2024-05-25T13:00:12Z","headline":"Candel Reports Upbeat Data From Lung Cancer Study","image_url":"","primary_symbol_code":"CADL","sid":"c7kpUwHbj0EX","source":{"id":104,"source_name":"Benzinga","url_domain":"Benzinga"},"subcategory":{"id":0},"summary":"Candel Therapeutics, Inc.\nread more...","symbol_codes":["CADL"],"tags":null,"type":"article","updated_at":"2024-05-25T13:00:12Z"},{"author":{},"canonical_url":"https://www.prnewswire.com/news-releases/pancreatic-cancer-battle-intensifies-biotech-innovations-aim-to-boost-survival-rates-302154430.html","category":{"id":0},"content":"","created_at":"2024-05-24T13:00:47Z","headline":"Pancreatic Cancer Battle Intensifies: Biotech Innovations Aim to Boost Survival Rates","image_url":"","primary_symbol_code":"LTRN","sid":"c7kFqAgbjigz","source":{"id":93,"source_name":"PR Newswire","url_domain":"PR Newswire"},"subcategory":{"id":0},"summary":"Pancreatic Cancer Battle Intensifies: Biotech Innovations Aim to Boost Survival Rates Pancreatic Cancer Battle Intensifies: Biotech Innovations Aim to Boost Survival Rates PR Newswire VANCOUVER, BC...","symbol_codes":["LTRN","CADL","MRUS","AZN.XLON","AZN","ONC.XTSE","ONCY"],"tags":null,"type":"article","updated_at":"2024-05-24T13:00:47Z"},{"author":{},"canonical_url":"https://www.prnewswire.com/news-releases/biotech-companies-making-strides-in-pancreatic-cancer-treatment-and-early-detection-302146514.html","category":{"id":0},"content":"","created_at":"2024-05-16T13:00:11Z","headline":"Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection","image_url":"","primary_symbol_code":"ABVC","sid":"c7k5EmkbjQ7H","source":{"id":93,"source_name":"PR Newswire","url_domain":"PR Newswire"},"subcategory":{"id":0},"summary":"Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection PR Newswire VANCOUVER, BC, May...","symbol_codes":["ABVC","CADL","CTMX","AMGN","ONC.XTSE","ONCY"],"tags":null,"type":"article","updated_at":"2024-05-16T13:00:11Z"}]},"tracking":{"instrumentClass":"Stock","instrumenttype":"Stock","pid":"symbol-cadl","quotetype":"Biotechnology","s1":"symbol","ticker":"CADL"},"dehydratedState":{"mutations":[],"queries":[{"state":{"data":[{"id":4979,"symbol":"DIA","symbol_mic":"DIA.ARCX","exchange":"NYSEArca","region":"US","title":"SPDR Dow Jones Industrial Average ETF","aliases":[],"is_following":false,"watchlist_count":41045,"has_pricing":true,"instrument_class":"ExchangeTradedFund","live_event":false,"price":null,"change":null,"percent":null},{"id":7271,"symbol":"SPY","symbol_mic":"SPY.ARCX","exchange":"NYSEArca","region":"US","title":"SPDR S\u0026P 500 ETF","aliases":[],"is_following":false,"watchlist_count":563359,"has_pricing":true,"instrument_class":"ExchangeTradedFund","live_event":false,"price":null,"change":null,"percent":null},{"id":9581,"symbol":"QQQ","symbol_mic":"NASDAQ","exchange":"NASDAQ","region":"US","title":"Invesco QQQ Trust Series 1","aliases":["QQQQ"],"is_following":false,"watchlist_count":211843,"has_pricing":true,"instrument_class":"ExchangeTradedFund","live_event":false,"price":null,"change":null,"percent":null}],"dataUpdateCount":1,"dataUpdatedAt":1742032280908,"error":null,"errorUpdateCount":0,"errorUpdatedAt":0,"fetchFailureCount":0,"fetchMeta":null,"isFetching":false,"isInvalidated":false,"isPaused":false,"status":"success"},"queryKey":["fetchIndices","ALL"],"queryHash":"[\"fetchIndices\",\"ALL\"]"},{"state":{"data":{"cursor":{"limit":15,"more":true,"page_num":1},"response":{"ranks":[{"pricing":{"percentage_price_change":13.846,"price":5.92},"rank":1,"stock":{"name":"Altimmune Inc","stock_id":8253,"symbol":"ALT"},"watcher_count":35858},{"pricing":{"percentage_price_change":0.09985,"price":0},"rank":2,"stock":{"name":"4Chan","stock_id":29841,"symbol":"4CHAN.X"},"watcher_count":995},{"pricing":{"percentage_price_change":6.8805092028,"price":2.4066021105},"rank":3,"stock":{"name":"Ripple","stock_id":13528,"symbol":"XRP.X"},"watcher_count":213372},{"pricing":{"percentage_price_change":-0.93,"price":7.46},"rank":4,"stock":{"name":"McEwen Mining Inc","stock_id":11256,"symbol":"MUX"},"watcher_count":5796},{"pricing":{"percentage_price_change":4.778,"price":9.43},"rank":5,"stock":{"name":"Anavex Life Sciences Corporation","stock_id":12844,"symbol":"AVXL"},"watcher_count":22375},{"pricing":{"percentage_price_change":46.889,"price":10.15},"rank":6,"stock":{"name":"D-Wave Quantum Inc","stock_id":26885,"symbol":"QBTS"},"watcher_count":28257},{"pricing":{"percentage_price_change":1.167,"price":6.26},"rank":7,"stock":{"name":"Green Thumb Industries","stock_id":16063,"symbol":"GTBIF"},"watcher_count":5692},{"pricing":{"percentage_price_change":10.2,"price":40.84},"rank":8,"stock":{"name":"TG Therapeutics Inc","stock_id":11391,"symbol":"TGTX"},"watcher_count":20371},{"pricing":{"percentage_price_change":-6.0769327152,"price":0.7496},"rank":9,"stock":{"name":"Propy","stock_id":23294,"symbol":"PRO.X"},"watcher_count":1689},{"pricing":{"percentage_price_change":0.663,"price":95.62},"rank":10,"stock":{"name":"Kaspi.kz JSC - ADR","stock_id":32735,"symbol":"KSPI"},"watcher_count":295},{"pricing":{"percentage_price_change":-2.738,"price":6.75},"rank":11,"stock":{"name":"Karyopharm Therapeutics Inc","stock_id":11653,"symbol":"KPTI"},"watcher_count":7862},{"pricing":{"percentage_price_change":2.93,"price":244.17},"rank":12,"stock":{"name":"Workday Inc","stock_id":11329,"symbol":"WDAY"},"watcher_count":13317},{"pricing":{"percentage_price_change":-3.467,"price":6.96},"rank":13,"stock":{"name":"Verastem Inc","stock_id":11183,"symbol":"VSTM"},"watcher_count":23758},{"pricing":{"percentage_price_change":1.952,"price":78.87},"rank":14,"stock":{"name":"Utilities Select Sector SPDR ETF","stock_id":7821,"symbol":"XLU"},"watcher_count":5932},{"pricing":{"percentage_price_change":3.033,"price":10.19},"rank":15,"stock":{"name":"Warner Bros.Discovery Inc","stock_id":7703,"symbol":"WBD"},"watcher_count":7644}],"type":"ts"},"status":{"success":true}},"dataUpdateCount":1,"dataUpdatedAt":1742032280908,"error":null,"errorUpdateCount":0,"errorUpdatedAt":0,"fetchFailureCount":0,"fetchMeta":null,"isFetching":false,"isInvalidated":false,"isPaused":false,"status":"success"},"queryKey":["fetchRankings","trending",15,"ALL",null,1,null,0],"queryHash":"[\"fetchRankings\",\"trending\",15,\"ALL\",null,1,null,0]"},{"state":{"data":{"4CHAN.X":{"PercentChange":"0.099850","Change":"0.000000","Last":"0.000000","DateTime":"2025-03-15 09:48:31","Symbol":"4CHAN.X","symbol":"4CHAN.X","Identifier":"4CHAN.X","Type":"crypto","type":"crypto"},"ALT":{"Open":"5.39","Change":"0.72","Outcome":"Success","ExtendedHoursPercentChange":"1.691","Message":"Delay times are 15 mins for NASDAQ.","Identifier":"ALT","Volume":"12203885","PercentChange":"13.846","ExtendedHoursPrice":"6.0201","ExtendedHoursDateTime":"2025-03-14 19:59:51","ISO8601":"2025-03-14T20:00:00Z","High":"6.05","Low":"5.355","Last":"5.92","ExtendedHoursType":"PostMarket","ExtendedHoursChange":"0.1001","DateTime":"2025-03-14 16:00:00","UTCOffset":"-4","Symbol":"ALT","LastSize":"240412","PreviousClose":"5.2","PreviousCloseDate":"2025-03-13","Type":"equity"},"AVXL":{"Low":"9.07","Last":"9.43","ExtendedHoursPrice":"9.4683","UTCOffset":"-4","Type":"equity","LastSize":"88615","Volume":"909503","PreviousClose":"9","ExtendedHoursChange":"0.0383","Message":"Delay times are 15 mins for NASDAQ.","Symbol":"AVXL","ExtendedHoursDateTime":"2025-03-14 18:57:00","Identifier":"AVXL","Open":"9.14","PreviousCloseDate":"2025-03-13","PercentChange":"4.778","Change":"0.43","Outcome":"Success","High":"9.5","ExtendedHoursType":"PostMarket","ExtendedHoursPercentChange":"0.406","DateTime":"2025-03-14 16:00:00","ISO8601":"2025-03-14T20:00:00Z"},"DIA":{"PreviousClose":"408.78","ExtendedHoursDateTime":"2025-03-14 19:58:37","Symbol":"DIA","Type":"equity","Open":"410.83","LastSize":"100","PercentChange":"1.61","ExtendedHoursPrice":"414.73","ExtendedHoursChange":"-0.63","UTCOffset":"-4","Volume":"2422739","PreviousCloseDate":"2025-03-13","Change":"6.58","Outcome":"Success","ExtendedHoursPercentChange":"-0.152","DateTime":"2025-03-14 16:00:00","ISO8601":"2025-03-14T20:00:00Z","Identifier":"DIA","High":"415.91","Low":"409.91","Last":"415.36","ExtendedHoursType":"PostMarket","Message":"Delay times are 15 mins for NYSEARCA."},"GTBIF":{"High":"6.35","Volume":"531724","Type":"equity","UTCOffset":"-4","Open":"6.19","ISO8601":"2025-03-14T19:59:51Z","ExtendedHoursChange":"0","Message":"Delay times are 15 mins for OTHEROTC. You are not authorized to access OOTCBidAsk data (Data Group: OOTCBidAsk). Your user token is ******. Consider upgrading your subscription to gain access. Please visit http://www.xignite.com/Support/FAQ.aspx?faqtype=Topics\u0026faqcat=Subscriptions for more information. Your request was authenticated using an HTTP request parameter. Your token is ******. Please visit https://www.xignite.com/registration-help for more information. (superquotes.xignite.com: 20).","Identifier":"GTBIF","Low":"6.183","ExtendedHoursPercentChange":"0","Change":"0.0722","ExtendedHoursPrice":"0","Symbol":"GTBIF","LastSize":"200","Last":"6.26","Outcome":"Success","PreviousClose":"6.1878","PercentChange":"1.167","DateTime":"2025-03-14 15:59:51","PreviousCloseDate":"2025-03-13"},"KPTI":{"PreviousCloseDate":"2025-03-13","ExtendedHoursType":"PostMarket","ExtendedHoursDateTime":"2025-03-14 18:57:00","Identifier":"KPTI","High":"7.1511","Low":"6.75","Volume":"101786","PreviousClose":"6.94","ISO8601":"2025-03-14T20:00:00Z","Open":"7","Last":"6.75","LastSize":"630","Outcome":"Success","ExtendedHoursChange":"0.33","Change":"-0.19","UTCOffset":"-4","Symbol":"KPTI","Type":"equity","PercentChange":"-2.738","ExtendedHoursPrice":"7.08","ExtendedHoursPercentChange":"4.889","DateTime":"2025-03-14 16:00:00","Message":"Delay times are 15 mins for NASDAQ."},"KSPI":{"ISO8601":"2025-03-14T20:00:00Z","Open":"97","PercentChange":"0.663","ExtendedHoursChange":"0","ExtendedHoursDateTime":"2025-03-14 16:48:57","Type":"equity","Volume":"247693","ExtendedHoursPercentChange":"0","DateTime":"2025-03-14 16:00:00","Message":"Delay times are 15 mins for NASDAQ.","Change":"0.63","Identifier":"KSPI","High":"97.21","Low":"95.39","PreviousClose":"94.99","ExtendedHoursType":"PostMarket","ExtendedHoursPrice":"95.62","UTCOffset":"-4","Symbol":"KSPI","Last":"95.62","LastSize":"8516","PreviousCloseDate":"2025-03-13","Outcome":"Success"},"MUX":{"Identifier":"MUX","Volume":"734691","Outcome":"Success","ExtendedHoursType":"PostMarket","PreviousClose":"7.53","PercentChange":"-0.93","Change":"-0.07","ExtendedHoursPrice":"7.28","ExtendedHoursPercentChange":"-2.413","Symbol":"MUX","PreviousCloseDate":"2025-03-13","UTCOffset":"-4","DateTime":"2025-03-14 16:00:00","Open":"7.67","High":"7.69","Low":"7.36","Last":"7.46","LastSize":"86422","ExtendedHoursChange":"-0.18","ExtendedHoursDateTime":"2025-03-14 19:51:35","Message":"Delay times are 15 mins for NYSE.","ISO8601":"2025-03-14T20:00:00Z","Type":"equity"},"PRO.X":{"Symbol":"PRO.X","symbol":"PRO.X","Change":"-0.0485","Last":"0.7496","PercentChange":"-6.0769327152","Identifier":"PRO.X","type":"crypto","Type":"crypto","DateTime":"2025-03-15 09:50:31"},"QBTS":{"Symbol":"QBTS","Open":"7.7","Last":"10.15","PercentChange":"46.889","Change":"3.24","ExtendedHoursChange":"-0.1902","UTCOffset":"-4","Low":"7.62","PreviousClose":"6.91","Outcome":"Success","ExtendedHoursType":"PostMarket","ExtendedHoursPrice":"9.9598","ExtendedHoursPercentChange":"-1.874","Identifier":"QBTS","High":"10.2","Message":"Delay times are 15 mins for NYSE.","Type":"equity","LastSize":"665442","Volume":"261242342","PreviousCloseDate":"2025-03-13","ExtendedHoursDateTime":"2025-03-14 19:59:59","DateTime":"2025-03-14 16:00:00","ISO8601":"2025-03-14T20:00:00Z"},"QQQ":{"Last":"479.66","LastSize":"1272588","Outcome":"Success","ExtendedHoursPercentChange":"-0.085","ISO8601":"2025-03-14T20:00:00Z","UTCOffset":"-4","Symbol":"QQQ","Open":"473.73","Volume":"43563010","PreviousCloseDate":"2025-03-13","PercentChange":"2.417","ExtendedHoursType":"PostMarket","DateTime":"2025-03-14 16:00:00","Identifier":"QQQ","High":"480.56","Low":"473.12","Change":"11.32","ExtendedHoursChange":"-0.41","Message":"Delay times are 15 mins for NASDAQ.","PreviousClose":"468.34","ExtendedHoursPrice":"479.25","ExtendedHoursDateTime":"2025-03-14 19:59:56","Type":"equity"},"SPY":{"Last":"562.81","ExtendedHoursChange":"-0.65","ExtendedHoursDateTime":"2025-03-14 19:59:59","Message":"Delay times are 15 mins for NYSEARCA.","Type":"equity","PreviousClose":"551.42","PreviousCloseDate":"2025-03-13","PercentChange":"2.066","Change":"11.39","ExtendedHoursType":"PostMarket","ExtendedHoursPrice":"562.16","DateTime":"2025-03-14 16:00:00","Symbol":"SPY","Volume":"62660321","Outcome":"Success","UTCOffset":"-4","Identifier":"SPY","Open":"556.11","High":"563.83","Low":"551.4917","LastSize":"2000","ExtendedHoursPercentChange":"-0.115","ISO8601":"2025-03-14T20:00:00Z"},"TGTX":{"DateTime":"2025-03-14 16:00:00","Open":"37.5","Low":"37.4421","Last":"40.84","LastSize":"291253","Change":"3.78","ExtendedHoursPrice":"41","ExtendedHoursChange":"0.16","Symbol":"TGTX","Type":"equity","PreviousCloseDate":"2025-03-13","Outcome":"Success","ISO8601":"2025-03-14T20:00:00Z","Identifier":"TGTX","UTCOffset":"-4","Message":"Delay times are 15 mins for NASDAQ.","High":"41.8499","Volume":"4816712","PreviousClose":"37.06","PercentChange":"10.2","ExtendedHoursType":"PostMarket","ExtendedHoursPercentChange":"0.392","ExtendedHoursDateTime":"2025-03-14 19:56:29"},"VSTM":{"Outcome":"Success","ExtendedHoursDateTime":"2025-03-14 19:32:34","Identifier":"VSTM","Open":"7.39","Low":"6.95","ISO8601":"2025-03-14T20:00:00Z","High":"7.5","Volume":"424326","ExtendedHoursChange":"0.02","ExtendedHoursType":"PostMarket","ExtendedHoursPrice":"6.98","DateTime":"2025-03-14 16:00:00","Last":"6.96","PreviousClose":"7.21","PreviousCloseDate":"2025-03-13","ExtendedHoursPercentChange":"0.287","UTCOffset":"-4","Message":"Delay times are 15 mins for NASDAQ.","Symbol":"VSTM","Type":"equity","LastSize":"18274","PercentChange":"-3.467","Change":"-0.25"},"WBD":{"Outcome":"Success","ExtendedHoursDateTime":"2025-03-14 19:51:16","UTCOffset":"-4","Symbol":"WBD","Type":"equity","PreviousCloseDate":"2025-03-13","PercentChange":"3.033","DateTime":"2025-03-14 16:00:00","Message":"Delay times are 15 mins for NASDAQ.","Identifier":"WBD","Open":"10.05","High":"10.38","Last":"10.19","LastSize":"2909813","Volume":"27637199","PreviousClose":"9.89","Change":"0.3","ExtendedHoursPrice":"10.1607","ExtendedHoursChange":"-0.0293","ExtendedHoursPercentChange":"-0.288","ISO8601":"2025-03-14T20:00:00Z","Low":"10.01","ExtendedHoursType":"PostMarket"},"WDAY":{"Last":"244.17","LastSize":"219463","ExtendedHoursPercentChange":"-0.008","ExtendedHoursDateTime":"2025-03-14 19:12:05","UTCOffset":"-4","Message":"Delay times are 15 mins for NASDAQ.","Identifier":"WDAY","Open":"239.57","Type":"equity","Outcome":"Success","ExtendedHoursPrice":"244.15","ExtendedHoursChange":"-0.02","ISO8601":"2025-03-14T20:00:00Z","Low":"238.55","PreviousCloseDate":"2025-03-13","PercentChange":"2.93","ExtendedHoursType":"PostMarket","DateTime":"2025-03-14 16:00:00","Symbol":"WDAY","High":"245.15","PreviousClose":"237.22","Volume":"1365935","Change":"6.95"},"XLU":{"Open":"77.59","High":"78.96","Low":"77.31","Last":"78.87","PreviousCloseDate":"2025-03-13","Message":"Delay times are 15 mins for NYSEARCA.","Type":"equity","LastSize":"500","PreviousClose":"77.36","Change":"1.51","Outcome":"Success","ExtendedHoursPrice":"78.86","ExtendedHoursChange":"-0.01","UTCOffset":"-4","Identifier":"XLU","Volume":"9134951","PercentChange":"1.952","ExtendedHoursDateTime":"2025-03-14 19:17:22","DateTime":"2025-03-14 16:00:00","ISO8601":"2025-03-14T20:00:00Z","ExtendedHoursType":"PostMarket","ExtendedHoursPercentChange":"-0.013","Symbol":"XLU"},"XRP.X":{"Last":"2.4066021105","PercentChange":"6.8805092028","Symbol":"XRP.X","Type":"crypto","Change":"0.1549267317","DateTime":"2025-03-15 09:51:20","type":"crypto","symbol":"XRP.X","Identifier":"XRP.X"}},"dataUpdateCount":1,"dataUpdatedAt":1742032280908,"error":null,"errorUpdateCount":0,"errorUpdatedAt":0,"fetchFailureCount":0,"fetchMeta":null,"isFetching":false,"isInvalidated":false,"isPaused":false,"status":"success"},"queryKey":["fetchBatchSymbolData","4CHAN.X","ALT","AVXL","DIA","GTBIF","KPTI","KSPI","MUX","PRO.X","QBTS","QQQ","SPY","TGTX","VSTM","WBD","WDAY","XLU","XRP.X"],"queryHash":"[\"fetchBatchSymbolData\",\"4CHAN.X\",\"ALT\",\"AVXL\",\"DIA\",\"GTBIF\",\"KPTI\",\"KSPI\",\"MUX\",\"PRO.X\",\"QBTS\",\"QQQ\",\"SPY\",\"TGTX\",\"VSTM\",\"WBD\",\"WDAY\",\"XLU\",\"XRP.X\"]"}]},"deviceContext":{"desktop":true,"desktopDown":false,"mobile":false,"screen":false,"tablet":false,"tabletUp":true,"family":"other"},"everythingData":{"announcement":[],"indexes":[{"id":4979,"symbol":"DIA","symbol_mic":"DIA.ARCX","exchange":"NYSEArca","region":"US","title":"SPDR Dow Jones Industrial Average ETF","aliases":[],"is_following":false,"watchlist_count":41045,"has_pricing":true,"instrument_class":"ExchangeTradedFund","live_event":false,"price":null,"change":null,"percent":null},{"id":7271,"symbol":"SPY","symbol_mic":"SPY.ARCX","exchange":"NYSEArca","region":"US","title":"SPDR S\u0026P 500 ETF","aliases":[],"is_following":false,"watchlist_count":563359,"has_pricing":true,"instrument_class":"ExchangeTradedFund","live_event":false,"price":null,"change":null,"percent":null},{"id":9581,"symbol":"QQQ","symbol_mic":"NASDAQ","exchange":"NASDAQ","region":"US","title":"Invesco QQQ Trust Series 1","aliases":["QQQQ"],"is_following":false,"watchlist_count":211843,"has_pricing":true,"instrument_class":"ExchangeTradedFund","live_event":false,"price":null,"change":null,"percent":null}],"trending":[{"id":8253,"symbol":"ALT","symbol_mic":"ALT.XNAS","exchange":"NASDAQ","region":"US","title":"Altimmune Inc","aliases":[],"is_following":false,"watchlist_count":35858,"has_pricing":true,"instrument_class":"Stock","live_event":false,"earnings_cta":"res_earn_tab","earnings_id":"3fb9ba69-3fd6-4e56-9965-31e53b396485","sector":"HealthTechnology","industry":"Biotechnology","logo_url":"https://logos.stocktwits-cdn.com/ALT.png","trending":true,"trending_score":9.83702,"trends":{"all":1,"region":1,"exchange":1,"summary":"Following Friday's unconfirmed buyout rumors from Betaville, Altimmune Inc. ($ALT) is trending as investors debate the likelihood of a deal amidst mixed interpretations of recent R\u0026D updates and a small insider purchase. While many are bullish, citing the potential for multiple pharmaceutical companies to compete for Altimmune, others remain skeptical, emphasizing that the stock's limited price movement suggests the buyout speculation may be overblown. The broader biotech sector's performance and upcoming clinical trial data could play significant roles in the stock's trajectory.","summary_at":"2025-03-15T08:46:15Z"},"trade_status":"FRACTIONAL","features":{"alerts_price":true,"social_data":true,"trending_messages":true,"earnings":true},"cusip":"02155H200","isin":"US02155H2004","sentiment_change":3.79,"volume_change":36.2,"should_seo_index":true},{"id":29841,"symbol":"4CHAN.X","symbol_mic":"4CHAN.X","exchange":"CRYPTO","region":"X","title":"4Chan","aliases":[],"is_following":false,"watchlist_count":995,"has_pricing":true,"instrument_class":"CRYPTO","live_event":false,"sector":null,"industry":null,"logo_url":"https://logos.stocktwits-cdn.com/placeholder.png","trending":false,"trending_score":6.25765,"trends":{"all":2,"region":1,"exchange":1,"summary":"Following increased online chatter, 4Chan.X CRYPTO is trending due to its association with the popular online forum 4chan, the birthplace of many popular internet memes; the community largely expresses bullish sentiment, viewing it as an undervalued meme coin with significant growth potential, though some express skepticism; its low market capitalization makes it a high-risk, high-reward investment within the broader meme coin sector.","summary_at":"2025-03-15T09:36:26Z"},"features":{"alerts_price":false,"social_data":false,"trending_messages":true,"earnings":false},"cusip":null,"isin":null,"sentiment_change":0,"volume_change":80,"should_seo_index":true},{"id":13528,"symbol":"XRP.X","symbol_mic":"XRP.X","exchange":"CRYPTO","region":"X","title":"Ripple","aliases":["XRPUSD"],"is_following":false,"watchlist_count":213372,"has_pricing":true,"instrument_class":"CRYPTO","live_event":false,"sector":"Miscellaneous","industry":"InvestmentTrustsOrMutualFunds","logo_url":"https://logos.stocktwits-cdn.com/XRP.png","trending":false,"trending_score":6.07477,"trends":{"all":3,"region":2,"exchange":2,"summary":"Following Ripple's licensing as Dubai's first blockchain payments provider and amid ongoing SEC settlement talks, XRP is trending as traders actively discuss short-term price movements and the potential implications of the SEC's review of XRP's regulatory status; while some express bullish sentiment based on Ripple's recent success and potential commodity classification, others remain skeptical, highlighting the volatility of the cryptocurrency market and ongoing legal uncertainty.","summary_at":"2025-03-15T09:06:30Z"},"features":{"alerts_price":false,"social_data":true,"trending_messages":true,"earnings":false},"cusip":null,"isin":null,"sentiment_change":1.03,"volume_change":-9.56,"should_seo_index":true},{"id":11256,"symbol":"MUX","symbol_mic":"MUX.XNYS","exchange":"NYSE","region":"US","title":"McEwen Mining Inc","aliases":["UXG"],"is_following":false,"watchlist_count":5796,"has_pricing":true,"instrument_class":"Stock","live_event":false,"sector":"NonEnergyMinerals","industry":"PreciousMetals","logo_url":"https://logos.stocktwits-cdn.com/placeholder.png","trending":false,"trending_score":5.4121,"trends":{"all":4,"region":2,"exchange":1,"summary":"Following McEwen Mining's (MUX) Q4 2024 earnings release, the community is debating the company's performance, particularly given the lack of a subsequent conference call and the stock's underperformance relative to the rising gold price. While some point to the CEO's other ventures and past stock performance as concerns, others highlight positive aspects like increased revenue and gross profit, despite a net loss attributed to prior year gains. Broader implications in the gold and copper mining sectors are being discussed, especially regarding the Los Azules project.","summary_at":"2025-03-15T09:16:14Z"},"trade_status":"FRACTIONAL","features":{"alerts_price":true,"social_data":true,"trending_messages":false,"earnings":true},"cusip":"58039P305","isin":"US58039P3055","sentiment_change":-33.33,"volume_change":140,"should_seo_index":true},{"id":12844,"symbol":"AVXL","symbol_mic":"AVXL.XNAS","exchange":"NASDAQ","region":"US","title":"Anavex Life Sciences Corporation","aliases":[],"is_following":false,"watchlist_count":22375,"has_pricing":true,"instrument_class":"Stock","live_event":false,"sector":"HealthTechnology","industry":"Biotechnology","logo_url":"https://logos.stocktwits-cdn.com/placeholder.png","trending":true,"trending_score":5.26798,"trends":{"all":6,"region":4,"exchange":2,"summary":"Following today's presentation at the Cowen Healthcare Conference, Anavex Life Sciences ($AVXL) is trending due to increased discussion around potential partnerships for its Alzheimer's drug, blarcamesine. While many investors express confidence in a lucrative deal, contrasting views focus on the CEO's communication style and strategy, creating notable uncertainty amidst a broader market downturn and substantial short interest.","summary_at":"2025-03-15T09:01:28Z"},"trade_status":"FRACTIONAL","features":{"alerts_price":true,"social_data":true,"trending_messages":true,"earnings":true},"cusip":"032797300","isin":"US0327973006","sentiment_change":1.19,"volume_change":12.85,"should_seo_index":true},{"id":26885,"symbol":"QBTS","symbol_mic":"QBTS.XNYS","exchange":"NYSE","region":"US","title":"D-Wave Quantum Inc","aliases":[],"is_following":false,"watchlist_count":28257,"has_pricing":true,"instrument_class":"Stock","live_event":false,"earnings_cta":"res_earn_tab","earnings_id":"","sector":"ElectronicTechnology","industry":"ComputerProcessingHardware","logo_url":"https://logos.stocktwits-cdn.com/placeholder.png","trending":true,"trending_score":6.50055,"trends":{"all":3,"region":2,"exchange":1,"summary":"Following today's surge in D-Wave Quantum Inc. ($QBTS) stock, the community is buzzing about the company's recent claim of quantum computational supremacy, though some dispute its significance and practicality. Contrasting views exist, with some celebrating the potential of the technology while others express skepticism, citing concerns about its commercial viability and the accuracy of the results. The broader market context centers on the burgeoning quantum computing sector's rising profile, with this event driving renewed interest in the industry and its leading players.","summary_at":"2025-03-15T09:12:22Z"},"trade_status":"DISABLED","features":{"alerts_price":true,"social_data":true,"trending_messages":true,"earnings":true},"cusip":"26740W109","isin":"US26740W1099","sentiment_change":-0.97,"volume_change":50.68,"should_seo_index":true},{"id":16063,"symbol":"GTBIF","symbol_mic":"GTBIF.OOTC","exchange":"OTC","region":"US","title":"Green Thumb Industries","aliases":[],"is_following":false,"watchlist_count":5692,"has_pricing":true,"instrument_class":"Stock","live_event":false,"earnings_cta":"res_earn_tab","earnings_id":null,"sector":"ProcessIndustries","industry":"AgriculturalCommoditiesOrMilling","logo_url":"https://logos.stocktwits-cdn.com/placeholder.png","trending":false,"trending_score":4.34821,"trends":{"all":8,"region":5,"exchange":1,"summary":"Following today's announcement of a new leadership team, Green Thumb Industries (GTBIF) is trending as investors debate the company's future direction and potential implications for its market position within the cannabis sector. The dominant community perspective is bullish, citing the company's strong fundamentals and potential benefits from cannabis reform, while contrasting views express concern about ongoing regulatory uncertainties and broader sector challenges. This situation plays out against a broader backdrop of evolving cannabis laws and regulations, both domestically and internationally.","summary_at":"2025-03-15T09:16:38Z"},"features":{"alerts_price":true,"social_data":false,"trending_messages":true,"earnings":true},"cusip":"","isin":"","sentiment_change":-14.29,"volume_change":5,"should_seo_index":true},{"id":11391,"symbol":"TGTX","symbol_mic":"TGTX.XNAS","exchange":"NASDAQ","region":"US","title":"TG Therapeutics Inc","aliases":[],"is_following":false,"watchlist_count":20371,"has_pricing":true,"instrument_class":"Stock","live_event":false,"earnings_cta":"res_earn_tab","earnings_id":"3f93c1de-d835-4fbf-a782-909a64534182","sector":"HealthTechnology","industry":"PharmaceuticalsMajor","logo_url":"https://logos.stocktwits-cdn.com/placeholder.png","trending":false,"trending_score":4.09448,"trends":{"all":null,"region":6,"exchange":3,"summary":"Following today's surge in TG Therapeutics Inc. (TGTX) stock, online discussions center around the potential for a buyout, fueled by the company's strong Q4 earnings and the recent Seeking Alpha article highlighting Briumvi's performance. While many are optimistic about TGTX's future, some express concerns about the broader market's impact and the possibility of a pullback.","summary_at":"2025-03-15T09:31:18Z"},"trade_status":"FRACTIONAL","features":{"alerts_price":true,"social_data":true,"trending_messages":true,"earnings":true},"cusip":"88322Q108","isin":"US88322Q1085","sentiment_change":-0.51,"volume_change":8.22,"should_seo_index":true},{"id":23294,"symbol":"PRO.X","symbol_mic":"PRO.X","exchange":"CRYPTO","region":"X","title":"Propy","aliases":[],"is_following":false,"watchlist_count":1689,"has_pricing":true,"instrument_class":"CRYPTO","live_event":false,"sector":null,"industry":null,"logo_url":"https://logos.stocktwits-cdn.com/placeholder.png","trending":false,"trending_score":3.38011,"trends":{"all":null,"region":3,"exchange":3,"summary":"Following recent news of a partnership with Coinbase Prime, Propy ($PRO.X) is trending as community discussion centers on its potential impact and whether the coin will sustain a price increase. While some are optimistic about its future, others express skepticism, citing past volatility and concerns about top holder activity. Broader market context shows that Propy is moving against the grain amid overall crypto market uncertainty.","summary_at":"2025-03-15T09:36:26Z"},"features":{"alerts_price":false,"social_data":true,"trending_messages":false,"earnings":false},"cusip":null,"isin":null,"sentiment_change":7.27,"volume_change":0,"should_seo_index":true},{"id":32735,"symbol":"KSPI","symbol_mic":"KSPI.XNAS","exchange":"NASDAQ","region":"US","title":"Kaspi.kz JSC - ADR","aliases":[],"is_following":false,"watchlist_count":295,"has_pricing":true,"instrument_class":"DepositoryReceipt","live_event":false,"sector":"Finance","industry":"FinanceOrRentalOrLeasing","logo_url":"https://logos.stocktwits-cdn.com/KSPI.png","trending":true,"trending_score":3.35757,"trends":null,"features":{"alerts_price":true,"social_data":true,"trending_messages":false,"earnings":true},"cusip":"48581R205","isin":"US48581R2058","should_seo_index":true},{"id":11653,"symbol":"KPTI","symbol_mic":"KPTI.XNAS","exchange":"NASDAQ","region":"US","title":"Karyopharm Therapeutics Inc","aliases":[],"is_following":false,"watchlist_count":7862,"has_pricing":true,"instrument_class":"Stock","live_event":false,"sector":"HealthTechnology","industry":"PharmaceuticalsMajor","logo_url":"https://logos.stocktwits-cdn.com/KPTI.png","trending":false,"trending_score":2.89834,"trends":null,"trade_status":"WHOLE","features":{"alerts_price":true,"social_data":true,"trending_messages":true,"earnings":true},"cusip":"48576U106","isin":"US48576U1060","sentiment_change":-2.34,"volume_change":-31.25,"should_seo_index":true},{"id":11329,"symbol":"WDAY","symbol_mic":"WDAY.XNAS","exchange":"NASDAQ","region":"US","title":"Workday Inc","aliases":[],"is_following":false,"watchlist_count":13317,"has_pricing":true,"instrument_class":"Stock","live_event":false,"sector":"TechnologyServices","industry":"InformationTechnologyServices","logo_url":"https://logos.stocktwits-cdn.com/placeholder.png","trending":true,"trending_score":2.08572,"trends":null,"trade_status":"FRACTIONAL","features":{"alerts_price":true,"social_data":true,"trending_messages":true,"earnings":true},"cusip":"98138H101","isin":"US98138H1014","sentiment_change":0,"volume_change":0,"should_seo_index":true},{"id":11183,"symbol":"VSTM","symbol_mic":"VSTM.XNAS","exchange":"NASDAQ","region":"US","title":"Verastem Inc","aliases":[],"is_following":false,"watchlist_count":23758,"has_pricing":true,"instrument_class":"Stock","live_event":false,"earnings_cta":"res_earn_tab","earnings_id":"","sector":"HealthTechnology","industry":"Biotechnology","logo_url":"https://logos.stocktwits-cdn.com/VSTM.png","trending":true,"trending_score":3.25107,"trends":null,"trade_status":"FRACTIONAL","features":{"alerts_price":true,"social_data":true,"trending_messages":true,"earnings":true},"cusip":"92337C203","isin":"US92337C2035","sentiment_change":0,"volume_change":-8.93,"should_seo_index":true},{"id":7821,"symbol":"XLU","symbol_mic":"XLU.ARCX","exchange":"NYSEArca","region":"US","title":"Utilities Select Sector SPDR ETF","aliases":[],"is_following":false,"watchlist_count":5932,"has_pricing":true,"instrument_class":"ExchangeTradedFund","live_event":false,"sector":"Miscellaneous","industry":"InvestmentTrustsOrMutualFunds","logo_url":"https://logos.stocktwits-cdn.com/XLU.png","trending":true,"trending_score":3.38746,"trends":{"all":null,"region":9,"exchange":1,"summary":"Following a recent market correction, the Utilities Select Sector SPDR ETF (XLU) is trending as investors seek safe havens; the dominant view highlights utilities' defensive qualities, while some express concern about the sector's recent performance. Broader market implications include a potential sector rotation towards defensive plays amid economic uncertainty.","summary_at":"2025-03-15T08:26:57Z"},"trade_status":"FRACTIONAL","features":{"alerts_price":true,"social_data":true,"trending_messages":true,"earnings":false},"cusip":"81369Y886","isin":"US81369Y8865","sentiment_change":0,"volume_change":0,"should_seo_index":true},{"id":7703,"symbol":"WBD","symbol_mic":"WBD.XNAS","exchange":"NASDAQ","region":"US","title":"Warner Bros.Discovery Inc","aliases":[],"is_following":false,"watchlist_count":7644,"has_pricing":true,"instrument_class":"Stock","live_event":false,"sector":"ConsumerServices","industry":"CableOrSatelliteTV","logo_url":"https://logos.stocktwits-cdn.com/placeholder.png","trending":true,"trending_score":3.28566,"trends":null,"trade_status":"FRACTIONAL","features":{"alerts_price":false,"social_data":true,"trending_messages":true,"earnings":true},"cusip":"934423104","isin":"US9344231041","sentiment_change":5.56,"volume_change":-10.81,"should_seo_index":true},{"id":3720,"symbol":"SWKS","symbol_mic":"SWKS.XNAS","exchange":"NASDAQ","region":"US","title":"Skyworks Solutions, Inc.","aliases":[],"is_following":false,"watchlist_count":16492,"has_pricing":true,"instrument_class":"Stock","live_event":false,"sector":"ElectronicTechnology","industry":"Semiconductors","logo_url":"https://logos.stocktwits-cdn.com/placeholder.png","trending":false,"trending_score":-0.358967,"trends":null,"trade_status":"FRACTIONAL","features":{"alerts_price":true,"social_data":true,"trending_messages":true,"earnings":true},"cusip":"83088M102","isin":"US83088M1027","sentiment_change":0,"volume_change":-21.43,"should_seo_index":true},{"id":1807,"symbol":"EXEL","symbol_mic":"EXEL.XNAS","exchange":"NASDAQ","region":"US","title":"Exelixis Inc","aliases":[],"is_following":false,"watchlist_count":12055,"has_pricing":true,"instrument_class":"Stock","live_event":false,"earnings_cta":"res_earn_tab","earnings_id":"69d82b38-3525-455f-b2c8-1d278585c32c","sector":"HealthTechnology","industry":"PharmaceuticalsMajor","logo_url":"https://logos.stocktwits-cdn.com/placeholder.png","trending":true,"trending_score":3.375,"trends":{"all":null,"region":9,"exchange":4,"summary":"Following today's announcement of a new $500 million stock repurchase program, Exelixis ($EXEL) is trending as investors react positively to this shareholder-friendly move. While many in the community see this as a sign of confidence in the company's future, some express concern over the recent Wells Fargo downgrade and the potential for profit-taking after recent gains. This news comes amidst broader market interest in the oncology sector and ongoing discussions about the company's pipeline and potential acquisition targets.","summary_at":"2025-03-15T09:21:19Z"},"trade_status":"FRACTIONAL","features":{"alerts_price":true,"social_data":true,"trending_messages":false,"earnings":true},"cusip":"30161Q104","isin":"US30161Q1040","sentiment_change":0,"volume_change":-5.56,"should_seo_index":true},{"id":8251,"symbol":"DAX","symbol_mic":"DAX.XNAS","exchange":"NASDAQ","region":"US","title":"Global X DAX Germany ETF","aliases":[],"is_following":false,"watchlist_count":6480,"has_pricing":true,"instrument_class":"ExchangeTradedFund","live_event":false,"sector":"Miscellaneous","industry":"InvestmentTrustsOrMutualFunds","logo_url":"https://logos.stocktwits-cdn.com/placeholder.png","trending":true,"trending_score":3.37148,"trends":{"all":null,"region":10,"exchange":5,"summary":"Following a historic German debt deal for increased defense and infrastructure spending, the Global X DAX Germany ETF (DAX) is trending higher, boosted by optimism regarding long-term growth. While the dominant community perspective is bullish, some express caution about the challenges ahead. This positive momentum is occurring within a broader market context of mixed signals and rising interest rate concerns in other global markets.","summary_at":"2025-03-15T08:46:16Z"},"trade_status":"WHOLE","features":{"alerts_price":true,"social_data":true,"trending_messages":true,"earnings":false},"cusip":"37954Y491","isin":"US37954Y4917","sentiment_change":0,"volume_change":0,"should_seo_index":true},{"id":28668,"symbol":"KAS.X","symbol_mic":"KAS.X","exchange":"CRYPTO","region":"X","title":"Kaspa","aliases":[],"is_following":false,"watchlist_count":4458,"has_pricing":true,"instrument_class":"CRYPTO","live_event":false,"sector":null,"industry":null,"logo_url":"https://logos.stocktwits-cdn.com/placeholder.png","trending":false,"trending_score":2.75793,"trends":{"all":null,"region":9,"exchange":9,"summary":"Following its recent inclusion on CoinMarketCap's \"Made in America\" list, Kaspa ($KAS.X) is trending, sparking community debate on its potential. While many express bullish sentiment and discuss potential exchange listings, others voice concerns about past price drops and the possibility of future market corrections. The broader crypto market's performance is also influencing the conversation.","summary_at":"2025-03-15T08:36:14Z"},"features":{"alerts_price":false,"social_data":true,"trending_messages":true,"earnings":false},"cusip":null,"isin":null,"sentiment_change":-0.82,"volume_change":8.78,"should_seo_index":true},{"id":28758,"symbol":"TSLY","symbol_mic":"TSLY.ARCX","exchange":"NYSEArca","region":"US","title":"YIELDMAX TSLA OPTION INCOME STRATEGY ETF","aliases":[],"is_following":false,"watchlist_count":4992,"has_pricing":true,"instrument_class":"ExchangeTradedFund","live_event":false,"sector":"Miscellaneous","industry":"InvestmentTrustsOrMutualFunds","logo_url":"https://logos.stocktwits-cdn.com/placeholder.png","trending":true,"trending_score":3.24702,"trends":null,"trade_status":"WHOLE","features":{"alerts_price":true,"social_data":true,"trending_messages":true,"earnings":false},"cusip":"88634T709","isin":"US88634T7090","sentiment_change":12.5,"volume_change":2.63,"should_seo_index":true},{"id":14196,"symbol":"TRX.X","symbol_mic":"TRX.X","exchange":"CRYPTO","region":"X","title":"Tron","aliases":[],"is_following":false,"watchlist_count":35935,"has_pricing":true,"instrument_class":"CRYPTO","live_event":false,"sector":"Miscellaneous","industry":"InvestmentTrustsOrMutualFunds","logo_url":"https://logos.stocktwits-cdn.com/placeholder.png","trending":false,"trending_score":3.238,"trends":{"all":null,"region":6,"exchange":6,"summary":"Following recent news of a 60-day extension in a fraud case against Tron founder Justin Sun, the cryptocurrency TRX.X is trending, with the community largely focused on speculation about the implications of the extension and its potential effect on price. While some express optimism and point to other positive developments like possible adoption in Trump's reserve strategy, others remain cautious or skeptical, citing past controversies.","summary_at":"2025-03-15T09:06:45Z"},"features":{"alerts_price":false,"social_data":true,"trending_messages":true,"earnings":false},"cusip":null,"isin":null,"sentiment_change":0,"volume_change":-20,"should_seo_index":true},{"id":6998,"symbol":"SHEL","symbol_mic":"SHEL.XNYS","exchange":"NYSE","region":"US","title":"Shell Plc - ADR (Representing - Ordinary Shares)","aliases":["RDSA"],"is_following":false,"watchlist_count":8570,"has_pricing":true,"instrument_class":"DepositoryReceipt","live_event":false,"earnings_cta":"res_earn_tab","earnings_id":null,"sector":"EnergyMinerals","industry":"IntegratedOil","logo_url":"https://logos.stocktwits-cdn.com/placeholder.png","trending":false,"trending_score":2.87716,"trends":null,"features":{"alerts_price":true,"social_data":true,"trending_messages":true,"earnings":true},"cusip":"780259305","isin":"US7802593050","sentiment_change":25,"volume_change":-8.33,"should_seo_index":true},{"id":6507,"symbol":"NLY","symbol_mic":"NLY.XNYS","exchange":"NYSE","region":"US","title":"Annaly Capital Management Inc","aliases":[],"is_following":false,"watchlist_count":9902,"has_pricing":true,"instrument_class":"Stock","live_event":false,"sector":"Finance","industry":"RealEstateInvestmentTrusts","logo_url":"https://logos.stocktwits-cdn.com/NLY.png","trending":true,"trending_score":2.92232,"trends":null,"trade_status":"FRACTIONAL","features":{"alerts_price":true,"social_data":true,"trending_messages":true,"earnings":true},"cusip":"035710839","isin":"US0357108390","sentiment_change":0,"volume_change":18.18,"should_seo_index":true},{"id":5694,"symbol":"HMC","symbol_mic":"HMC.XNYS","exchange":"NYSE","region":"US","title":"Honda Motor Co., Ltd.","aliases":[],"is_following":false,"watchlist_count":4445,"has_pricing":true,"instrument_class":"DepositoryReceipt","live_event":false,"earnings_cta":"res_earn_tab","earnings_id":null,"sector":"ConsumerDurables","industry":"MotorVehicles","logo_url":"https://logos.stocktwits-cdn.com/placeholder.png","trending":true,"trending_score":2.56205,"trends":null,"features":{"alerts_price":true,"social_data":true,"trending_messages":false,"earnings":true},"cusip":"438128308","isin":"US4381283088","sentiment_change":0,"volume_change":0,"should_seo_index":true},{"id":3623,"symbol":"SPIR","symbol_mic":"SPIR.XNYS","exchange":"NYSE","region":"US","title":"Spire Global Inc - Ordinary Shares - Class A","aliases":[],"is_following":false,"watchlist_count":3383,"has_pricing":true,"instrument_class":"Stock","live_event":false,"earnings_cta":"res_earn_tab","earnings_id":"1f98f97f-4e91-4884-88b1-be166bf5d17f","sector":"TechnologyServices","industry":"PackagedSoftware","logo_url":"https://logos.stocktwits-cdn.com/placeholder.png","trending":false,"trending_score":2.83298,"trends":null,"trade_status":"WHOLE","features":{"alerts_price":true,"social_data":true,"trending_messages":true,"earnings":true},"cusip":"848560306","isin":"US8485603067","sentiment_change":0,"volume_change":27.27,"should_seo_index":true},{"id":33898,"symbol":"DRIFT.X","symbol_mic":"DRIFT.X","exchange":"CRYPTO","region":"X","title":"Drift","aliases":[],"is_following":false,"watchlist_count":476,"has_pricing":true,"instrument_class":"CRYPTO","live_event":false,"sector":null,"industry":null,"logo_url":"https://logos.stocktwits-cdn.com/placeholder.png","trending":false,"trending_score":1.88806,"trends":null,"features":{"alerts_price":false,"social_data":false,"trending_messages":true,"earnings":false},"cusip":null,"isin":null,"volume_change":4000,"should_seo_index":true},{"id":21004,"symbol":"ONON","symbol_mic":"ONON.XNYS","exchange":"NYSE","region":"US","title":"On Holding AG","aliases":[],"is_following":false,"watchlist_count":5478,"has_pricing":true,"instrument_class":"Stock","live_event":false,"earnings_cta":"res_earn_tab","earnings_id":"38750914-86cd-47a1-94d6-658e99e4ade3","sector":"ConsumerNonDurables","industry":"ApparelOrFootwear","logo_url":"https://logos.stocktwits-cdn.com/placeholder.png","trending":false,"trending_score":-0.433908,"trends":null,"trade_status":"WHOLE","features":{"alerts_price":true,"social_data":true,"trending_messages":true,"earnings":true},"cusip":"H5919C104","isin":"CH1134540470","sentiment_change":-3.58,"volume_change":-41.67,"should_seo_index":true},{"id":19721,"symbol":"RBRK","symbol_mic":"RBRK.XNYS","exchange":"NYSE","region":"US","title":"Rubrik Inc. - Class A","aliases":[],"is_following":false,"watchlist_count":2062,"has_pricing":true,"instrument_class":"Stock","live_event":false,"sector":"TechnologyServices","industry":"InformationTechnologyServices","logo_url":"https://logos.stocktwits-cdn.com/RBRK.png","trending":false,"trending_score":2.57716,"trends":null,"features":{"alerts_price":true,"social_data":true,"trending_messages":false,"earnings":true},"cusip":"781154109","isin":"US7811541090","sentiment_change":6.09,"volume_change":58.89,"should_seo_index":true},{"id":15277,"symbol":"REN.X","symbol_mic":"REN.X","exchange":"CRYPTO","region":"X","title":"Ren Coin","aliases":[],"is_following":false,"watchlist_count":2922,"has_pricing":true,"instrument_class":"CRYPTO","live_event":false,"sector":"Miscellaneous","industry":"InvestmentTrustsOrMutualFunds","logo_url":"https://logos.stocktwits-cdn.com/placeholder.png","trending":false,"trending_score":2.98678,"trends":{"all":null,"region":8,"exchange":8,"summary":"Ren Coin ($REN.X) is trending due to a confluence of factors, including the launch of a new Layer 1 blockchain, BlockDAG, and significant community discussion around its potential. While many express bullish sentiment anticipating a price increase, contrasting viewpoints exist, highlighting concerns about past performance and delistings from certain platforms. This activity occurs amid broader market fluctuations and ongoing regulatory scrutiny in the crypto sector.","summary_at":"2025-03-15T08:31:14Z"},"features":{"alerts_price":false,"social_data":true,"trending_messages":false,"earnings":false},"cusip":null,"isin":null,"sentiment_change":1.27,"volume_change":-14.5,"should_seo_index":true},{"id":34897,"symbol":"MSTX","symbol_mic":"MSTX.XNAS","exchange":"NASDAQ","region":"US","title":"Tidal Trust II - Defiance Daily Target 2x Long MSTR ETF","aliases":[],"is_following":false,"watchlist_count":3340,"has_pricing":true,"instrument_class":"ExchangeTradedFund","live_event":false,"sector":"Miscellaneous","industry":"InvestmentTrustsOrMutualFunds","logo_url":"https://logos.stocktwits-cdn.com/MSTX.png","trending":false,"trending_score":0.857305,"trends":null,"features":{"alerts_price":true,"social_data":true,"trending_messages":false,"earnings":false},"cusip":"88636J253","isin":"US88636J2539","sentiment_change":0,"volume_change":-0.76,"should_seo_index":true}],"events_present":false,"video_events_present":false,"prices":{"DIA":{"PreviousClose":"408.78","ExtendedHoursDateTime":"2025-03-14 19:58:37","Symbol":"DIA","Type":"equity","Open":"410.83","LastSize":"100","PercentChange":"1.61","ExtendedHoursPrice":"414.73","ExtendedHoursChange":"-0.63","UTCOffset":"-4","Volume":"2422739","PreviousCloseDate":"2025-03-13","Change":"6.58","Outcome":"Success","ExtendedHoursPercentChange":"-0.152","DateTime":"2025-03-14 16:00:00","ISO8601":"2025-03-14T20:00:00Z","Identifier":"DIA","High":"415.91","Low":"409.91","Last":"415.36","ExtendedHoursType":"PostMarket","Message":"Delay times are 15 mins for NYSEARCA."},"SPY":{"Last":"562.81","ExtendedHoursChange":"-0.65","ExtendedHoursDateTime":"2025-03-14 19:59:59","Message":"Delay times are 15 mins for NYSEARCA.","Type":"equity","PreviousClose":"551.42","PreviousCloseDate":"2025-03-13","PercentChange":"2.066","Change":"11.39","ExtendedHoursType":"PostMarket","ExtendedHoursPrice":"562.16","DateTime":"2025-03-14 16:00:00","Symbol":"SPY","Volume":"62660321","Outcome":"Success","UTCOffset":"-4","Identifier":"SPY","Open":"556.11","High":"563.83","Low":"551.4917","LastSize":"2000","ExtendedHoursPercentChange":"-0.115","ISO8601":"2025-03-14T20:00:00Z"},"QQQ":{"Last":"479.66","LastSize":"1272588","Outcome":"Success","ExtendedHoursPercentChange":"-0.085","ISO8601":"2025-03-14T20:00:00Z","UTCOffset":"-4","Symbol":"QQQ","Open":"473.73","Volume":"43563010","PreviousCloseDate":"2025-03-13","PercentChange":"2.417","ExtendedHoursType":"PostMarket","DateTime":"2025-03-14 16:00:00","Identifier":"QQQ","High":"480.56","Low":"473.12","Change":"11.32","ExtendedHoursChange":"-0.41","Message":"Delay times are 15 mins for NASDAQ.","PreviousClose":"468.34","ExtendedHoursPrice":"479.25","ExtendedHoursDateTime":"2025-03-14 19:59:56","Type":"equity"},"ALT":{"Open":"5.39","Change":"0.72","Outcome":"Success","ExtendedHoursPercentChange":"1.691","Message":"Delay times are 15 mins for NASDAQ.","Identifier":"ALT","Volume":"12203885","PercentChange":"13.846","ExtendedHoursPrice":"6.0201","ExtendedHoursDateTime":"2025-03-14 19:59:51","ISO8601":"2025-03-14T20:00:00Z","High":"6.05","Low":"5.355","Last":"5.92","ExtendedHoursType":"PostMarket","ExtendedHoursChange":"0.1001","DateTime":"2025-03-14 16:00:00","UTCOffset":"-4","Symbol":"ALT","LastSize":"240412","PreviousClose":"5.2","PreviousCloseDate":"2025-03-13","Type":"equity"},"4CHAN.X":{"PercentChange":"0.099850","Change":"0.000000","Last":"0.000000","DateTime":"2025-03-15 09:48:31","Symbol":"4CHAN.X","symbol":"4CHAN.X","Identifier":"4CHAN.X","Type":"crypto","type":"crypto"},"XRP.X":{"Last":"2.4066021105","PercentChange":"6.8805092028","Symbol":"XRP.X","Type":"crypto","Change":"0.1549267317","DateTime":"2025-03-15 09:51:20","type":"crypto","symbol":"XRP.X","Identifier":"XRP.X"},"MUX":{"Identifier":"MUX","Volume":"734691","Outcome":"Success","ExtendedHoursType":"PostMarket","PreviousClose":"7.53","PercentChange":"-0.93","Change":"-0.07","ExtendedHoursPrice":"7.28","ExtendedHoursPercentChange":"-2.413","Symbol":"MUX","PreviousCloseDate":"2025-03-13","UTCOffset":"-4","DateTime":"2025-03-14 16:00:00","Open":"7.67","High":"7.69","Low":"7.36","Last":"7.46","LastSize":"86422","ExtendedHoursChange":"-0.18","ExtendedHoursDateTime":"2025-03-14 19:51:35","Message":"Delay times are 15 mins for NYSE.","ISO8601":"2025-03-14T20:00:00Z","Type":"equity"},"AVXL":{"Low":"9.07","Last":"9.43","ExtendedHoursPrice":"9.4683","UTCOffset":"-4","Type":"equity","LastSize":"88615","Volume":"909503","PreviousClose":"9","ExtendedHoursChange":"0.0383","Message":"Delay times are 15 mins for NASDAQ.","Symbol":"AVXL","ExtendedHoursDateTime":"2025-03-14 18:57:00","Identifier":"AVXL","Open":"9.14","PreviousCloseDate":"2025-03-13","PercentChange":"4.778","Change":"0.43","Outcome":"Success","High":"9.5","ExtendedHoursType":"PostMarket","ExtendedHoursPercentChange":"0.406","DateTime":"2025-03-14 16:00:00","ISO8601":"2025-03-14T20:00:00Z"},"QBTS":{"Symbol":"QBTS","Open":"7.7","Last":"10.15","PercentChange":"46.889","Change":"3.24","ExtendedHoursChange":"-0.1902","UTCOffset":"-4","Low":"7.62","PreviousClose":"6.91","Outcome":"Success","ExtendedHoursType":"PostMarket","ExtendedHoursPrice":"9.9598","ExtendedHoursPercentChange":"-1.874","Identifier":"QBTS","High":"10.2","Message":"Delay times are 15 mins for NYSE.","Type":"equity","LastSize":"665442","Volume":"261242342","PreviousCloseDate":"2025-03-13","ExtendedHoursDateTime":"2025-03-14 19:59:59","DateTime":"2025-03-14 16:00:00","ISO8601":"2025-03-14T20:00:00Z"},"GTBIF":{"High":"6.35","Volume":"531724","Type":"equity","UTCOffset":"-4","Open":"6.19","ISO8601":"2025-03-14T19:59:51Z","ExtendedHoursChange":"0","Message":"Delay times are 15 mins for OTHEROTC. You are not authorized to access OOTCBidAsk data (Data Group: OOTCBidAsk). Your user token is ******. Consider upgrading your subscription to gain access. Please visit http://www.xignite.com/Support/FAQ.aspx?faqtype=Topics\u0026faqcat=Subscriptions for more information. Your request was authenticated using an HTTP request parameter. Your token is ******. Please visit https://www.xignite.com/registration-help for more information. (superquotes.xignite.com: 20).","Identifier":"GTBIF","Low":"6.183","ExtendedHoursPercentChange":"0","Change":"0.0722","ExtendedHoursPrice":"0","Symbol":"GTBIF","LastSize":"200","Last":"6.26","Outcome":"Success","PreviousClose":"6.1878","PercentChange":"1.167","DateTime":"2025-03-14 15:59:51","PreviousCloseDate":"2025-03-13"},"TGTX":{"DateTime":"2025-03-14 16:00:00","Open":"37.5","Low":"37.4421","Last":"40.84","LastSize":"291253","Change":"3.78","ExtendedHoursPrice":"41","ExtendedHoursChange":"0.16","Symbol":"TGTX","Type":"equity","PreviousCloseDate":"2025-03-13","Outcome":"Success","ISO8601":"2025-03-14T20:00:00Z","Identifier":"TGTX","UTCOffset":"-4","Message":"Delay times are 15 mins for NASDAQ.","High":"41.8499","Volume":"4816712","PreviousClose":"37.06","PercentChange":"10.2","ExtendedHoursType":"PostMarket","ExtendedHoursPercentChange":"0.392","ExtendedHoursDateTime":"2025-03-14 19:56:29"},"PRO.X":{"Symbol":"PRO.X","symbol":"PRO.X","Change":"-0.0485","Last":"0.7496","PercentChange":"-6.0769327152","Identifier":"PRO.X","type":"crypto","Type":"crypto","DateTime":"2025-03-15 09:50:31"},"KSPI":{"ISO8601":"2025-03-14T20:00:00Z","Open":"97","PercentChange":"0.663","ExtendedHoursChange":"0","ExtendedHoursDateTime":"2025-03-14 16:48:57","Type":"equity","Volume":"247693","ExtendedHoursPercentChange":"0","DateTime":"2025-03-14 16:00:00","Message":"Delay times are 15 mins for NASDAQ.","Change":"0.63","Identifier":"KSPI","High":"97.21","Low":"95.39","PreviousClose":"94.99","ExtendedHoursType":"PostMarket","ExtendedHoursPrice":"95.62","UTCOffset":"-4","Symbol":"KSPI","Last":"95.62","LastSize":"8516","PreviousCloseDate":"2025-03-13","Outcome":"Success"},"KPTI":{"PreviousCloseDate":"2025-03-13","ExtendedHoursType":"PostMarket","ExtendedHoursDateTime":"2025-03-14 18:57:00","Identifier":"KPTI","High":"7.1511","Low":"6.75","Volume":"101786","PreviousClose":"6.94","ISO8601":"2025-03-14T20:00:00Z","Open":"7","Last":"6.75","LastSize":"630","Outcome":"Success","ExtendedHoursChange":"0.33","Change":"-0.19","UTCOffset":"-4","Symbol":"KPTI","Type":"equity","PercentChange":"-2.738","ExtendedHoursPrice":"7.08","ExtendedHoursPercentChange":"4.889","DateTime":"2025-03-14 16:00:00","Message":"Delay times are 15 mins for NASDAQ."},"WDAY":{"Last":"244.17","LastSize":"219463","ExtendedHoursPercentChange":"-0.008","ExtendedHoursDateTime":"2025-03-14 19:12:05","UTCOffset":"-4","Message":"Delay times are 15 mins for NASDAQ.","Identifier":"WDAY","Open":"239.57","Type":"equity","Outcome":"Success","ExtendedHoursPrice":"244.15","ExtendedHoursChange":"-0.02","ISO8601":"2025-03-14T20:00:00Z","Low":"238.55","PreviousCloseDate":"2025-03-13","PercentChange":"2.93","ExtendedHoursType":"PostMarket","DateTime":"2025-03-14 16:00:00","Symbol":"WDAY","High":"245.15","PreviousClose":"237.22","Volume":"1365935","Change":"6.95"},"VSTM":{"Outcome":"Success","ExtendedHoursDateTime":"2025-03-14 19:32:34","Identifier":"VSTM","Open":"7.39","Low":"6.95","ISO8601":"2025-03-14T20:00:00Z","High":"7.5","Volume":"424326","ExtendedHoursChange":"0.02","ExtendedHoursType":"PostMarket","ExtendedHoursPrice":"6.98","DateTime":"2025-03-14 16:00:00","Last":"6.96","PreviousClose":"7.21","PreviousCloseDate":"2025-03-13","ExtendedHoursPercentChange":"0.287","UTCOffset":"-4","Message":"Delay times are 15 mins for NASDAQ.","Symbol":"VSTM","Type":"equity","LastSize":"18274","PercentChange":"-3.467","Change":"-0.25"},"XLU":{"Open":"77.59","High":"78.96","Low":"77.31","Last":"78.87","PreviousCloseDate":"2025-03-13","Message":"Delay times are 15 mins for NYSEARCA.","Type":"equity","LastSize":"500","PreviousClose":"77.36","Change":"1.51","Outcome":"Success","ExtendedHoursPrice":"78.86","ExtendedHoursChange":"-0.01","UTCOffset":"-4","Identifier":"XLU","Volume":"9134951","PercentChange":"1.952","ExtendedHoursDateTime":"2025-03-14 19:17:22","DateTime":"2025-03-14 16:00:00","ISO8601":"2025-03-14T20:00:00Z","ExtendedHoursType":"PostMarket","ExtendedHoursPercentChange":"-0.013","Symbol":"XLU"},"WBD":{"Outcome":"Success","ExtendedHoursDateTime":"2025-03-14 19:51:16","UTCOffset":"-4","Symbol":"WBD","Type":"equity","PreviousCloseDate":"2025-03-13","PercentChange":"3.033","DateTime":"2025-03-14 16:00:00","Message":"Delay times are 15 mins for NASDAQ.","Identifier":"WBD","Open":"10.05","High":"10.38","Last":"10.19","LastSize":"2909813","Volume":"27637199","PreviousClose":"9.89","Change":"0.3","ExtendedHoursPrice":"10.1607","ExtendedHoursChange":"-0.0293","ExtendedHoursPercentChange":"-0.288","ISO8601":"2025-03-14T20:00:00Z","Low":"10.01","ExtendedHoursType":"PostMarket"},"SWKS":{"LastSize":"643086","Volume":"2866197","PreviousCloseDate":"2025-03-13","Outcome":"Success","ExtendedHoursPrice":"69.4","ExtendedHoursChange":"0","Identifier":"SWKS","Last":"69.4","ExtendedHoursPercentChange":"0","Message":"Delay times are 15 mins for NASDAQ.","Low":"67.895","Type":"equity","Open":"68.19","High":"69.605","ExtendedHoursType":"PostMarket","ISO8601":"2025-03-14T20:00:00Z","Symbol":"SWKS","PreviousClose":"67.19","Change":"2.21","DateTime":"2025-03-14 16:00:00","UTCOffset":"-4","PercentChange":"3.289","ExtendedHoursDateTime":"2025-03-14 19:59:54"},"EXEL":{"ExtendedHoursPercentChange":"0.682","ISO8601":"2025-03-14T20:00:00Z","Symbol":"EXEL","Last":"36.65","Volume":"1994311","PreviousClose":"36.8","PreviousCloseDate":"2025-03-13","ExtendedHoursPrice":"36.9","Message":"Delay times are 15 mins for NASDAQ.","DateTime":"2025-03-14 16:00:00","UTCOffset":"-4","Open":"36.78","Low":"36.41","LastSize":"258846","PercentChange":"-0.408","Change":"-0.15","ExtendedHoursDateTime":"2025-03-14 19:51:24","Identifier":"EXEL","High":"37.38","Outcome":"Success","ExtendedHoursType":"PostMarket","ExtendedHoursChange":"0.25","Type":"equity"},"DAX":{"Change":"1.13","ExtendedHoursType":"PostMarket","ExtendedHoursPercentChange":"1.129","ExtendedHoursDateTime":"2025-03-14 19:59:55","Identifier":"DAX","Open":"40.47","PreviousClose":"39.61","PercentChange":"2.853","High":"40.77","Low":"40.34","Volume":"391135","PreviousCloseDate":"2025-03-13","LastSize":"27031","Outcome":"Success","ExtendedHoursPrice":"41.2","Symbol":"DAX","Message":"Delay times are 15 mins for NASDAQ.","ISO8601":"2025-03-14T20:00:00Z","Type":"equity","Last":"40.74","ExtendedHoursChange":"0.46","DateTime":"2025-03-14 16:00:00","UTCOffset":"-4"},"KAS.X":{"PercentChange":"12.4335990236","Change":"0.0087997204","Last":"0.0795734395","DateTime":"2025-03-15 09:51:04","Symbol":"KAS.X","symbol":"KAS.X","Identifier":"KAS.X","Type":"crypto","type":"crypto"},"TSLY":{"LastSize":"6100","ExtendedHoursPercentChange":"0.822","ISO8601":"2025-03-14T20:00:00Z","Change":"0.28","ExtendedHoursType":"PostMarket","ExtendedHoursDateTime":"2025-03-14 19:59:39","UTCOffset":"-4","Identifier":"TSLY","Open":"8.42","High":"8.56","Last":"8.52","Message":"Delay times are 15 mins for NYSEARCA.","Type":"equity","Outcome":"Success","ExtendedHoursPrice":"8.59","DateTime":"2025-03-14 16:00:00","Low":"8.2544","Volume":"3922712","PreviousCloseDate":"2025-03-13","PercentChange":"3.398","PreviousClose":"8.24","ExtendedHoursChange":"0.07","Symbol":"TSLY"},"TRX.X":{"Change":"-0.0043044683","symbol":"TRX.X","PercentChange":"-1.9114318366","Identifier":"TRX.X","Symbol":"TRX.X","DateTime":"2025-03-15 09:51:10","Type":"crypto","Last":"0.2208915471","type":"crypto"},"SHEL":{"ExtendedHoursPercentChange":"-0.044","ExtendedHoursDateTime":"2025-03-14 19:56:19","LastSize":"222696","Volume":"3572376","PreviousClose":"67.74","ExtendedHoursType":"PostMarket","Last":"68.77","PreviousCloseDate":"2025-03-13","ExtendedHoursChange":"-0.0303","DateTime":"2025-03-14 16:00:00","ISO8601":"2025-03-14T20:00:00Z","Symbol":"SHEL","Change":"1.03","Outcome":"Success","ExtendedHoursPrice":"68.7397","Message":"Delay times are 15 mins for NYSE.","PercentChange":"1.521","UTCOffset":"-4","Type":"equity","Identifier":"SHEL","Open":"67.87","High":"68.795","Low":"67.71"},"NLY":{"LastSize":"553069","UTCOffset":"-4","ISO8601":"2025-03-14T20:00:00Z","Open":"21.21","Volume":"6241182","PreviousCloseDate":"2025-03-13","ExtendedHoursChange":"0.02","ExtendedHoursDateTime":"2025-03-14 19:51:59","Message":"Delay times are 15 mins for NYSE.","Last":"21.61","Outcome":"Success","ExtendedHoursType":"PostMarket","ExtendedHoursPrice":"21.63","Type":"equity","ExtendedHoursPercentChange":"0.093","DateTime":"2025-03-14 16:00:00","Identifier":"NLY","High":"21.64","Low":"21.19","PreviousClose":"21.1","PercentChange":"2.417","Change":"0.51","Symbol":"NLY"},"HMC":{"Volume":"1258955","ExtendedHoursChange":"-0.4","ExtendedHoursPercentChange":"-1.36","ExtendedHoursDateTime":"2025-03-14 19:52:48","Identifier":"HMC","Low":"29.2","LastSize":"122954","PreviousClose":"28.83","PercentChange":"2.046","Outcome":"Success","High":"29.48","Last":"29.42","Change":"0.59","ExtendedHoursType":"PostMarket","ExtendedHoursPrice":"29.02","ISO8601":"2025-03-14T20:00:00Z","Open":"29.3","DateTime":"2025-03-14 16:00:00","UTCOffset":"-4","Message":"Delay times are 15 mins for NYSE.","Symbol":"HMC","Type":"equity","PreviousCloseDate":"2025-03-13"},"SPIR":{"Message":"Delay times are 15 mins for NYSE.","Volume":"985048","PreviousCloseDate":"2025-03-13","ExtendedHoursPrice":"8.87","ExtendedHoursDateTime":"2025-03-14 19:16:06","DateTime":"2025-03-14 16:00:00","Symbol":"SPIR","Open":"9.12","Last":"8.57","Outcome":"Success","ExtendedHoursType":"PostMarket","UTCOffset":"-4","Type":"equity","Low":"8.47","PreviousClose":"8.87","ExtendedHoursChange":"0.3","ExtendedHoursPercentChange":"3.501","ISO8601":"2025-03-14T20:00:00Z","Identifier":"SPIR","High":"9.45","LastSize":"37297","PercentChange":"-3.382","Change":"-0.3"},"DRIFT.X":{"PercentChange":"8.5131778275","Change":"0.0430767328","Last":"0.5490773559","DateTime":"2025-03-15 09:50:37","Symbol":"DRIFT.X","symbol":"DRIFT.X","Identifier":"DRIFT.X","Type":"crypto","type":"crypto"},"ONON":{"ExtendedHoursPercentChange":"-0.732","Message":"Delay times are 15 mins for NYSE.","Type":"equity","Open":"47.17","PreviousClose":"46.37","Change":"0.07","UTCOffset":"-4","ISO8601":"2025-03-14T20:00:00Z","Symbol":"ONON","Last":"46.44","High":"47.6","Volume":"2816901","ExtendedHoursPrice":"46.1","ExtendedHoursChange":"-0.34","ExtendedHoursDateTime":"2025-03-14 19:56:57","Identifier":"ONON","LastSize":"183651","PreviousCloseDate":"2025-03-13","PercentChange":"0.151","Outcome":"Success","ExtendedHoursType":"PostMarket","DateTime":"2025-03-14 16:00:00","Low":"46.15"},"RBRK":{"Identifier":"RBRK","High":"71.2","LastSize":"262517","PreviousClose":"55.28","PercentChange":"27.786","Outcome":"Success","ExtendedHoursPrice":"70.64","ExtendedHoursPercentChange":"0","UTCOffset":"-4","Symbol":"RBRK","Open":"67.8","PreviousCloseDate":"2025-03-13","ExtendedHoursChange":"0","ExtendedHoursDateTime":"2025-03-14 19:59:53","DateTime":"2025-03-14 16:00:00","Message":"Delay times are 15 mins for NYSE.","Low":"64.8001","Change":"15.36","ExtendedHoursType":"PostMarket","ISO8601":"2025-03-14T20:00:00Z","Type":"equity","Last":"70.64","Volume":"7273318"},"REN.X":{"symbol":"REN.X","DateTime":"2025-03-15 09:39:51","Last":"0.0094999996","PercentChange":"2.1505492567","Change":"0.000200001","Type":"crypto","Symbol":"REN.X","Identifier":"REN.X","type":"crypto"},"MSTX":{"High":"28.9499","ExtendedHoursChange":"-0.11","UTCOffset":"-4","Symbol":"MSTX","Last":"28.71","Volume":"14141985","Change":"5.79","ExtendedHoursType":"PostMarket","Message":"Delay times are 15 mins for NASDAQ.","ISO8601":"2025-03-14T20:00:00Z","Identifier":"MSTX","Open":"24.58","LastSize":"6072","PreviousClose":"22.92","DateTime":"2025-03-14 16:00:00","ExtendedHoursPercentChange":"-0.383","ExtendedHoursDateTime":"2025-03-14 19:59:58","Type":"equity","Low":"24.48","PreviousCloseDate":"2025-03-13","PercentChange":"25.262","Outcome":"Success","ExtendedHoursPrice":"28.6"}}},"flags":{"COM-194":false,"COM-327":false,"COM-393":false,"COM-519":false,"COM-532":false,"COM-62":{"US":[{"DIA":"DOW"},{"SPY":"S\u0026P 500"},{"QQQ":"NASDAQ"},{"IWM":"iShares Russell 2000 Index ETF"},{"ARKK":"ARK Innovation"}]},"COM-63":false,"COMMUNITY-110":true,"COMMUNITY-48":true,"COMSOC-14":true,"COMSOC-274":true,"COMSOC-275":true,"COMSOC-284":false,"COMSOC-285":false,"COMSOC-459":true,"COMSOC-465":true,"COMSOC-473":true,"COMSOC-5":false,"COMSOC-522":true,"COMSOC-600":true,"CORE-2473":false,"CORE1-1020":true,"CORE1-1151":true,"CORE1-1194":true,"CORE1-1253":true,"CORE1-1254":true,"CORE1-1350":false,"CORE1-1411":{"apple":"https://stocktwits.onelink.me/NjIT/ttq0iuad","google":"https://stocktwits.onelink.me/NjIT/l3d56r44"},"CORE1-1412":true,"CORE1-1697":false,"CORE1-1724":true,"CORE1-1827":true,"CORE1-1832":true,"CORE1-1966":true,"CORE1-2233":true,"CORE1-2295":true,"CORE1-2392-display-edge-annual-plan":true,"CORE1-2392-display-edge-monthly-plan":true,"CORE1-2392-use-new-marketing-page":true,"CORE1-2456":false,"CORE1-2490":true,"CORE1-2503":false,"CORE1-2527":false,"CORE1-2632-subscriptions-plan-term_default":true,"CORE1-2676-show-edge-annual-earlyadopter-plan":false,"CORE1-2779":false,"CORE1-2790":true,"CORE1-2956":true,"CORE1-3050":true,"CORE1-3071":true,"CORE1-3159":false,"CORE1-3174":false,"CORE1-3187":true,"CORE1-3282":false,"CORE1-3327":true,"CORE1-3338":false,"CORE1-3348":false,"CORE1-3354":true,"CORE1-3359":true,"CORE1-3399":true,"CORE1-3453":true,"CORE1-3464":true,"CORE1-3477":true,"CORE1-3745":true,"CORE1-3746":true,"CORE1-3775":false,"CORE1-3775-test-panel":false,"CORE1-3803":true,"CORE1-3807":true,"CORE1-3860":false,"CORE1-3862-desktop":200,"CORE1-3862-mobile":200,"CORE1-3933":true,"CORE1-397":false,"CORE1-3980":true,"CORE1-4035":false,"CORE1-4235":true,"CORE1-4365":true,"CORE1-4368":false,"CORE1-4419":true,"CORE1-4601":true,"CORE1-4972":true,"CORE1-5045":true,"CORE1-5051":true,"CORE1-5095":true,"CORE1-5122":false,"CORE1-5340":true,"CORE1-5345":true,"CORE1-5368":true,"CORE1-5392":true,"CORE1-5455":false,"CORE1-5464":true,"CORE1-5538":true,"CORE1-5583":true,"CORE1-5625":false,"CORE1-5674":true,"CORE1-5686-home-page":false,"CORE1-5686-symbol-page":false,"CORE1-5690":true,"CORE1-5723":false,"CORE1-5754":false,"CORE1-641":false,"CORE1-671":true,"CORE1-795":false,"CORE1-864":false,"CORE1-873":true,"CORE1-873-modal":false,"DATATOOLS-137":true,"EVERY-100":true,"EVERY-110":false,"EVERY-126":false,"EVERY-144":true,"EVERY-150":true,"EVERY-178":"press-releases","EVERY-186":false,"EVERY-206":false,"EVERY-206-B":false,"EVERY-211":false,"EVERY-211-use-community-sentiment-flag-ssr":true,"EVERY-217":false,"EVERY-230":true,"EVERY-244-is-mounted-symbol-page-sidebar":false,"EVERY-250":true,"EVERY-254":0,"EVERY-254-initial-articles":false,"EVERY-274":true,"EVERY-291":false,"EVERY-3":true,"EVERY-337":false,"EVERY-353":true,"EVERY-369":{},"EVERY-4":true,"EVERY-79":"press-releases","EVERY-91":false,"GROWTH-1010":true,"GROWTH-1085":false,"GROWTH-1107":true,"GROWTH-1152":false,"GROWTH-1195":false,"GROWTH-1206":true,"GROWTH-1212":"Popular","GROWTH-1252":"Sentiment","GROWTH-1302":false,"GROWTH-1357":true,"GROWTH-1386":true,"GROWTH-1459":"suggested","GROWTH-1470":true,"GROWTH-1489":true,"GROWTH-1517":true,"GROWTH-1554":false,"GROWTH-1568":true,"GROWTH-1570":true,"GROWTH-1601":true,"GROWTH-1623":true,"GROWTH-1643":"trending","GROWTH-1651":true,"GROWTH-1652":true,"GROWTH-1701":true,"GROWTH-1717":true,"GROWTH-1749":true,"GROWTH-1750":false,"GROWTH-1751":false,"GROWTH-1751-right-rail":false,"GROWTH-1797":"A","GROWTH-1852":false,"GROWTH-1893":true,"GROWTH-1984":false,"GROWTH-2069":true,"GROWTH-2074":true,"GROWTH-2097":true,"GROWTH-2138":true,"GROWTH-2173":true,"GROWTH-2197":true,"GROWTH-2220-side-bar-mid-left-ad-home-page":true,"GROWTH-2220-side-bar-mid-left-ad-symbol-page":false,"GROWTH-2220-side-bar-top-left-ad-home-page":true,"GROWTH-2220-side-bar-top-left-ad-symbol-page":false,"GROWTH-2245":true,"GROWTH-2246":true,"GROWTH-2273":true,"GROWTH-2304-Pre-tick-Newsletter-email-sign-up":true,"GROWTH-2304-Pre-tick-newsletter-google-apple-sign-up":true,"GROWTH-2309":true,"GROWTH-2369":true,"GROWTH-2394":false,"GROWTH-2394-scrolling-mobile-navbar":true,"GROWTH-2399":true,"GROWTH-2403-delaying-ad-query-params":false,"GROWTH-2403-hiding-left-rail-units-when-no-ad-fills":true,"GROWTH-2416":false,"GROWTH-2537":true,"GROWTH-2538":true,"GROWTH-2568":false,"GROWTH-2585-show-replies-in-following-stream":false,"GROWTH-2592":true,"GROWTH-2626-IN-unauthed-watchlist":{"symbols":[{"symbol":"NIFTY50.NSE","title":"Nifty 50","id":13409},{"symbol":"NIFTYBANK.NSE","title":"Nifty Bank","id":20004},{"id":19618,"symbol":"RELIANCE.NSE","title":"Reliance Industries Ltd."},{"title":"Zomato Ltd.","id":19706,"symbol":"ZOMATO.NSE"},{"title":"Tata Consultancy Services","id":19623,"symbol":"TCS.NSE"},{"symbol":"TATAMOTORS.NSE","title":"Tata Motors Ltd.","id":19466},{"id":19599,"symbol":"HDFCBANK.NSE","title":"HDFC Bank Ltd."},{"id":19608,"symbol":"ITC.NSE","title":"ITC Ltd."},{"id":11418,"symbol":"BTC.X","title":"Bitcoin"},{"symbol":"ADANIENT.NSE","title":"Adani Enterprises Ltd","id":19792},{"title":"Axis Bank Ltd","id":19584,"symbol":"AXISBANK.NSE"},{"title":"Bajaj Finance Ltd","id":19586,"symbol":"BAJFINANCE.NSE"}],"id":4673581,"name":"statis IN Watchlist","static":true},"GROWTH-2626-US-unauthed-watchlist":{"id":4673580,"name":"statis US Watchlist","static":true,"symbols":[{"title":"SPDR S\u0026P 500 ETF","id":7271,"symbol":"SPY"},{"title":"Invesco QQQ Trust Series 1","id":9581,"symbol":"QQQ"},{"id":11418,"symbol":"BTC.X","title":"Bitcoin"},{"id":686,"symbol":"AAPL","title":"Apple Inc."},{"symbol":"TSLA","title":"Tesla Inc","id":8660},{"symbol":"MSFT","title":"Microsoft Corporation","id":2735},{"id":2925,"symbol":"NVDA","title":"NVIDIA Corp"}]},"GROWTH-2687":"1","GROWTH-2691":false,"GROWTH-2698":false,"GROWTH-2704":true,"GROWTH-2705":true,"GROWTH-2710":true,"GROWTH-2712":true,"GROWTH-2739":false,"GROWTH-2744":1,"GROWTH-2753":false,"GROWTH-2761":true,"GROWTH-2784":true,"GROWTH-2801":true,"GROWTH-2809":0,"GROWTH-2814":false,"GROWTH-2840":true,"GROWTH-2882":true,"GROWTH-2904":true,"GROWTH-2917":true,"GROWTH-2951":false,"GROWTH-2970":true,"GROWTH-2992":true,"GROWTH-3030":2,"GROWTH-3051":true,"GROWTH-3056":true,"GROWTH-3086":true,"GROWTH-3150":true,"GROWTH-3184":true,"GROWTH-3197":true,"GROWTH-3264":false,"GROWTH-3349":true,"GROWTH-3413":true,"GROWTH-3536":true,"GROWTH-3536-cta":false,"GROWTH-3623":true,"GROWTH-3629":true,"GROWTH-3650":false,"GROWTH-788-animation":false,"GROWTH-788-toast":false,"GROWTH-795":true,"GROWTH-832":true,"GROWTH-881":false,"GROWTH-882":true,"GROWTH-891":true,"GROWTH-899":true,"GROWTH-904":true,"GROWTH-905":true,"GROWTH-914":true,"GROWTH-920":"market://details?id=org.stocktwits.android.activity\u0026referrer={code}","GROWTH-921":"https://apps.apple.com/app/id389157776","GROWTH-941":false,"GROWTH-942":false,"GROWTH-984":"Want to stay ahead of the game in the stock market? Join the Stocktwits community and connect with traders from around the world. Sign up with my referral link today!","GROWTH-985":"{ \"body\": \" Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below \\n \\n\", \"subject\": \" has invited you to join Stocktwits\" }","GROWTH-986":"Want to stay ahead of the game in the stock market? Join the Stocktwits community and connect with traders from around the world. Sign up with my referral link today!","POR-114":false,"POR-467":false,"POR-92":false,"PORT-76":false,"TRADING-2595":true,"TRADING-2664":false,"TRADING-2744":true,"TRADING-2988":true,"TRADING-3061":false,"TRADING-3663":false,"TRADING-4125":false,"TRADING-4133":false,"TRADING-4145":true,"TRADING-4146":true,"TRADING-4363":false,"TRADING-4520":false,"TRADING-4583":false,"TRADING-4592":false,"TRADING-4596":false,"TRADING-4621":false,"TRADING-4626":false,"TRADING-4689":false,"TRADING-4700":false,"WEB-1018":false,"WEB-1020":true,"WEB-1022":true,"WEB-1031":true,"WEB-1040":true,"WEB-1045":true,"WEB-1057":false,"WEB-1073":true,"WEB-1090":false,"WEB-1091":true,"WEB-1092":false,"WEB-1141":false,"WEB-1159":false,"WEB-1167":true,"WEB-1176":false,"WEB-1191":false,"WEB-1244":true,"WEB-1247":true,"WEB-1302":false,"WEB-1304":true,"WEB-1348":false,"WEB-1416":true,"WEB-1429":true,"WEB-1431":true,"WEB-1441":true,"WEB-1446":600,"WEB-1447":true,"WEB-1450":false,"WEB-1474":true,"WEB-1476":2000,"WEB-1487":true,"WEB-1514":true,"WEB-1524":false,"WEB-1525":false,"WEB-1543":false,"WEB-1564":false,"WEB-1573":true,"WEB-1583":false,"WEB-1584":false,"WEB-1596":false,"WEB-1597":true,"WEB-1604":false,"WEB-1612":false,"WEB-1633":false,"WEB-1639":true,"WEB-1640":false,"WEB-1649":true,"WEB-1650":false,"WEB-1651":true,"WEB-1657":true,"WEB-1659":false,"WEB-1666":true,"WEB-1668":false,"WEB-1671":true,"WEB-1674":true,"WEB-1678":true,"WEB-1679":false,"WEB-1680":true,"WEB-1682":true,"WEB-1695":true,"WEB-17":false,"WEB-1700":true,"WEB-1702":true,"WEB-1715":true,"WEB-1717":true,"WEB-1718":false,"WEB-1722":true,"WEB-1723":true,"WEB-1725":false,"WEB-1726":true,"WEB-1730":false,"WEB-1756":false,"WEB-1759":true,"WEB-1763":false,"WEB-1782":30,"WEB-1783":true,"WEB-1784":true,"WEB-1786":true,"WEB-1789":true,"WEB-1823":true,"WEB-1838":false,"WEB-1853":false,"WEB-1855":false,"WEB-1891":true,"WEB-1895":true,"WEB-1896":false,"WEB-1898":true,"WEB-1899":true,"WEB-1900":true,"WEB-1902":false,"WEB-1904":true,"WEB-1909":true,"WEB-1910":true,"WEB-1911":true,"WEB-1913":true,"WEB-1915":true,"WEB-1916":false,"WEB-1918":true,"WEB-1919":true,"WEB-1923":true,"WEB-1925":true,"WEB-1944":true,"WEB-1948":true,"WEB-1958":false,"WEB-1965":true,"WEB-2013":false,"WEB-2014":true,"WEB-2016":false,"WEB-2025":true,"WEB-2027":true,"WEB-2031":true,"WEB-2075":false,"WEB-2113":true,"WEB-2114":false,"WEB-2143":false,"WEB-2147":true,"WEB-2164":true,"WEB-2170":true,"WEB-2173":true,"WEB-2176":true,"WEB-2177":true,"WEB-2181":true,"WEB-2185":true,"WEB-2189":false,"WEB-2211":true,"WEB-2212":true,"WEB-2215":true,"WEB-2226":false,"WEB-2236":false,"WEB-2242":true,"WEB-2243":false,"WEB-2245":true,"WEB-2301":true,"WEB-2307":true,"WEB-347":false,"WEB-565":true,"WEB-654":["crazyegg"],"WEB-692":true,"WEB-742":false,"WEB-757":true,"WEB-759":true,"WEB-803":true,"WEB-806":false,"WEB-885":true,"WEB-886":true,"WEB-890":false,"WEB-912":true,"WEB-930":false,"WEB-980":false,"WEB-989":true,"WEB-990":true,"WEB-991":false,"WEB-992":3500,"WEB-994":true,"WEB-IO-DMS":false,"core-1-609-display-non-price-indicators-in-price-alerts":false,"core-1-663":false,"core-1-809":false,"core-1-889":true,"core-1-940-ios-trending-enabled":false,"core-1-947":false,"web-1368-autofocus-on-mobile-web-post-box":false,"web-1690-hide-show-indices-data-box-on-mobile-tablet-carousel":false,"web-1728-add-loader-icon-in-mobile-watchlist":false,"web-1907-grey-sparklines-on-rankings":true,"web-1950-remove-preload-image-on-conversation-page":true,"web-2035-web-version-in-footer":false,"web-2060-unblock-user-from-messages":true,"web-2091-reshared-message-notifications-do-not-fit-in-mobile-web":false,"web-2106-search-menu-does-not-scroll-on-mobile-web":false},"invalidateKeys":[["fetchIndices","ALL"],["fetchRankings","trending",15,"ALL",null,1,null,0],["fetchBatchSymbolData","4CHAN.X","ALT","AVXL","DIA","GTBIF","KPTI","KSPI","MUX","PRO.X","QBTS","QQQ","SPY","TGTX","VSTM","WBD","WDAY","XLU","XRP.X"]],"regionSSR":"ALL","serverAsPath":"/symbol/CADL","serverPathname":"/symbol/[symbol]/[[...tab]]","userData":{"cfCountry":"SG","isAuthenticated":false}},"deviceContext":{"desktop":true,"desktopDown":false,"mobile":false,"screen":false,"tablet":false,"tabletUp":true,"family":"other"},"flags":{"COM-194":false,"COM-327":false,"COM-393":false,"COM-519":false,"COM-532":false,"COM-62":{"US":[{"DIA":"DOW"},{"SPY":"S\u0026P 500"},{"QQQ":"NASDAQ"},{"IWM":"iShares Russell 2000 Index ETF"},{"ARKK":"ARK Innovation"}]},"COM-63":false,"COMMUNITY-110":true,"COMMUNITY-48":true,"COMSOC-14":true,"COMSOC-274":true,"COMSOC-275":true,"COMSOC-284":false,"COMSOC-285":false,"COMSOC-459":true,"COMSOC-465":true,"COMSOC-473":true,"COMSOC-5":false,"COMSOC-522":true,"COMSOC-600":true,"CORE-2473":false,"CORE1-1020":true,"CORE1-1151":true,"CORE1-1194":true,"CORE1-1253":true,"CORE1-1254":true,"CORE1-1350":false,"CORE1-1411":{"apple":"https://stocktwits.onelink.me/NjIT/ttq0iuad","google":"https://stocktwits.onelink.me/NjIT/l3d56r44"},"CORE1-1412":true,"CORE1-1697":false,"CORE1-1724":true,"CORE1-1827":true,"CORE1-1832":true,"CORE1-1966":true,"CORE1-2233":true,"CORE1-2295":true,"CORE1-2392-display-edge-annual-plan":true,"CORE1-2392-display-edge-monthly-plan":true,"CORE1-2392-use-new-marketing-page":true,"CORE1-2456":false,"CORE1-2490":true,"CORE1-2503":false,"CORE1-2527":false,"CORE1-2632-subscriptions-plan-term_default":true,"CORE1-2676-show-edge-annual-earlyadopter-plan":false,"CORE1-2779":false,"CORE1-2790":true,"CORE1-2956":true,"CORE1-3050":true,"CORE1-3071":true,"CORE1-3159":false,"CORE1-3174":false,"CORE1-3187":true,"CORE1-3282":false,"CORE1-3327":true,"CORE1-3338":false,"CORE1-3348":false,"CORE1-3354":true,"CORE1-3359":true,"CORE1-3399":true,"CORE1-3453":true,"CORE1-3464":true,"CORE1-3477":true,"CORE1-3745":true,"CORE1-3746":true,"CORE1-3775":false,"CORE1-3775-test-panel":false,"CORE1-3803":true,"CORE1-3807":true,"CORE1-3860":false,"CORE1-3862-desktop":200,"CORE1-3862-mobile":200,"CORE1-3933":true,"CORE1-397":false,"CORE1-3980":true,"CORE1-4035":false,"CORE1-4235":true,"CORE1-4365":true,"CORE1-4368":false,"CORE1-4419":true,"CORE1-4601":true,"CORE1-4972":true,"CORE1-5045":true,"CORE1-5051":true,"CORE1-5095":true,"CORE1-5122":false,"CORE1-5340":true,"CORE1-5345":true,"CORE1-5368":true,"CORE1-5392":true,"CORE1-5455":false,"CORE1-5464":true,"CORE1-5538":true,"CORE1-5583":true,"CORE1-5625":false,"CORE1-5674":true,"CORE1-5686-home-page":false,"CORE1-5686-symbol-page":false,"CORE1-5690":true,"CORE1-5723":false,"CORE1-5754":false,"CORE1-641":false,"CORE1-671":true,"CORE1-795":false,"CORE1-864":false,"CORE1-873":true,"CORE1-873-modal":false,"DATATOOLS-137":true,"EVERY-100":true,"EVERY-110":false,"EVERY-126":false,"EVERY-144":true,"EVERY-150":true,"EVERY-178":"press-releases","EVERY-186":false,"EVERY-206":false,"EVERY-206-B":false,"EVERY-211":false,"EVERY-211-use-community-sentiment-flag-ssr":true,"EVERY-217":false,"EVERY-230":true,"EVERY-244-is-mounted-symbol-page-sidebar":false,"EVERY-250":true,"EVERY-254":0,"EVERY-254-initial-articles":false,"EVERY-274":true,"EVERY-291":false,"EVERY-3":true,"EVERY-337":false,"EVERY-353":true,"EVERY-369":{},"EVERY-4":true,"EVERY-79":"press-releases","EVERY-91":false,"GROWTH-1010":true,"GROWTH-1085":false,"GROWTH-1107":true,"GROWTH-1152":false,"GROWTH-1195":false,"GROWTH-1206":true,"GROWTH-1212":"Popular","GROWTH-1252":"Sentiment","GROWTH-1302":false,"GROWTH-1357":true,"GROWTH-1386":true,"GROWTH-1459":"suggested","GROWTH-1470":true,"GROWTH-1489":true,"GROWTH-1517":true,"GROWTH-1554":false,"GROWTH-1568":true,"GROWTH-1570":true,"GROWTH-1601":true,"GROWTH-1623":true,"GROWTH-1643":"trending","GROWTH-1651":true,"GROWTH-1652":true,"GROWTH-1701":true,"GROWTH-1717":true,"GROWTH-1749":true,"GROWTH-1750":false,"GROWTH-1751":false,"GROWTH-1751-right-rail":false,"GROWTH-1797":"A","GROWTH-1852":false,"GROWTH-1893":true,"GROWTH-1984":false,"GROWTH-2069":true,"GROWTH-2074":true,"GROWTH-2097":true,"GROWTH-2138":true,"GROWTH-2173":true,"GROWTH-2197":true,"GROWTH-2220-side-bar-mid-left-ad-home-page":true,"GROWTH-2220-side-bar-mid-left-ad-symbol-page":false,"GROWTH-2220-side-bar-top-left-ad-home-page":true,"GROWTH-2220-side-bar-top-left-ad-symbol-page":false,"GROWTH-2245":true,"GROWTH-2246":true,"GROWTH-2273":true,"GROWTH-2304-Pre-tick-Newsletter-email-sign-up":true,"GROWTH-2304-Pre-tick-newsletter-google-apple-sign-up":true,"GROWTH-2309":true,"GROWTH-2369":true,"GROWTH-2394":false,"GROWTH-2394-scrolling-mobile-navbar":true,"GROWTH-2399":true,"GROWTH-2403-delaying-ad-query-params":false,"GROWTH-2403-hiding-left-rail-units-when-no-ad-fills":true,"GROWTH-2416":false,"GROWTH-2537":true,"GROWTH-2538":true,"GROWTH-2568":false,"GROWTH-2585-show-replies-in-following-stream":false,"GROWTH-2592":true,"GROWTH-2626-IN-unauthed-watchlist":{"symbols":[{"symbol":"NIFTY50.NSE","title":"Nifty 50","id":13409},{"symbol":"NIFTYBANK.NSE","title":"Nifty Bank","id":20004},{"id":19618,"symbol":"RELIANCE.NSE","title":"Reliance Industries Ltd."},{"title":"Zomato Ltd.","id":19706,"symbol":"ZOMATO.NSE"},{"title":"Tata Consultancy Services","id":19623,"symbol":"TCS.NSE"},{"symbol":"TATAMOTORS.NSE","title":"Tata Motors Ltd.","id":19466},{"id":19599,"symbol":"HDFCBANK.NSE","title":"HDFC Bank Ltd."},{"id":19608,"symbol":"ITC.NSE","title":"ITC Ltd."},{"id":11418,"symbol":"BTC.X","title":"Bitcoin"},{"symbol":"ADANIENT.NSE","title":"Adani Enterprises Ltd","id":19792},{"title":"Axis Bank Ltd","id":19584,"symbol":"AXISBANK.NSE"},{"title":"Bajaj Finance Ltd","id":19586,"symbol":"BAJFINANCE.NSE"}],"id":4673581,"name":"statis IN Watchlist","static":true},"GROWTH-2626-US-unauthed-watchlist":{"id":4673580,"name":"statis US Watchlist","static":true,"symbols":[{"title":"SPDR S\u0026P 500 ETF","id":7271,"symbol":"SPY"},{"title":"Invesco QQQ Trust Series 1","id":9581,"symbol":"QQQ"},{"id":11418,"symbol":"BTC.X","title":"Bitcoin"},{"id":686,"symbol":"AAPL","title":"Apple Inc."},{"symbol":"TSLA","title":"Tesla Inc","id":8660},{"symbol":"MSFT","title":"Microsoft Corporation","id":2735},{"id":2925,"symbol":"NVDA","title":"NVIDIA Corp"}]},"GROWTH-2687":"1","GROWTH-2691":false,"GROWTH-2698":false,"GROWTH-2704":true,"GROWTH-2705":true,"GROWTH-2710":true,"GROWTH-2712":true,"GROWTH-2739":false,"GROWTH-2744":1,"GROWTH-2753":false,"GROWTH-2761":true,"GROWTH-2784":true,"GROWTH-2801":true,"GROWTH-2809":0,"GROWTH-2814":false,"GROWTH-2840":true,"GROWTH-2882":true,"GROWTH-2904":true,"GROWTH-2917":true,"GROWTH-2951":false,"GROWTH-2970":true,"GROWTH-2992":true,"GROWTH-3030":2,"GROWTH-3051":true,"GROWTH-3056":true,"GROWTH-3086":true,"GROWTH-3150":true,"GROWTH-3184":true,"GROWTH-3197":true,"GROWTH-3264":false,"GROWTH-3349":true,"GROWTH-3413":true,"GROWTH-3536":true,"GROWTH-3536-cta":false,"GROWTH-3623":true,"GROWTH-3629":true,"GROWTH-3650":false,"GROWTH-788-animation":false,"GROWTH-788-toast":false,"GROWTH-795":true,"GROWTH-832":true,"GROWTH-881":false,"GROWTH-882":true,"GROWTH-891":true,"GROWTH-899":true,"GROWTH-904":true,"GROWTH-905":true,"GROWTH-914":true,"GROWTH-920":"market://details?id=org.stocktwits.android.activity\u0026referrer={code}","GROWTH-921":"https://apps.apple.com/app/id389157776","GROWTH-941":false,"GROWTH-942":false,"GROWTH-984":"Want to stay ahead of the game in the stock market? Join the Stocktwits community and connect with traders from around the world. Sign up with my referral link today!","GROWTH-985":"{ \"body\": \" Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below \\n \\n\", \"subject\": \" has invited you to join Stocktwits\" }","GROWTH-986":"Want to stay ahead of the game in the stock market? Join the Stocktwits community and connect with traders from around the world. Sign up with my referral link today!","POR-114":false,"POR-467":false,"POR-92":false,"PORT-76":false,"TRADING-2595":true,"TRADING-2664":false,"TRADING-2744":true,"TRADING-2988":true,"TRADING-3061":false,"TRADING-3663":false,"TRADING-4125":false,"TRADING-4133":false,"TRADING-4145":true,"TRADING-4146":true,"TRADING-4363":false,"TRADING-4520":false,"TRADING-4583":false,"TRADING-4592":false,"TRADING-4596":false,"TRADING-4621":false,"TRADING-4626":false,"TRADING-4689":false,"TRADING-4700":false,"WEB-1018":false,"WEB-1020":true,"WEB-1022":true,"WEB-1031":true,"WEB-1040":true,"WEB-1045":true,"WEB-1057":false,"WEB-1073":true,"WEB-1090":false,"WEB-1091":true,"WEB-1092":false,"WEB-1141":false,"WEB-1159":false,"WEB-1167":true,"WEB-1176":false,"WEB-1191":false,"WEB-1244":true,"WEB-1247":true,"WEB-1302":false,"WEB-1304":true,"WEB-1348":false,"WEB-1416":true,"WEB-1429":true,"WEB-1431":true,"WEB-1441":true,"WEB-1446":600,"WEB-1447":true,"WEB-1450":false,"WEB-1474":true,"WEB-1476":2000,"WEB-1487":true,"WEB-1514":true,"WEB-1524":false,"WEB-1525":false,"WEB-1543":false,"WEB-1564":false,"WEB-1573":true,"WEB-1583":false,"WEB-1584":false,"WEB-1596":false,"WEB-1597":true,"WEB-1604":false,"WEB-1612":false,"WEB-1633":false,"WEB-1639":true,"WEB-1640":false,"WEB-1649":true,"WEB-1650":false,"WEB-1651":true,"WEB-1657":true,"WEB-1659":false,"WEB-1666":true,"WEB-1668":false,"WEB-1671":true,"WEB-1674":true,"WEB-1678":true,"WEB-1679":false,"WEB-1680":true,"WEB-1682":true,"WEB-1695":true,"WEB-17":false,"WEB-1700":true,"WEB-1702":true,"WEB-1715":true,"WEB-1717":true,"WEB-1718":false,"WEB-1722":true,"WEB-1723":true,"WEB-1725":false,"WEB-1726":true,"WEB-1730":false,"WEB-1756":false,"WEB-1759":true,"WEB-1763":false,"WEB-1782":30,"WEB-1783":true,"WEB-1784":true,"WEB-1786":true,"WEB-1789":true,"WEB-1823":true,"WEB-1838":false,"WEB-1853":false,"WEB-1855":false,"WEB-1891":true,"WEB-1895":true,"WEB-1896":false,"WEB-1898":true,"WEB-1899":true,"WEB-1900":true,"WEB-1902":false,"WEB-1904":true,"WEB-1909":true,"WEB-1910":true,"WEB-1911":true,"WEB-1913":true,"WEB-1915":true,"WEB-1916":false,"WEB-1918":true,"WEB-1919":true,"WEB-1923":true,"WEB-1925":true,"WEB-1944":true,"WEB-1948":true,"WEB-1958":false,"WEB-1965":true,"WEB-2013":false,"WEB-2014":true,"WEB-2016":false,"WEB-2025":true,"WEB-2027":true,"WEB-2031":true,"WEB-2075":false,"WEB-2113":true,"WEB-2114":false,"WEB-2143":false,"WEB-2147":true,"WEB-2164":true,"WEB-2170":true,"WEB-2173":true,"WEB-2176":true,"WEB-2177":true,"WEB-2181":true,"WEB-2185":true,"WEB-2189":false,"WEB-2211":true,"WEB-2212":true,"WEB-2215":true,"WEB-2226":false,"WEB-2236":false,"WEB-2242":true,"WEB-2243":false,"WEB-2245":true,"WEB-2301":true,"WEB-2307":true,"WEB-347":false,"WEB-565":true,"WEB-654":["crazyegg"],"WEB-692":true,"WEB-742":false,"WEB-757":true,"WEB-759":true,"WEB-803":true,"WEB-806":false,"WEB-885":true,"WEB-886":true,"WEB-890":false,"WEB-912":true,"WEB-930":false,"WEB-980":false,"WEB-989":true,"WEB-990":true,"WEB-991":false,"WEB-992":3500,"WEB-994":true,"WEB-IO-DMS":false,"core-1-609-display-non-price-indicators-in-price-alerts":false,"core-1-663":false,"core-1-809":false,"core-1-889":true,"core-1-940-ios-trending-enabled":false,"core-1-947":false,"web-1368-autofocus-on-mobile-web-post-box":false,"web-1690-hide-show-indices-data-box-on-mobile-tablet-carousel":false,"web-1728-add-loader-icon-in-mobile-watchlist":false,"web-1907-grey-sparklines-on-rankings":true,"web-1950-remove-preload-image-on-conversation-page":true,"web-2035-web-version-in-footer":false,"web-2060-unblock-user-from-messages":true,"web-2091-reshared-message-notifications-do-not-fit-in-mobile-web":false,"web-2106-search-menu-does-not-scroll-on-mobile-web":false},"isSymbolPage":true,"symbolTab":"feed","userData":{"cfCountry":"SG","isAuthenticated":false}},"page":"/symbol/[symbol]/[[...tab]]","query":{"symbol":"CADL"},"buildId":"WXsZwB9OA8hIuXCTVBkbf","assetPrefix":"https://chunks-prd.stocktwits-cdn.com","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[51499,88195],"gssp":true,"appGip":true,"scriptLoader":[]}</script></body></html>